"gene","baseMean","log2FoldChange","lfcSE","stat","pvalue","padj","start","end","saccver","spid","gene_uni","evalue","protein_names","gene_ontology_biological_process","gene_ontology_i_ds"
"g30042",102.836066252272,5.95582909803547,0.749369336167303,7.94778864117517,1.8987023338546e-15,1.0678681666065e-10,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12054",655.427997846771,8.22128550457213,1.106729808782,7.42844860537369,1.09878758225087e-13,3.08990056004768e-09,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29611",80.3458877166156,4.51435205384072,0.617137470594569,7.31498615615003,2.5740792787853e-13,3.9653748057656e-09,0,35434,"sp|B3EWZ5|MLRP1_ACRMI","B3EWZ5","MLRP1",9.38e-173,"MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment)",NA,"GO:0005576; GO:0016020"
"g30043",241.464053049787,6.34075273917339,0.86827357591286,7.30271301013282,2.82022318250816e-13,3.9653748057656e-09,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52273",45.7311305577461,6.56251001482542,0.904745951427315,7.25342843974321,4.0635211415742e-13,4.57081112088832e-09,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55150",441.250151675037,6.50980341003641,0.907549473055798,7.17294605231529,7.3400783500708e-13,6.88034477607803e-09,0,9464,"sp|Q4R4T8|LGMN_MACFA","Q4R4T8","LGMN",5.67e-32,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)","negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]","GO:0003014; GO:0004197; GO:0005764; GO:0006508; GO:0032801; GO:0051603; GO:1901185"
"g11730",138.486666534113,6.5680658524124,0.93083497304502,7.05610128820841,1.71239027816321e-12,1.37583220034936e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11904",93.0112242476842,3.82856010708331,0.556337008115288,6.88172825326394,5.91307330853265e-12,4.15703836273117e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36661",59.4018347297661,6.26750015010448,0.921737909460196,6.79965539637505,1.04869692810436e-11,6.55342362560502e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103777",72.1665996518102,4.36360251703264,0.646601105375532,6.74852313235431,1.49357590917946e-11,8.40016962840712e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52187",52.9965323211327,6.35070063163453,0.966069524647968,6.57375113240292,4.9063211288055e-11,2.5085573902389e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67692",47.362014385733,4.45605122058763,0.683159312204164,6.52271167351947,6.90475168540072e-11,3.23614203575256e-07,0,11389,"sp|P22985|XDH_RAT","P22985","XDH",2.67e-11,"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; aging [GO:0007568]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; response to azide [GO:0097184]; response to carbon monoxide [GO:0034465]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; xanthine catabolic process [GO:0009115]","GO:0000255; GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006147; GO:0006148; GO:0006149; GO:0006154; GO:0006157; GO:0006161; GO:0006196; GO:0006204; GO:0006919; GO:0007568; GO:0007595; GO:0009114; GO:0009115; GO:0009408; GO:0010044; GO:0010629; GO:0016226; GO:0016491; GO:0016529; GO:0030856; GO:0032496; GO:0034465; GO:0042542; GO:0042802; GO:0042803; GO:0043546; GO:0045602; GO:0046038; GO:0046055; GO:0046059; GO:0050421; GO:0050660; GO:0051537; GO:0051898; GO:0070674; GO:0070675; GO:0071347; GO:0071356; GO:0071949; GO:0097184; GO:1900745; GO:1900747; GO:2000379; GO:2001213"
"g23420",56.1104291794293,3.80405990903382,0.584724025379899,6.50573560161532,7.73141060178614e-11,3.34484611588966e-07,0,32832,"sp|B3EWZ6|MLRP2_ACRMI","B3EWZ6","MLRP2",0,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)",NA,"GO:0005576; GO:0016020"
"g96133",24.3926282054693,3.92935267516131,0.621131531309922,6.32612011641816,2.51402146922115e-10,1.00995425337097e-06,1193,6945,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.5e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g68732",53.5885092873462,4.33386938382435,0.692544958404699,6.25788886516128,3.90223727522139e-10,1.37168518020626e-06,0,11159,"sp|P22985|XDH_RAT","P22985","XDH",2.61e-11,"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; aging [GO:0007568]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; response to azide [GO:0097184]; response to carbon monoxide [GO:0034465]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; xanthine catabolic process [GO:0009115]","GO:0000255; GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006147; GO:0006148; GO:0006149; GO:0006154; GO:0006157; GO:0006161; GO:0006196; GO:0006204; GO:0006919; GO:0007568; GO:0007595; GO:0009114; GO:0009115; GO:0009408; GO:0010044; GO:0010629; GO:0016226; GO:0016491; GO:0016529; GO:0030856; GO:0032496; GO:0034465; GO:0042542; GO:0042802; GO:0042803; GO:0043546; GO:0045602; GO:0046038; GO:0046055; GO:0046059; GO:0050421; GO:0050660; GO:0051537; GO:0051898; GO:0070674; GO:0070675; GO:0071347; GO:0071356; GO:0071949; GO:0097184; GO:1900745; GO:1900747; GO:2000379; GO:2001213"
"g146797",21.5004246539841,4.73979814418283,0.757272350174106,6.25904028199774,3.87353818300736e-10,1.37168518020626e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29384",105.195659022056,2.54434593246015,0.41140816908654,6.18448082377514,6.23071864163693e-10,2.06134163437026e-06,0,36208,"sp|B3EWZ5|MLRP1_ACRMI","B3EWZ5","MLRP1",1.16e-172,"MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment)",NA,"GO:0005576; GO:0016020"
"g122771",31.8349645954176,4.63497841985056,0.756138288113274,6.12980256748514,8.798819220217e-10,2.7492399476858e-06,0,4239,"sp|B3EWZ6|MLRP2_ACRMI","B3EWZ6","MLRP2",1.85e-128,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)",NA,"GO:0005576; GO:0016020"
"g58468",38.3672066208464,2.43462226317646,0.400927627281919,6.07247317846849,1.25955141265053e-09,3.72840476580481e-06,0,13937,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.03e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g9738",115.413020120168,3.26998516376613,0.540185250411829,6.05345140629653,1.41774853731747e-09,3.98685066179045e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41900",182.50243307106,0.706091943499758,0.117757084293776,5.99617379909157,2.02020807798848e-09,5.41050203439182e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72496",42.0970116403082,5.41185924925646,0.911672126399882,5.93619031726619,2.9172114843763e-09,7.45771855928599e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3440",28.8379979634964,-2.94159709149187,0.496195431345002,-5.92830345801107,3.06080471576475e-09,7.48459907930614e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72502",18.3453321557053,6.49451260673109,1.11045282076393,5.84852637166813,4.95947021889853e-09,1.16221051688038e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94663",48.4818250758263,3.50836862054187,0.601854039650946,5.82926821024014,5.56709646419816e-09,1.25241855735773e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114167",41.0544540557035,2.94479658644634,0.5103012020468,5.77070282146087,7.89415861529228e-09,1.7076279570818e-05,0,5044,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",1.68e-27,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g94664",48.665168453471,3.29451100880575,0.5743037279577,5.73653077357076,9.6635498153021e-09,2.01295321745267e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37881",18.5540459393947,2.62348110280209,0.459774218554414,5.70602047033136,1.15648096286588e-08,2.32295722548224e-05,0,21764,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.78e-12,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g11932",34.7801360640469,1.85818609696727,0.328622344144137,5.65447277118883,1.5632537654861e-08,2.93068394261564e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146361",97.2925415330253,3.80149911898574,0.672123315894527,5.65595483609483,1.54982220810776e-08,2.93068394261564e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113541",38.6156318763354,4.73396282380151,0.847841271869166,5.58354845520192,2.35660079930378e-08,4.27548200498203e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56507",34.3905578040759,2.91894905580381,0.526240694203446,5.54679462830623,2.90954154531485e-08,5.0350417992029e-05,625,5588,"sp|P04323|POL3_DROME","P04323","POL3",4.37e-82,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g148164",37.0440552314528,6.34487291977866,1.14443220924654,5.54412298825105,2.95431135759212e-08,5.0350417992029e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99479",26.2732989446257,3.88769632421584,0.704870631891684,5.51547496564341,3.4783925829578e-08,5.75387516619743e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139790",22.9912672293845,4.61022237168976,0.844822504734347,5.45703073231867,4.8416258160578e-08,7.6494855033516e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155721",219.161044892657,0.844135753694791,0.154744381659231,5.4550332919595,4.896367094354e-08,7.6494855033516e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87706",26.6243421640747,5.49776876587073,1.01700062078904,5.40586569318445,6.44961134744406e-08,9.80375787575537e-05,0,6628,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",9.78e-17,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g27050",79.8981985374977,-0.746106646410977,0.138315117034064,-5.39425235946715,6.88094537168056e-08,0.000101841613051068,9731,16074,"sp|Q32LE3|CETN1_BOVIN","Q32LE3","CETN1",2.44e-69,"Centrin-1","cell division [GO:0051301]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair [GO:0006289]","GO:0000278; GO:0000922; GO:0005509; GO:0005737; GO:0005813; GO:0005814; GO:0006289; GO:0007099; GO:0051301"
"g65912",21.4878739627767,1.13064131257011,0.210674907924949,5.366758308839,8.01643627184234e-08,0.000115605233025886,6578,11850,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",1.59e-69,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g59432",24.6120755081074,4.18598692021871,0.78404019653109,5.33899529480657,9.34630696007179e-08,0.000131413749012089,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145502",52.9082977826007,2.35334414380284,0.443077665757134,5.31135808838712,1.08811285129693e-07,0.000149262543860103,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11930",22.1219789357473,1.84688383457287,0.348867041327558,5.29394759546459,1.19703749080535e-07,0.000160294720375891,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18751",26.3275158589099,1.79390805841905,0.339863448718885,5.27832005819155,1.30373604411734e-07,0.000170522610681971,436,32054,"sp|O02467|ASPG_SPOFR","O02467","ASPG",2.52e-75,"N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] (Fragment)",NA,"GO:0003948; GO:0005764; GO:0008233"
"g27859",1208.3026496016,1.12384169233028,0.216545322808212,5.18986823523143,2.10442944054882e-07,0.00026899391044397,23825,37860,"sp|C5FK77|DPEP1_ARTOC","C5FK77","DPEP1",3.83e-14,"Putative dipeptidase MCYG_02918 (EC 3.4.13.19)",NA,"GO:0046872; GO:0070573"
"g104526",21.2284446239816,4.10943392928118,0.793467755041288,5.17908119538815,2.22981407968792e-07,0.000278687118821796,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148980",212.078033814716,-1.00167735970814,0.193578989248514,-5.17451487682994,2.2850390423078e-07,0.000279380795255381,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89290",215.971289402357,1.8244598988649,0.355417519849355,5.13328633782093,2.84726224671189e-07,0.00034071430485015,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56502",54.7291456371754,0.636728474179459,0.125005381727381,5.09360849413727,3.5131185698306e-07,0.000410904377741134,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120971",29.4417768125285,2.50971123408132,0.493063488227534,5.09003666668413,3.57994283797083e-07,0.000410904377741134,0,4405,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",8.79e-20,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g21471",50.2383126054997,3.78437163504706,0.745795377319857,5.07427606838601,3.88973995622437e-07,0.000429097622979562,24355,27804,"sp|O19015|BGAL_FELCA","O19015","BGAL",7.75e-11,"Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)","carbohydrate metabolic process [GO:0005975]","GO:0004565; GO:0005764; GO:0005773; GO:0005975"
"g149788",51.0839657789539,2.72145975838172,0.536331442439817,5.07421259138112,3.89103850715794e-07,0.000429097622979562,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79937",26.4222786017294,4.63856758750736,0.920644504609195,5.03839165311304,4.69460046540452e-07,0.000498176829009964,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120970",29.9948023746372,2.43929818131843,0.484011958211093,5.03974775816298,4.66145814342777e-07,0.000498176829009964,0,4405,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",8.79e-20,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g119843",20.9418345607972,2.24318314476227,0.448163356610459,5.00528013206585,5.57808499843449e-07,0.000580967882373987,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70960",23.8099166310696,-1.14281927267026,0.229885724650205,-4.97124940841447,6.65228066484496e-07,0.000680250125731291,0,10700,"sp|O00255|MEN1_HUMAN","O00255","MEN1",3.26e-15,"Menin","brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose stimulus [GO:0071333]; cellular response to peptide hormone stimulus [GO:0071375]; chromatin organization [GO:0006325]; decidualization [GO:0046697]; DNA repair [GO:0006281]; histone H3-K4 methylation [GO:0051568]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to gamma radiation [GO:0010332]; response to transforming growth factor beta [GO:0071559]; response to UV [GO:0009411]; type B pancreatic cell differentiation [GO:0003309]","GO:0000122; GO:0000165; GO:0000278; GO:0000400; GO:0000403; GO:0000781; GO:0000785; GO:0000976; GO:0001933; GO:0002076; GO:0003309; GO:0003682; GO:0003690; GO:0005634; GO:0005654; GO:0005737; GO:0005788; GO:0005829; GO:0006281; GO:0006325; GO:0006357; GO:0006974; GO:0007420; GO:0008285; GO:0009411; GO:0010332; GO:0010812; GO:0016363; GO:0017053; GO:0030511; GO:0030674; GO:0032092; GO:0032154; GO:0032925; GO:0032991; GO:0035097; GO:0043433; GO:0044665; GO:0045668; GO:0045736; GO:0045786; GO:0045892; GO:0045944; GO:0046329; GO:0046697; GO:0047485; GO:0050680; GO:0051219; GO:0051568; GO:0051974; GO:0061469; GO:0070412; GO:0071333; GO:0071339; GO:0071375; GO:0071559; GO:1902807"
"g88738",48.5520358646211,1.14511788141767,0.230790887131364,4.96171185808512,6.9874600036611e-07,0.000701765581296263,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4000",50.566885488818,1.00148390039189,0.202171722060217,4.95362996459813,7.28416673728494e-07,0.00070633811316962,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87028",55.3532672674842,-0.848281373503728,0.171217754403426,-4.954400765618,7.25535318785149e-07,0.00070633811316962,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111963",44.8773712516472,1.13566445048449,0.229633506859619,4.94555200595683,7.59283957040268e-07,0.000723790649353538,2926,5252,"sp|Q93112|GST1C_ANOGA","Q93112","GST1C",1.29e-13,"Glutathione S-transferase 1, isoform C (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-5) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g154026",219.156025384691,1.0794604571465,0.218538882989829,4.93944346369126,7.83458541781612e-07,0.000734387921781357,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58313",132.740452720642,0.828294116801804,0.167896017394459,4.93337560744987,8.08205210260165e-07,0.000745165203859872,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99050",23.8725401494463,2.73272712098821,0.555549763840851,4.91896009836314,8.7005201559852e-07,0.000789249442924064,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111234",24.6167491996174,7.61806296255861,1.55057135651638,4.91306828966185,8.96620294098594e-07,0.00080043997747132,0,2734,"sp|Q6DCX5|PCFT_XENLA","Q6DCX5","PCFT",2.11e-13,"Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1)",NA,"GO:0005542; GO:0016021; GO:0022857"
"g86828",24.1692844424855,2.39388271480529,0.489808622465699,4.88738377604393,1.02184781969884e-06,0.00089798070430472,0,8116,"sp|P21328|RTJK_DROME","P21328","RTJK",1.54e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g57249",19.6194612519392,3.01176442509698,0.619374722108269,4.86258853904359,1.15860526148328e-06,0.00100249657102065,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97904",110.670229827984,1.50199137457269,0.309786142188393,4.84847825652341,1.24412164560662e-06,0.00106018014533648,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124730",354.747362749753,0.857566712826523,0.177769133763123,4.82404731728753,1.40674021631635e-06,0.00116349828303035,0,4064,"sp|Q6GMC7|AK1A1_XENLA","Q6GMC7","AK1A1",6.14e-11,"Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase)","aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; lipid metabolic process [GO:0006629]","GO:0005829; GO:0006629; GO:0008106; GO:0016324; GO:0046185; GO:0110095"
"g135902",18.8300419751347,6.23848818537731,1.29283895110988,4.82541787592466,1.39710025538688e-06,0.00116349828303035,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17476",93.8669943668863,0.881840336599115,0.182958027927316,4.8199051257234,1.43626508113896e-06,0.00117070174917997,162,12244,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.42e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g153882",28.1557820552982,2.81102977809754,0.583806418072887,4.81500321181222,1.47197522636997e-06,0.00118266900973571,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132823",23.9597605092424,0.989391694023155,0.205948783012069,4.80406671771969,1.5547498459812e-06,0.00122655516853892,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133012",191.770618428845,0.58339241869014,0.121487296345535,4.80208578377489,1.57021393504503e-06,0.00122655516853892,0,1861,"sp|O00370|LORF2_HUMAN","O00370","LORF2",5.92e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g69922",94.5951135982837,1.09714826572037,0.228677366602,4.79779998354579,1.60417849122287e-06,0.00123592063977201,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99049",64.5815764471212,2.70857282940772,0.565035652309204,4.79363172631364,1.63788826670193e-06,0.00124483934994392,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18004",254.712626810967,1.22361215930056,0.257287402610225,4.75581838398148,1.97644096749805e-06,0.00146883402363947,41025,51234,"sp|F4KHQ8|NCER3_ARATH","F4KHQ8","NCER3",6.14e-19,"Neutral ceramidase 3 (AtNCER3) (N-CDase 3) (NCDase 3) (EC 3.5.1.23) (Acylsphingosine deacylase 3) (N-acylsphingosine amidohydrolase 3)","cellular response to oxidative stress [GO:0034599]; ceramide catabolic process [GO:0046514]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingosine biosynthetic process [GO:0046512]","GO:0005576; GO:0005783; GO:0005794; GO:0017040; GO:0034599; GO:0042759; GO:0046512; GO:0046514; GO:0102121"
"g88617",174.15002133818,1.86750104468369,0.392747861298884,4.75496171642423,1.9848402581096e-06,0.00146883402363947,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105347",223.929961841423,1.38308048333359,0.291246393984837,4.74883298780205,2.04593807180163e-06,0.00149438505239308,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21443",817.527619166743,-0.582102136576693,0.122821648873405,-4.73940988348626,2.14341534498664e-06,0.0015320858511463,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46895",39.1484870991064,2.40631627905857,0.507812025184171,4.7385964879147,2.15203552932965e-06,0.0015320858511463,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26893",39.3541579185456,0.853016631524747,0.180805094804752,4.71787939629634,2.38315692840133e-06,0.00167541889958935,0,4706,"sp|Q8BTV1|TUSC3_MOUSE","Q8BTV1","TUSC3",2.1e-15,"Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3) (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33)","cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0005739; GO:0008250; GO:0015095; GO:0015693; GO:0016021; GO:0018279; GO:0050890; GO:0062062"
"g5581",42.6417945362422,1.85033894044057,0.393124196272556,4.70675414534321,2.51692149314882e-06,0.00174292007054311,71535,112204,"sp|P21328|RTJK_DROME","P21328","RTJK",9.87e-17,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g19223",92.559744607587,0.708072853198954,0.150547037616992,4.70333302074245,2.55948432079503e-06,0.00174292007054311,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41649",425.982223380232,0.619327192253135,0.131752742307183,4.70067781063081,2.59299357786964e-06,0.00174292007054311,14645,18044,"sp|Q93113|GST1D_ANOGA","Q93113","GST1D",1.86e-19,"Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g90986",29.0063461444187,2.77908102144878,0.591308800964687,4.69988103832526,2.60313086173361e-06,0.00174292007054311,0,3881,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",2.91e-54,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g6770",35.3055117365127,1.41543515184244,0.301774563150392,4.69037263136404,2.72707944539973e-06,0.00180442826080202,0,4854,"sp|P21328|RTJK_DROME","P21328","RTJK",5.56e-20,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g144112",166.177986876626,1.62300229535513,0.346988020247372,4.6774015258454,2.90533017239637e-06,0.00190001836692926,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31622",20.6311474318388,3.05766033489543,0.654458009247065,4.67204968339097,2.98208798990949e-06,0.00190238235161867,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41645",239.481498832691,0.658292138693882,0.140958665615847,4.67010762210191,3.01041978048543e-06,0.00190238235161867,0,9889,"sp|P30104|GSTT1_DROER","P30104","GSTT1",2.76e-23,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (EC 4.5.1.1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g157582",38.3107353071782,4.53999832248712,0.971175521670961,4.6747454205557,2.94318485354308e-06,0.00190238235161867,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10833",82.6888622797959,-0.714292883303024,0.153130989143819,-4.66458740518007,3.09236871841748e-06,0.00191121979627732,12575,20351,"sp|Q9BY12|SCAPE_HUMAN","Q9BY12","SCAPE",2.5e-13,"S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291)","antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]","GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0072520; GO:1990917"
"g105743",67.3946162283133,0.64819434467253,0.138898519477328,4.66667569324476,3.0611190512643e-06,0.00191121979627732,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122571",86.8224348643171,1.66421687718648,0.35701624238682,4.66145984300438,3.13974334796879e-06,0.00191940701496153,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28258",141.25758256595,1.98074370192359,0.42725205990461,4.63600737785984,3.55203293228005e-06,0.00214810146427198,34446,37594,"sp|Q2KIG3|CBPB2_BOVIN","Q2KIG3","CBPB2",2.62e-15,"Carboxypeptidase B2 (EC 3.4.17.20) (Carboxypeptidase U) (CPU) (Plasma carboxypeptidase B) (pCPB) (Thrombin-activable fibrinolysis inhibitor) (TAFI)","blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; proteolysis [GO:0006508]","GO:0004181; GO:0005615; GO:0006508; GO:0007596; GO:0008270; GO:0042730"
"g20234",345.052610296434,1.86573020515599,0.403118728862345,4.6282399491121,3.68786577091453e-06,0.00220652070944442,0,49764,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.71e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g55151",67.4058307334419,7.46431447428841,1.61461602100982,4.62296569410976,3.78292304089169e-06,0.00223957008069295,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100996",135.574096232893,1.13608668658167,0.246260420621694,4.61335477180447,3.96221143720477e-06,0.00232127807970074,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102257",27.7223118607683,0.87699071698861,0.191344130629529,4.58331653081429,4.57658447507336e-06,0.00265356973244408,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9739",38.0742405190881,2.5590723587443,0.559063723665006,4.57742516714912,4.70734100388149e-06,0.00266309948131854,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30962",94.3174161463078,0.560895709748197,0.122568116879973,4.57619586582588,4.73507251043444e-06,0.00266309948131854,11636,26574,"sp|Q7ZVM1|WASC5_DANRE","Q7ZVM1","WASC5",2.61e-33,"WASH complex subunit 5 (WASH complex subunit strumpellin)","actin filament polymerization [GO:0030041]; axonogenesis [GO:0007409]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; heart contraction [GO:0060047]; neuron development [GO:0048666]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]","GO:0005768; GO:0005769; GO:0007032; GO:0007409; GO:0015031; GO:0030041; GO:0048666; GO:0051125; GO:0060047; GO:0071203; GO:0140285"
"g135071",42.651755376724,4.57222416198611,0.998423897764036,4.57944183049462,4.66218423118604e-06,0.00266309948131854,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21070",277.468355412237,0.495300685807377,0.108429001254632,4.5679724066094,4.92464842781876e-06,0.00272223750178845,30746,43654,"sp|P46087|NOP2_HUMAN","P46087","NOP2",9.93e-22,"Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120)","maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]","GO:0000027; GO:0000470; GO:0001510; GO:0003723; GO:0005654; GO:0005730; GO:0008284; GO:0009383; GO:0070475; GO:1901796"
"g56778",102.58063652317,0.478519238056025,0.104767353459956,4.56744608175032,4.93702615807442e-06,0.00272223750178845,0,7244,"sp|Q23381|MUTA_CAEEL","Q23381","MUTA",2.9e-28,"Probable methylmalonyl-CoA mutase, mitochondrial (EC 5.4.99.2) (MethylmalonylCoA mutase homolog 1) (MCM)","cellular amino acid metabolic process [GO:0006520]; fatty acid metabolic process [GO:0006631]","GO:0004494; GO:0005739; GO:0005759; GO:0006520; GO:0006631; GO:0031419; GO:0046872"
"g75956",39.95150278013,6.7047038221697,1.47308615466574,4.55146754379147,5.3273016725806e-06,0.00290891359873086,4775,9762,"sp|P04323|POL3_DROME","P04323","POL3",6.08e-70,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g68623",2543.99034109177,0.355368266860487,0.0782505403602727,4.54141613878113,5.58776126295857e-06,0.00302179681683958,3875,11232,"sp|Q08473|SQD_DROME","Q08473","SQD",4.68e-45,"RNA-binding protein squid (Heterogeneous nuclear ribonucleoprotein 40) (HNRNP 40)","dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; RNA export from nucleus [GO:0006405]","GO:0000184; GO:0000381; GO:0000398; GO:0000785; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0006405; GO:0006406; GO:0007293; GO:0007297; GO:0007314; GO:0008069; GO:0008298; GO:0009953; GO:0010468; GO:0016325; GO:0017148; GO:0019094; GO:0030720; GO:0033119; GO:0035062; GO:0045451; GO:0048477; GO:0071011; GO:0071013"
"g104459",188.413001232081,0.593614805745545,0.130984659622584,4.53194143082079,5.8444055879536e-06,0.00310095338752534,0,4484,"sp|Q7ZT42|SND1_DANRE","Q7ZT42","SND1",6.41e-20,"Staphylococcal nuclease domain-containing protein 1 (100 kDa coactivator) (4SNc-Tudor domain protein) (p100 co-activator)","gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]","GO:0003723; GO:0004518; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0016442; GO:0031047"
"g143434",50.8564064174845,3.09360240715447,0.682492240646476,4.53280231321622,5.82062843781957e-06,0.00310095338752534,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18003",84.4711659672173,1.36453734841935,0.30134452677071,4.52816370365873,5.9498480300294e-06,0.00310655218977456,38106,43224,"sp|Q9JHE3|ASAH2_MOUSE","Q9JHE3","ASAH2",7.87e-15,"Neutral ceramidase (N-CDase) (NCDase) (EC 3.5.1.-) (EC 3.5.1.23) (Acylsphingosine deacylase 2) (N-acylsphingosine amidohydrolase 2) [Cleaved into: Neutral ceramidase soluble form]","apoptotic process [GO:0006915]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; ceramide metabolic process [GO:0006672]; lipid digestion [GO:0044241]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of apoptotic signaling pathway [GO:2001234]; regulation of mitotic cell cycle [GO:0007346]; response to organic substance [GO:0010033]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]","GO:0000139; GO:0005509; GO:0005576; GO:0005615; GO:0005739; GO:0005794; GO:0005886; GO:0005887; GO:0005901; GO:0006670; GO:0006672; GO:0006915; GO:0007346; GO:0008270; GO:0010033; GO:0016020; GO:0017040; GO:0042759; GO:0044241; GO:0046512; GO:0046513; GO:0046514; GO:0070062; GO:0070774; GO:0071633; GO:0102121; GO:2001234"
"g26334",143.765800031906,0.5675049882608,0.12534314380918,4.52761093279068,5.96542862088213e-06,0.00310655218977456,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4918",24.2415483815471,1.85425961815764,0.410429313733108,4.51785375974246,6.24696034880517e-06,0.00319401403579546,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87964",23.031737230893,2.11216896889353,0.467454265674372,4.51845051803392,6.22938272007184e-06,0.00319401403579546,5318,7664,"sp|Q9Y4A0|JERKL_HUMAN","Q9Y4A0","JERKL",4.13e-41,"Jerky protein homolog-like (Human homolog of mouse jerky gene protein) (HHMJG)","central nervous system development [GO:0007417]","GO:0003677; GO:0005634; GO:0007417"
"g83832",34.9666114713412,3.2020673084059,0.709394902172105,4.51380084435545,6.36760154720399e-06,0.00319863102252538,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147186",23.0668629154035,4.53442448416432,1.00458482745898,4.51372981178083,6.36973568725939e-06,0.00319863102252538,0,2234,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.98e-13,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g14600",99.4700950558003,-0.514527348972411,0.114156289423091,-4.50721858228457,6.56829600804095e-06,0.00326915136357734,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50644",146.519790261175,2.29435325757502,0.509447347156886,4.50361214044847,6.68080886734617e-06,0.00329598291506389,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103363",35.1126359540397,0.794504429170127,0.176807322586222,4.49361721872509,7.00234483028924e-06,0.00340605412881719,0,6127,"sp|O15438|MRP3_HUMAN","O15438","MRP3",2.35e-20,"ATP-binding cassette sub-family C member 3 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3)","bile acid and bile salt transport [GO:0015721]; leukotriene transport [GO:0071716]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908]","GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0008559; GO:0015164; GO:0015431; GO:0015432; GO:0015721; GO:0016020; GO:0016323; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0071714; GO:0071716; GO:0150104"
"g153811",224.998612772568,3.91245139891815,0.870802073141701,4.49292843872398,7.02503963128611e-06,0.00340605412881719,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44466",236.183036266385,-0.437369344087085,0.0974283297042169,-4.48913930285879,7.15115234342874e-06,0.00343756504358221,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104479",52.8655075768483,3.14344274448639,0.700656476889048,4.48642501449989,7.2428191681656e-06,0.00345212403098279,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15143",78.9284763052269,1.37366386582905,0.307503984557435,4.46714167885029,7.92716331114829e-06,0.00363472579899966,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27724",43.6480026224811,1.43963093691557,0.32190024509949,4.47228903622182,7.73867312940591e-06,0.00363472579899966,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31320",82.4480903537943,0.515507760772894,0.11541516868556,4.46655120504444,7.94906428073252e-06,0.00363472579899966,9550,15004,"sp|P87115|NAT10_SCHPO","P87115","NAT10",2.51e-11,"RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase)","rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]","GO:0000049; GO:0005524; GO:0005634; GO:0005730; GO:0030686; GO:0051391; GO:0051392; GO:1904812; GO:1990883"
"g39675",18.4564235459261,1.15672997635087,0.258789867009538,4.46976533400451,7.83054631026015e-06,0.00363472579899966,17055,21289,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",1.03e-49,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g58503",23.242400584272,0.792768083245069,0.177439630135318,4.46781861887613,7.90212624108995e-06,0.00363472579899966,3734,10726,"sp|Q9UT21|YFY7_SCHPO","Q9UT21","YFY7",4.54e-25,"Uncharacterized GTP-binding protein C9.07c","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005829"
"g20154",156.245514174814,1.66659816430045,0.373558862398559,4.46140710890782,8.14232396378858e-06,0.00366352467497118,0,49874,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.73e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g109772",30.5198968013625,2.19597125228083,0.49214838813252,4.46201045301306,8.11942642840781e-06,0.00366352467497118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28257",100.351723547881,1.78807616619595,0.401485009571485,4.45365611060898,8.44202758643642e-06,0.00373855524028628,30686,36144,"sp|Q2KIG3|CBPB2_BOVIN","Q2KIG3","CBPB2",5.24e-15,"Carboxypeptidase B2 (EC 3.4.17.20) (Carboxypeptidase U) (CPU) (Plasma carboxypeptidase B) (pCPB) (Thrombin-activable fibrinolysis inhibitor) (TAFI)","blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; proteolysis [GO:0006508]","GO:0004181; GO:0005615; GO:0006508; GO:0007596; GO:0008270; GO:0042730"
"g68955",103.510440714142,0.99474445921832,0.223282617508599,4.45509135604795,8.38574787997233e-06,0.00373855524028628,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10279",827.242977940959,-0.849890664134717,0.191627421914055,-4.43512027477932,9.20208986049066e-06,0.00404331201510715,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5778",49.1837800131616,1.70945591319532,0.38593422871933,4.4293969956174,9.44969325957209e-06,0.00408330131717043,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61350",19.3572124176837,2.94831874415893,0.665721688475936,4.42875573260747,9.47782912776208e-06,0.00408330131717043,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151147",954.918468508609,0.386434746677098,0.0872706381038612,4.42800413831283,9.51090772997629e-06,0.00408330131717043,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99309",32.5071546128915,2.55587021388802,0.577496547796559,4.4257757447035,9.60963159861975e-06,0.00409443106340585,0,5224,"sp|O46108|LIP3_DROME","O46108","LIP3",9.99e-15,"Lipase 3 (DmLip3) (EC 3.1.1.-)","lipid catabolic process [GO:0016042]","GO:0004806; GO:0016042"
"g85374",119.720473416631,0.886804657256468,0.201339512280896,4.40452371822205,1.06016541858904e-05,0.00448314462197631,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10773",283.516018792641,-0.883456797968107,0.201137345878404,-4.39230613345267,1.12154624861009e-05,0.00467244474920954,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146509",101.777790174915,1.62811866712713,0.370601531161782,4.3931784685919,1.11705351815583e-05,0.00467244474920954,0,1792,"sp|Q8N0N3|BGBP_PENMO","Q8N0N3","BGBP",7.49e-22,"Beta-1,3-glucan-binding protein (GBP)","carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]","GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087"
"g43487",33.3388837413065,2.28694514511179,0.521320513889035,4.38683129511104,1.15013927705947e-05,0.00475633332502787,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11892",20.8509434882381,1.40390562466124,0.320296402685532,4.38314515208465,1.1697811612113e-05,0.00480225051597414,1015,30236,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.2e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g21400",406.962512084518,-0.573034242406125,0.130868092159127,-4.37871625506204,1.19380442391435e-05,0.00486535858041964,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5463",344.240109508523,-0.849506580063543,0.194181519153107,-4.37480654064576,1.21540218900294e-05,0.00491774459812254,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23704",37.1153696510246,-0.900864876757562,0.206210250848206,-4.36867164969747,1.25004545835638e-05,0.00498617423183541,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45295",26.078223724204,2.57705724112603,0.589692264488207,4.37017304841646,1.24148111783126e-05,0.00498617423183541,7505,12128,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",4.46e-72,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g90822",50.7504671972802,0.850294284479726,0.194711520990751,4.36694387755368,1.25997085541172e-05,0.00499037189084973,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18607",118.671921329669,-0.721520872826667,0.165309573222574,-4.36466478475029,1.27317844671002e-05,0.0050074197342563,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35652",173.043980760101,0.409168537060183,0.0938807519834063,4.35838580769469,1.31025257375368e-05,0.0051174461981288,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143206",43.6572626410662,1.0247870608925,0.235254957162757,4.356069998489,1.32418445469701e-05,0.00513619186903927,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106928",41.8220038419451,0.947154399812329,0.217547237078885,4.35378730858751,1.33805532185859e-05,0.00515444571314868,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50646",23.9157803566442,2.56554068588203,0.589867107835894,4.3493536964529,1.36539339949392e-05,0.00519125638024224,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62055",39.9653484665664,0.606747531228668,0.139553807131629,4.34776767255352,1.37530173296841e-05,0.00519125638024224,0,12822,"sp|P21328|RTJK_DROME","P21328","RTJK",4.66e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g99410",122.776744613598,1.66628795826222,0.383196275191741,4.34839288933186,1.37138766789298e-05,0.00519125638024224,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8962",119.831223069175,0.552264548552818,0.127472655179666,4.33241582498166,1.47482056499173e-05,0.00552979054775099,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33909",377.986137455969,-1.16326344553639,0.269979201950244,-4.30871503113331,1.64205778922705e-05,0.00611606716435151,10185,30381,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.56e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g103134",43.509322468052,6.22064476923067,1.44527587483434,4.30412274746072,1.67648699251104e-05,0.00620322246268458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39021",303.781974922143,0.31388522963289,0.0730477390721629,4.29698760864874,1.73134869448425e-05,0.00636434727288778,14005,24645,"sp|P17027|ZNF23_HUMAN","P17027","ZNF23",9.85e-38,"Zinc finger protein 23 (Zinc finger protein 359) (Zinc finger protein 612) (Zinc finger protein KOX16)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837"
"g34192",19.5584062336803,1.7769505363195,0.414053509087997,4.29159636935199,1.77393184616234e-05,0.00647605187466536,26015,28500,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",1.15e-60,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g53587",18.9623048119064,0.899735595091423,0.209917326961785,4.28614258819719,1.81802321848925e-05,0.00647605187466536,13102,14384,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",7.65e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g55782",63.818955142937,0.577265415551475,0.134625606480615,4.28793177347428,1.80344464474299e-05,0.00647605187466536,0,3886,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.16e-21,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g73940",186.064057192153,2.47998959071231,0.579005464590848,4.28318857485185,1.84233899922915e-05,0.00647605187466536,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80973",55.9242698208731,1.0544148436591,0.246124685648844,4.2840678125374,1.83506941276879e-05,0.00647605187466536,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91166",35.8891475160314,-0.691956437070653,0.161376288116458,-4.28784454734328,1.80415278744733e-05,0.00647605187466536,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113402",801.569929199474,0.709013095872059,0.165521225902704,4.28351766974485,1.83961481759788e-05,0.00647605187466536,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99315",18.9043126778115,2.45791264086091,0.574125227090829,4.28114377296307,1.85935177318646e-05,0.00649525853587286,835,2860,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",6.89e-60,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g4920",101.768375741274,2.34239379064262,0.547737953656114,4.27648618286774,1.89866335258629e-05,0.00659164347383693,14296,26864,"sp|Q7LHG5|YI31B_YEAST","Q7LHG5","YI31B",2.51e-64,"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g105245",367.923147496321,4.0409861134281,0.945462987710253,4.27408176306792,1.91926601635424e-05,0.00662229198109172,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120101",125.907813629537,-0.532437935263107,0.124671448964287,-4.27072870080807,1.94835306459942e-05,0.00668166299141468,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16072",481.178136865437,0.764757886293327,0.179448647951899,4.26170882323014,2.02869662295875e-05,0.00689750405631093,9950,60394,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.45e-26,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g115973",68.94747430898,-0.561306834548476,0.131733543721507,-4.26092564347251,2.03581962474239e-05,0.00689750405631093,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28922",20.6033111777163,1.67662007809976,0.393701693358464,4.2586051987671,2.05706408331217e-05,0.00692774839363133,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129274",273.099187431503,-0.972772665145754,0.229067610761173,-4.24666176904412,2.16979133437636e-05,0.00726389310880923,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2955",246.945937744434,-0.561333732446918,0.132234446753373,-4.24498870172495,2.18604435528045e-05,0.00727500039228894,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61855",56.0558901394019,-0.751541111155443,0.17719515555571,-4.24131861166576,2.22210432505494e-05,0.00731380026648701,10537,12484,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",3.13e-35,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g66310",108.864016040558,0.552268236631657,0.130216429263607,4.241156356036,2.22371154220917e-05,0.00731380026648701,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116231",87.8874681593351,1.38930743207004,0.327780752876893,4.23852657569505,2.24991552720923e-05,0.00735696215588962,20,4288,"sp|Q64581|CP3AI_RAT","Q64581","CP3AI",3.78e-14,"Cytochrome P450 3A18 (EC 1.14.14.1) (CYPIIIA18) (Cytochrome P450(6)beta-2)","oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]","GO:0005506; GO:0005789; GO:0008202; GO:0008390; GO:0008395; GO:0020037; GO:0050649; GO:0070330; GO:0070989"
"g86110",526.837855411978,0.312403051036304,0.0739562893486164,4.22415799640369,2.39835756746006e-05,0.00779701886179702,0,8212,"sp|P21328|RTJK_DROME","P21328","RTJK",1.37e-17,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g18907",843.576534651555,-0.65187983586473,0.154627967468331,-4.21579515360467,2.48899618476471e-05,0.00796625782124964,2233,22804,"sp|P20482|CNC_DROME","P20482","CNC",5.28e-19,"Segmentation protein cap'n'collar","blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]","GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005703; GO:0006357; GO:0006979; GO:0007310; GO:0007317; GO:0007350; GO:0008103; GO:0008340; GO:0008359; GO:0034976; GO:0036335; GO:0045944; GO:0046982; GO:0048813; GO:0051663; GO:0060322; GO:0060465; GO:2000378"
"g36577",18.3826477621881,3.09102328801551,0.733347044291156,4.21495295041825,2.49830266939205e-05,0.00796625782124964,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38947",42.4501514948705,2.31213439003145,0.54865815822338,4.21416205223014,2.5070723558216e-05,0.00796625782124964,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90212",472.873441773594,-0.465886059428029,0.110469279196908,-4.2173359219408,2.47205573030506e-05,0.00796625782124964,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85761",114.863751107634,0.530154015229619,0.125882256154432,4.2115070973881,2.53672582431229e-05,0.00801519852870627,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27179",30.8420050752617,1.22691341624977,0.291461429076104,4.20952240623719,2.5591106416317e-05,0.00804075422942178,37067,39249,"sp|Q5U3U0|PHYD1_DANRE","Q5U3U0","PHYD1",2.1e-13,"Phytanoyl-CoA dioxygenase domain-containing protein 1 (Protein PHYHD1) (EC 1.14.11.-)",NA,"GO:0046872; GO:0051213"
"g158393",24.6623654061665,1.95235588665491,0.464480139862559,4.2033140259401,2.63035273612337e-05,0.00821868325472502,0,1311,"sp|P21328|RTJK_DROME","P21328","RTJK",5.3e-29,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g9964",964.168290337047,0.383497619967357,0.0913228153856623,4.19936264938637,2.67667334804587e-05,0.00827553075932272,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44922",91.1787092892242,-0.695417061343186,0.165604961808091,-4.19925256918969,2.67797481987969e-05,0.00827553075932272,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10916",125.132065761161,-0.477304566819304,0.113714529366731,-4.19739297587902,2.70005184036142e-05,0.00829815932271076,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41593",812.372039787796,0.536259577798257,0.127974101696962,4.19037579234663,2.78492831540061e-05,0.00842760970034266,0,18081,"sp|P30104|GSTT1_DROER","P30104","GSTT1",6.13e-23,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (EC 4.5.1.1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g79278",944.161573378774,0.403170321558045,0.0962175142655507,4.19019681224912,2.78712599883314e-05,0.00842760970034266,2216,7571,"sp|P60060|SC61G_MOUSE","P60060","SC61G",4.72e-14,"Protein transport protein Sec61 subunit gamma","posttranslational protein targeting to membrane, translocation [GO:0031204]","GO:0008320; GO:0016020; GO:0016021; GO:0031204; GO:0043022; GO:0071261"
"g89205",142.862091148044,0.322665009685587,0.0769765996560743,4.1917285399359,2.76837123182053e-05,0.00842760970034266,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17510",1743.84915437717,-0.395841934788781,0.0945733511008976,-4.18555470627734,2.84470543026207e-05,0.00852071972889528,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46650",2942.62679909806,-0.522060880359806,0.124737553078507,-4.18527434181133,2.84821896275437e-05,0.00852071972889528,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2451",216.269681374098,-0.60382963018939,0.144419574695997,-4.18107885624543,2.90129216131315e-05,0.00860472852881059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146477",2385.53328077203,0.498190637011875,0.119166121382762,4.18063985997903,2.90689950655029e-05,0.00860472852881059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150994",53.0955582988051,0.617970209296822,0.147967252713603,4.17639847982398,2.96160827229662e-05,0.00872077342672809,0,1824,"sp|Q9HD20|AT131_HUMAN","Q9HD20","AT131",9.2e-14,"Endoplasmic reticulum transmembrane helix translocase (EC 7.4.2.-) (Endoplasmic reticulum P5A-ATPase)","cellular calcium ion homeostasis [GO:0006874]; extraction of mislocalized protein from ER membrane [GO:0140569]; ion transmembrane transport [GO:0034220]; protein transport [GO:0015031]","GO:0005524; GO:0005789; GO:0006874; GO:0015031; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872; GO:0140567; GO:0140569"
"g17631",127.108224792359,2.23830112768985,0.537465615745294,4.16454757684553,3.11970569830159e-05,0.00887230439321343,10075,44675,"sp|P21328|RTJK_DROME","P21328","RTJK",3.95e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g33176",996.727265999487,0.322947813388257,0.0775520726158167,4.16427056679839,3.12349537686473e-05,0.00887230439321343,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33519",103.195158440469,-0.820138612226725,0.196661578101851,-4.17030423605152,3.04193267110764e-05,0.00887230439321343,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56373",36.7001312584385,0.620980354253751,0.149110485526861,4.16456530243065,3.11946334949795e-05,0.00887230439321343,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65208",70.266961769314,2.14366900130506,0.514638665712244,4.16538659865031,3.10825397085921e-05,0.00887230439321343,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128634",90.4461684375986,1.49863042940268,0.35938988399583,4.16992936122839,3.04694065810498e-05,0.00887230439321343,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138964",218.58311631469,0.688660342173211,0.165257006239216,4.16720814351646,3.08352922867095e-05,0.00887230439321343,0,2924,"sp|P20000|ALDH2_BOVIN","P20000","ALDH2",2.21e-34,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)","aldehyde catabolic process [GO:0046185]; ethanol catabolic process [GO:0006068]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627]","GO:0004029; GO:0005739; GO:0005759; GO:0006068; GO:0008957; GO:0018547; GO:0043878; GO:0046185; GO:0051287; GO:0052689; GO:1903179; GO:1905627"
"g34469",163.437773544083,1.24008007053422,0.29838900442609,4.15591745050843,3.23984796291886e-05,0.00915655925278806,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2800",29.0003824058442,-0.809581216287462,0.195157856735733,-4.14834037342258,3.348942326316e-05,0.00933076329862072,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21054",73.0342141937431,1.15689392173932,0.278861311052344,4.14863545385168,3.34462925234787e-05,0.00933076329862072,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138378",70.762629603449,3.23395936892849,0.77960881732496,4.14818213578579,3.35125739895698e-05,0.00933076329862072,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32947",154.755947634245,-1.02333381665926,0.246869961550143,-4.14523423681664,3.39466516160588e-05,0.00940506197138116,23721,30164,"sp|Q80U96|XPO1_RAT","Q80U96","XPO1",1.26e-35,"Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)","mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to xenobiotic stimulus [GO:0009410]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]","GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005730; GO:0005737; GO:0006611; GO:0006913; GO:0009410; GO:0010824; GO:0015030; GO:0019904; GO:0031267; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0046825; GO:0051028; GO:1990904"
"g24136",133.690115054608,1.40583272065563,0.339336012106725,4.14289279799009,3.42952279720568e-05,0.00940893761758252,13175,35182,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.45e-11,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g140086",31.584567248345,0.646877480831873,0.15612011615137,4.14346015605497,3.42104531070694e-05,0.00940893761758252,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41210",144.937089139368,-0.340467436884759,0.0823104114056274,-4.13638361260191,3.52822178393556e-05,0.00954588618496877,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73630",110.503479393474,2.91164346007036,0.703791133480811,4.13708460018522,3.51746448167753e-05,0.00954588618496877,3116,8914,"sp|P00688|AMYP_MOUSE","P00688","AMYP",2.2e-23,"Pancreatic alpha-amylase (PA) (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate catabolic process [GO:0016052]","GO:0004556; GO:0005509; GO:0005615; GO:0016052; GO:0016160; GO:0031404"
"g78144",34.2325412861381,0.911312093181242,0.220323549491919,4.13624460609313,3.53035867585346e-05,0.00954588618496877,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4979",276.995127326562,-1.02833506824023,0.248724376972656,-4.13443620105352,3.55827080812668e-05,0.00957532376988807,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55668",138.910960729204,0.460809735941445,0.111566951575938,4.13034262774308,3.62222982135602e-05,0.00970102141012883,2086,14916,"sp|Q91W96|APC4_MOUSE","Q91W96","APC4",1.27e-64,"Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]","GO:0005634; GO:0005680; GO:0007049; GO:0019903; GO:0031145; GO:0034399; GO:0045842; GO:0051301; GO:0070979"
"g116616",29.0358103245644,0.705529102017461,0.170986396299566,4.12622943863548,3.6875937987019e-05,0.00982927253206599,1864,4806,"sp|P0C6T1|CTF8_RAT","P0C6T1","CTF8",1.95e-12,"Chromosome transmission fidelity protein 8 homolog","DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]","GO:0003677; GO:0005634; GO:0006260; GO:0007064; GO:0031390; GO:0032508; GO:1900264"
"g38948",38.850374715847,1.9646741127763,0.476485328289485,4.12326255632928,3.73543498404504e-05,0.00990982709305006,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103355",59.8514370924274,-0.687792778204359,0.166885299048969,-4.1213503054127,3.76658181274494e-05,0.00994554433391552,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2450",884.940567321357,-0.36318776749928,0.0882910152149669,-4.11353031353198,3.89653846184033e-05,0.0101313198784735,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9804",22.4163241890396,-2.5427954105155,0.618163670707941,-4.11346627278082,3.89762008663473e-05,0.0101313198784735,3785,7410,"sp|Q09575|YRD6_CAEEL","Q09575","YRD6",1.89e-16,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0008270; GO:0015074"
"g30758",338.203936766244,0.363254167809753,0.0882806704184846,4.11476449020819,3.87574923754447e-05,0.0101313198784735,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32960",723.037397330522,0.437899278434313,0.106472459535393,4.11279386561694,3.90899401448874e-05,0.0101313198784735,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4291",359.058222881933,0.740483798490274,0.180134070424643,4.11073705681929,3.94398130846916e-05,0.0101751099427029,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69936",26.9805594869241,1.88709822058943,0.459331375675023,4.10835906390281,3.98480252850847e-05,0.0102334823656791,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18683",150.141234918755,0.517145694111898,0.126060838232727,4.10235011413435,4.08974788488293e-05,0.0104552545700721,46,4414,"sp|Q6DJ55|FAKD4_XENTR","Q6DJ55","FAKD4",4.38e-45,"FAST kinase domain-containing protein 4 (Protein TBRG4) (Transforming growth factor beta regulator 4)","mitochondrial mRNA processing [GO:0090615]; mitochondrial RNA processing [GO:0000963]; mRNA metabolic process [GO:0016071]; regulation of mitochondrial mRNA stability [GO:0044528]","GO:0000963; GO:0003723; GO:0005739; GO:0005759; GO:0016071; GO:0035770; GO:0044528; GO:0090615"
"g33907",100.945940760124,-0.843396036897776,0.206105478390245,-4.0920602571314,4.27557509156141e-05,0.0108436777330994,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52019",401.386035015363,1.05771524185082,0.258495873235487,4.09180707069644,4.28024689155446e-05,0.0108436777330994,1429,16384,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.44e-53,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g13019",758.57342145445,0.520496403278133,0.127307689869204,4.08849146357846,4.34187521450182e-05,0.0109000057948702,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73734",185.120775681942,2.38823033638978,0.584277719607124,4.08749171198186,4.36062249536963e-05,0.0109000057948702,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126551",20.817492426479,-0.928352004883176,0.227009224852965,-4.08949021998764,4.32322295393286e-05,0.0109000057948702,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74523",5856.40861228115,-0.272945482042424,0.0668985338240402,-4.07999198846927,4.50372529597221e-05,0.0112078990307995,0,6289,"sp|Q9NL83|ORCKA_PROCL","Q9NL83","ORCKA",9.52e-50,"Orcokinin peptides type A [Cleaved into: Orcomyotropin-like peptide; Orcokinin; Orcokinin-like peptide 1; Orcokinin-like peptide 2; Orcokinin-like peptide 3; Orcokinin-like peptide 4]","neuropeptide signaling pathway [GO:0007218]","GO:0005184; GO:0005576; GO:0007218"
"g311",32.7527438517398,-0.856658895428058,0.210282649667814,-4.073844878697,4.62432885148714e-05,0.0114573349456097,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140128",19.4758982034434,1.09299794173553,0.268382262818061,4.07254164362001,4.65028823744777e-05,0.0114711189057253,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119583",23.2966855648256,1.19085042002495,0.292581237433015,4.07015306406171,4.69822592729442e-05,0.0115387608123534,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4292",30.0203115377645,1.03300859491506,0.254059674303731,4.06600771155869,4.78253538524029e-05,0.0116947545711602,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17924",217.544936310526,-0.536286829057233,0.131986849969902,-4.06318378822985,4.84078847498639e-05,0.0117351562676804,41776,52524,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5e-11,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g160502",98.3457994036482,1.27301550909042,0.31328632588246,4.06342506492937,4.83578515422075e-05,0.0117351562676804,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1344",48.6826411034085,-0.814337016960356,0.200702355344041,-4.05743627454909,4.9614348818259e-05,0.0118272289512595,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9144",107.74391984203,-0.438199428753222,0.107989523443112,-4.05779574519619,4.95380640954921e-05,0.0118272289512595,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19705",125.639339871214,0.480084958053713,0.118288708794438,4.05858651215816,4.93706433591517e-05,0.0118272289512595,0,14836,"sp|Q2KJJ9|F16P2_BOVIN","Q2KJJ9","F16P2",3.87e-12,"Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)","fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; sucrose biosynthetic process [GO:0005986]","GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0030018; GO:0030054; GO:0030388; GO:0042132; GO:0042802; GO:0046872"
"g38625",27.0820378713392,1.23010445425194,0.303285472515643,4.05592936598206,4.99353494725029e-05,0.0118272289512595,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129575",89.783947909065,0.554906982038141,0.13678284722209,4.05684625892569,4.97397998551756e-05,0.0118272289512595,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155268",112.59978154244,1.22413296434381,0.301852880638915,4.05539599871552,5.00494379716184e-05,0.0118272289512595,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3678",736.633930003668,-0.550872258206499,0.136075206595988,-4.04829264630151,5.1592612962334e-05,0.0120984321251736,0,51393,"sp|P21328|RTJK_DROME","P21328","RTJK",1.1e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g17579",131.70535662958,1.9807331314147,0.489295200367491,4.04813521556527,5.16273196195309e-05,0.0120984321251736,34425,50323,"sp|P21328|RTJK_DROME","P21328","RTJK",1.79e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g86267",26.2185968848541,0.770424589793287,0.190449663884532,4.04529246247652,5.22578434275653e-05,0.0121953760583117,0,5514,"sp|P0C2X9|AL4A1_RAT","P0C2X9","AL4A1",1.2e-29,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)","proline catabolic process to glutamate [GO:0010133]","GO:0003842; GO:0004029; GO:0005759; GO:0010133; GO:0042802"
"g2444",40.3077777036099,-0.804757635190171,0.199115157818586,-4.04166937367664,5.30720267520925e-05,0.0123342021842611,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63887",75.1481597174963,1.72913557150295,0.428008128905535,4.039959651992,5.34603976123189e-05,0.0123733320267985,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67644",50.5169495785923,0.876025243581352,0.217350666233822,4.03046955760854,5.56655384540481e-05,0.0128179519359884,0,11114,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.01e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g104316",23.7113042972454,2.44413554915809,0.606523531540612,4.02974562742819,5.58372430624293e-05,0.0128179519359884,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117546",31.6418267484138,0.713432947025495,0.17712524763725,4.02784445776242,5.62905620578755e-05,0.0128694869563375,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10906",967.194834253308,0.560089408500025,0.139088476828142,4.02685701412974,5.65273836267924e-05,0.0128713081374011,40406,62154,"sp|Q02253|MMSA_RAT","Q02253","MMSA",1.33e-34,"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1)","beta-alanine catabolic process [GO:0019484]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]","GO:0000062; GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0016790; GO:0018478; GO:0019484; GO:0019859; GO:0050873; GO:0102662"
"g4154",1641.29296066838,0.376996707189431,0.0938182457357972,4.01837301723907,5.86013758170724e-05,0.0128744475730617,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10524",208.035512093094,0.783001288690722,0.194746579721508,4.02061638160954,5.80460637413315e-05,0.0128744475730617,4159,13604,"sp|Q99NB1|ACS2L_MOUSE","Q99NB1","ACS2L",5.16e-30,"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)","acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]","GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218"
"g17633",64.8646183846288,1.69166898324707,0.420559303152671,4.02242673165397,5.76015754633716e-05,0.0128744475730617,43915,53258,"sp|Q04519|ASM_MOUSE","Q04519","ASM",3.3e-13,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g41501",45.7450397374734,0.998925376612154,0.248566760771832,4.01874077415001,5.85099994936338e-05,0.0128744475730617,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54019",160.770871049057,-0.37534238317008,0.0932999320323563,-4.0229652368869,5.74699816728881e-05,0.0128744475730617,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87960",58.9499268425303,0.596332153047234,0.148343836621011,4.01993211602545,5.82149132483849e-05,0.0128744475730617,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131580",32.6990735607164,0.707607876208587,0.175830044594361,4.02438546746111,5.71242862707337e-05,0.0128744475730617,0,3502,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.85e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g143778",160.391380345229,0.520794202111664,0.129453599897655,4.02301830558129,5.74570287725515e-05,0.0128744475730617,0,1564,"sp|Q2KJJ9|F16P2_BOVIN","Q2KJJ9","F16P2",1.98e-12,"Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)","fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; sucrose biosynthetic process [GO:0005986]","GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0030018; GO:0030054; GO:0030388; GO:0042132; GO:0042802; GO:0046872"
"g157842",43.3686545707952,1.08322586107001,0.269562074205108,4.0184653730101,5.85784155382895e-05,0.0128744475730617,0,1264,"sp|Q3LSM4|AGT_AEDAE","Q3LSM4","AGT",2.1e-21,"Alanine--glyoxylate aminotransferase (EC 2.6.1.44)","glyoxylate catabolic process [GO:0009436]","GO:0005777; GO:0008453; GO:0009436; GO:0030170"
"g8760",120.198581122381,-0.610533069593041,0.152087216386546,-4.01436152293894,5.96069260257674e-05,0.0130444075235066,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3492",50.1584989132508,-0.610033220577482,0.152070176844709,-4.01152437141198,6.03279477645661e-05,0.0131028633597083,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137245",23.995455627266,2.71803959841422,0.677565748853481,4.0114772669862,6.03399880901188e-05,0.0131028633597083,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81992",6398.4731325213,0.501808592691124,0.125173198274549,4.00891404556492,6.09986125893992e-05,0.0131949383432807,0,1274,"sp|Q4R6V2|TCPE_MACFA","Q4R6V2","TCPE",0,"T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]","GO:0003730; GO:0005524; GO:0005813; GO:0005832; GO:0005874; GO:0007339; GO:0009615; GO:0016887; GO:0031681; GO:0032212; GO:0044183; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0061077; GO:1901998; GO:1904851"
"g4714",1514.44233045725,0.280308711422441,0.0699751439268188,4.00583258128905,6.17994113057025e-05,0.0132198723104608,48571,57994,"sp|Q94613|RS19_MYAAR","Q94613","RS19",3.68e-17,"40S ribosomal protein S19","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g13459",2744.81477501215,0.574346944749483,0.143393023777629,4.00540367737952,6.19116590745003e-05,0.0132198723104608,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33250",126.887013895208,-0.55086434414013,0.137507536427926,-4.00606656515051,6.17382570096518e-05,0.0132198723104608,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132349",374.428421816095,0.487705312348551,0.121778352474257,4.00486048989413,6.2054092848079e-05,0.0132198723104608,0,3278,"sp|O16797|RL3_DROME","O16797","RL3",1.66e-20,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g21562",130.691266739801,-0.788690335337186,0.197076869801239,-4.00194267410791,6.28245220314517e-05,0.0132810740726569,0,30170,"sp|P47736|RPGP1_HUMAN","P47736","RPGP1",2.84e-11,"Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1)","activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]","GO:0000139; GO:0002250; GO:0003924; GO:0005096; GO:0005737; GO:0005769; GO:0005829; GO:0007165; GO:0016020; GO:0030424; GO:0030425; GO:0031267; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0051056; GO:0090630; GO:1903697; GO:1904425; GO:1904442; GO:1990792"
"g27152",156.545146898845,-0.663362733355158,0.165753856650392,-4.00209531627565,6.27839944676131e-05,0.0132810740726569,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114986",28.7044599906161,1.17845424018266,0.294532865974139,4.0010958922531,6.30497986806905e-05,0.0132810740726569,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31820",281.351282994289,-0.648445006646305,0.162122866662263,-3.99971342720675,6.34192318479046e-05,0.0133090464089173,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50088",76.7815124360578,1.57481494689518,0.393935570538538,3.99764597226469,6.39755389916964e-05,0.013375882022197,3755,7349,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.94e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g38673",47.8362208829532,0.44765907657464,0.112056459805541,3.99494216889854,6.47100463781619e-05,0.0134793423274096,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22455",277.998507221242,0.365173024135648,0.0914918093844676,3.99131929505422,6.5706745008457e-05,0.0135365522079327,0,10750,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.19e-31,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g63143",22.0577753058713,0.990715915942588,0.248191974445214,3.99173227964823,6.55923982849884e-05,0.0135365522079327,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127088",37.3016191548238,-0.642994798476122,0.161034534600732,-3.99290003271882,6.52700903660723e-05,0.0135365522079327,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g307",61.6154157746045,-0.667143266812854,0.16728218029673,-3.98813110654976,6.65958584409532e-05,0.0135918779079154,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18709",25.2046779189139,1.94394921841723,0.48738013889002,3.98856880554153,6.64731234114372e-05,0.0135918779079154,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70822",302.315635267337,0.313797430208797,0.0786901643115576,3.98775924480701,6.67003005331362e-05,0.0135918779079154,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2954",114.92346767779,-0.570548505774255,0.143190792879697,-3.984533462662,6.76128294098011e-05,0.0137280893561951,3695,16900,"sp|Q640T2|WIPI3_XENTR","Q640T2","WIPI3",8.23e-24,"WD repeat domain phosphoinositide-interacting protein 3 (WIPI-3) (WD repeat-containing protein 45-like) (WDR45-like protein) (WD repeat-containing protein 45B)","autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]","GO:0000045; GO:0000407; GO:0000422; GO:0005764; GO:0005829; GO:0006497; GO:0009267; GO:0019898; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0080025"
"g91021",203.877742249406,0.305221810346285,0.0766220994478441,3.98346968493139,6.79163386652787e-05,0.0137401105007648,0,7562,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.79e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g72805",7143.57233651064,0.380518719608564,0.0955560853062738,3.98215057041041,6.82944893376791e-05,0.0137670920047661,0,5886,"sp|Q01768|NDKB_MOUSE","Q01768","NDKB",4.29e-33,"Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3) (P18) (nm23-M2)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; CTP biosynthetic process [GO:0006241]; dTMP biosynthetic process [GO:0006231]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; UTP biosynthetic process [GO:0006228]","GO:0001726; GO:0002762; GO:0003677; GO:0003713; GO:0004550; GO:0004673; GO:0004674; GO:0005504; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006165; GO:0006183; GO:0006228; GO:0006231; GO:0006241; GO:0007189; GO:0007229; GO:0010976; GO:0019003; GO:0019215; GO:0019899; GO:0030027; GO:0031966; GO:0042802; GO:0042981; GO:0043066; GO:0043209; GO:0045618; GO:0045893; GO:0045944; GO:0046777; GO:0046872; GO:0048471; GO:0050679; GO:0051880; GO:0071944; GO:1901363"
"g84238",21.8400668857014,-1.23079282568274,0.309216675797577,-3.98035721232725,6.88117876983592e-05,0.013821830584754,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122431",262.437328998174,-0.434033195875346,0.109077058132465,-3.97914284916128,6.91641763743581e-05,0.0138431729809489,135,4267,"sp|Q94HW2|POLR1_ARATH","Q94HW2","POLR1",3.02e-19,"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872"
"g23925",1359.43434882016,0.790999531999903,0.198921226221128,3.97644608886836,6.995284831192e-05,0.0139513762225497,2288,4934,"sp|P70691|UD12_MOUSE","P70691","UD12",3.24e-12,"UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2)","flavonoid glucuronidation [GO:0052696]; xenobiotic glucuronidation [GO:0052697]","GO:0001972; GO:0005783; GO:0005789; GO:0015020; GO:0016021; GO:0019899; GO:0042803; GO:0046982; GO:0052696; GO:0052697"
"g13015",59.6526660716774,0.535368771970699,0.134678470439367,3.97516225291351,7.03312904750221e-05,0.0139772877699512,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7875",85.1731817281588,-0.984714301536252,0.248378583604598,-3.96457008187088,7.35283432494808e-05,0.0141087763687532,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10915",163.306783955721,0.676405979126024,0.170435982972355,3.96868059977533,7.22716736664551e-05,0.0141087763687532,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16039",161.158222625702,0.816189053752667,0.205914204534905,3.96373361224001,7.37865871881215e-05,0.0141087763687532,26206,36094,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.35e-21,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g16100",675.831355552904,-0.904223476238531,0.22813244019721,-3.96359007713621,7.38309870323253e-05,0.0141087763687532,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17339",22.2004305021409,0.722205601554019,0.181921842693557,3.96986744890529,7.19126264375199e-05,0.0141087763687532,0,5072,"sp|P19971|TYPH_HUMAN","P19971","TYPH",2.35e-16,"Thymidine phosphorylase (TP) (EC 2.4.2.4) (Gliostatin) (Platelet-derived endothelial cell growth factor) (PD-ECGF) (TdRPase)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; dTMP catabolic process [GO:0046074]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969]","GO:0000002; GO:0001525; GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0006935; GO:0008083; GO:0009032; GO:0016154; GO:0030154; GO:0031641; GO:0042803; GO:0046074; GO:0051969; GO:1905333"
"g17629",53.7412179414732,2.39665027316585,0.604751368894752,3.96303406066857,7.40032187472387e-05,0.0141087763687532,0,6370,"sp|Q04519|ASM_MOUSE","Q04519","ASM",1.14e-13,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g60891",1407.32189027176,-0.216794770681492,0.0546748114747344,-3.96516722845354,7.33445089079968e-05,0.0141087763687532,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67413",270.88235527454,0.92195971078891,0.232558603670193,3.96441884427722,7.35749715579523e-05,0.0141087763687532,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87501",1037.56721696768,0.472325707865447,0.119175566556196,3.96327637882659,7.39281115882972e-05,0.0141087763687532,455,6717,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.24e-16,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g120975",167.158803880136,-1.05014513056154,0.264869256397474,-3.96476791925465,7.3467389875708e-05,0.0141087763687532,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134094",22.1428488066148,3.05363441132378,0.769957485520368,3.96597795170471,7.30956196381948e-05,0.0141087763687532,314,3224,"sp|O42563|CP3AR_ONCMY","O42563","CP3AR",7.86e-14,"Cytochrome P450 3A27 (EC 1.14.14.1) (CYPIIIA27)","progesterone metabolic process [GO:0042448]","GO:0005506; GO:0005737; GO:0005789; GO:0016020; GO:0020037; GO:0042448; GO:0050649; GO:0070330"
"g134669",45.4125919272409,-1.10905483522318,0.279456419565228,-3.96861463031917,7.22916804987967e-05,0.0141087763687532,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22467",64.6231321474287,-0.573489268908225,0.144838989344352,-3.95949510214246,7.51083847288392e-05,0.0141743021683872,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45918",489.627790121012,-0.429986053175128,0.108582624537698,-3.95998950113647,7.49530585322783e-05,0.0141743021683872,0,12193,"sp|Q99315|YG31B_YEAST","Q99315","YG31B",1.56e-90,"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g101034",19.7506907277681,-0.617404604918144,0.155960976901322,-3.95871209058136,7.53550077939579e-05,0.0141743021683872,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142948",50.3477577016272,0.619776446925465,0.156527023906857,3.95954916573555,7.50913846638495e-05,0.0141743021683872,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38063",50.7859072734902,-0.507654034239953,0.128296360940652,-3.95688568653,7.59332450469813e-05,0.0142354585597744,15986,26149,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.15e-71,"PiggyBac transposable element-derived protein 4",NA,NA
"g5442",76.9041941802788,-0.633843116172221,0.160612930949399,-3.94640152835461,7.93345277805633e-05,0.014689255574046,48662,54264,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.1e-14,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g22396",25.9117459056437,1.03183829854481,0.261475884980843,3.94620826551714,7.9398557919526e-05,0.014689255574046,16969,27844,"sp|A1ZAY1|DLISH_DROME","A1ZAY1","DLISH",2.66e-26,"SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains)","establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251]","GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219"
"g41621",450.296524409642,-0.495453359084904,0.125535778702399,-3.94671036581092,7.92323077993357e-05,0.014689255574046,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56253",704.317838168804,-0.477376920012539,0.120963843226137,-3.94644306332183,7.93207731557845e-05,0.014689255574046,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29962",3262.35510156472,0.355889800311313,0.0902217505780824,3.94461200354684,7.99292886609408e-05,0.0146907942904204,8955,35418,"sp|P29775|ETS4_DROME","P29775","ETS4",4.28e-43,"DNA-binding protein D-ETS-4","cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565"
"g41024",37.1564248341637,0.958860392211657,0.243077357913535,3.94467177215549,7.99093562977655e-05,0.0146907942904204,0,17758,"sp|P04323|POL3_DROME","P04323","POL3",8.46e-89,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g144353",29.6295827901067,-0.72275402368635,0.183299979342208,-3.94301203022516,8.04646174411257e-05,0.0147410130753218,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8449",33.5975808991663,-0.821229956423262,0.208445073463166,-3.93979067376894,8.15527363488103e-05,0.0148918473952266,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3491",37.8495424404625,-0.713588210330617,0.181194985868504,-3.93823375912002,8.20836068554079e-05,0.0149142779070245,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119744",586.901716255868,0.570621783105024,0.14490596760576,3.9378763520457,8.22059341982431e-05,0.0149142779070245,0,4512,"sp|Q7YRU4|MDHC_FELCA","Q7YRU4","MDHC",1.13e-18,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase)","malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]","GO:0005813; GO:0005829; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0030060"
"g131016",119.39258445324,-0.393878462899404,0.100112555429134,-3.93435629737987,8.34199601476434e-05,0.015085869448951,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123234",165.66650555701,0.574441847330928,0.146108679795378,3.93160658309568,8.43800714986783e-05,0.0152105896834252,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10302",155.026218500261,0.76420477164857,0.19449939583938,3.92908558070617,8.52694914102654e-05,0.0152858745296319,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17401",441.199338232806,-0.605096255835572,0.154012280280531,-3.92888316914338,8.53412859127419e-05,0.0152858745296319,0,31413,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.61e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g119755",112.475731942544,0.851048579189496,0.216739817763248,3.9265908219925,8.61583680788913e-05,0.0153832347222,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75461",44.1835021069431,0.81915498361743,0.208705974398648,3.92492350052599,8.67573040243258e-05,0.0154411528257472,4485,8448,"sp|Q16851|UGPA_HUMAN","Q16851","UGPA",2.89e-14,"UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase)","brain development [GO:0007420]; glucose 1-phosphate metabolic process [GO:0019255]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011]","GO:0003983; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0005977; GO:0005978; GO:0006011; GO:0007420; GO:0019255; GO:0032557; GO:0042802; GO:0046872; GO:0070062"
"g117608",627.227124847191,0.924162392846713,0.235567128452158,3.9231381683816,8.7402992141104e-05,0.0154582361132075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132561",454.18016770999,4.95843241806453,1.26367220364426,3.92382803369819,8.71529571744043e-05,0.0154582361132075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87705",142.237224531049,-0.460951366006265,0.11763861764715,-3.91836775393657,8.9150619109746e-05,0.0157178969278067,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33312",427.345996419425,0.523177548376071,0.133612820043756,3.9156238765467,9.01707310261956e-05,0.0158480695449228,0,5414,"sp|Q9SF16|TCPH_ARATH","Q9SF16","TCPH",4.42e-17,"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (Chaperonin CCT7)","protein folding [GO:0006457]","GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0016887; GO:0051082"
"g88041",205.259713023226,0.730253911571023,0.186550556246962,3.91450942984211,9.05881976299089e-05,0.0158718424021848,0,7324,"sp|Q6NVG7|GT252_MOUSE","Q6NVG7","GT252",1.35e-103,"Procollagen galactosyltransferase 2 (EC 2.4.1.50) (Collagen beta(1-O)galactosyltransferase 2) (Glycosyltransferase 25 family member 2) (Hydroxylysine galactosyltransferase 2)",NA,"GO:0005788; GO:0050211"
"g102901",39.2487665754583,0.88245885169901,0.225532328960408,3.91278206440162,9.1238870393961e-05,0.0159362004617924,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17387",171.651938022084,-0.706889492405421,0.180961973001557,-3.90628749609918,9.37249925103899e-05,0.0162693858912634,0,27002,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.42e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g89746",31.9346666666255,2.62552301381433,0.672039538991184,3.90679842700264,9.35271127671103e-05,0.0162693858912634,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65016",118.600264094458,0.569214583907827,0.145783874604137,3.90450991547231,9.44165213094849e-05,0.0163389968968863,777,11544,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.53e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g29989",3063.6097657303,0.354598838350935,0.0909219795340512,3.90003429498732,9.61790631726501e-05,0.0165929535918901,9085,35022,"sp|P29775|ETS4_DROME","P29775","ETS4",4.19e-43,"DNA-binding protein D-ETS-4","cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565"
"g31683",92.6433588369986,0.407160625823015,0.104526454025078,3.89528784479124,9.80821807120776e-05,0.0168181036817337,21915,28562,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.2e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g101166",91.8148266850656,0.627504445278807,0.161091783487837,3.89532247823295,9.80681663521207e-05,0.0168181036817337,0,4064,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.14e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g17577",43.1955651211497,2.36143078080472,0.606491114266731,3.89359501772713,9.87694896046331e-05,0.016884479131744,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24981",640.661880151373,0.52038365511461,0.133806144308169,3.88908639289475,0.000100622296730227,0.0169390163700399,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25658",67.5536759205412,-0.49930346255641,0.128420888038381,-3.88802374896508,0.000101063740069859,0.0169390163700399,14200,20344,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.82e-15,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g69919",49.8153442712146,0.992472559209145,0.255126319088211,3.8901222059571,0.000100193751743225,0.0169390163700399,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75088",457.78753802876,-0.868117819285016,0.223231628911951,-3.88886567515674,0.000100713837215829,0.0169390163700399,2761,9912,"sp|Q292F9|GDAP2_DROPS","Q292F9","GDAP2",8.31e-15,"Protein GDAP2 homolog","response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]","GO:0006979; GO:0042594"
"g109499",240.837074422901,0.475933114458366,0.122420089640401,3.88770434539281,0.000101196783548476,0.0169390163700399,152,3654,"sp|Q66HV4|COPB_DANRE","Q66HV4","COPB",4.6e-11,"Coatomer subunit beta (Beta-coat protein) (Beta-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; notochord development [GO:0030903]; somite development [GO:0061053]","GO:0000139; GO:0005198; GO:0006886; GO:0006888; GO:0006891; GO:0030126; GO:0030903; GO:0061053"
"g113121",32.5256421004676,1.32379992579602,0.340206690479179,3.89116370383975,9.97645923088618e-05,0.0169390163700399,0,2824,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.07e-19,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g113228",321.944869295035,0.527223092755797,0.135488213135841,3.8912838287062,9.97152054442275e-05,0.0169390163700399,0,5132,"sp|Q2T9X2|TCPD_BOVIN","Q2T9X2","TCPD",1.86e-31,"T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","protein folding [GO:0006457]","GO:0005524; GO:0005815; GO:0005832; GO:0005929; GO:0006457; GO:0016887; GO:0042470; GO:0051082"
"g83009",25.0941159190227,-0.63384860736271,0.163146814583543,-3.88514240367307,0.000102269924605896,0.0170678489604889,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5108",91.1328217077686,-0.514191230215078,0.132456254545725,-3.88197017935135,0.000103613585792113,0.0172350174663104,43095,53844,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.01e-25,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g32321",4150.62503225257,3.48618519864944,0.898192219104465,3.88133533613252,0.000103884479945223,0.0172350174663104,5250,13374,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.93e-25,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g36240",317.985878420225,0.627916875933742,0.161809926727435,3.88058315477426,0.000104206308636132,0.0172375623832744,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93463",114.513752311324,1.33945269607168,0.345473273193418,3.87715287984597,0.000105685954350267,0.0174310540896415,0,6382,"sp|H9J9M0|CDA1_BOMMO","H9J9M0","CDA1",2.26e-15,"Chitin deacetylase 1 (BmCDA1) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0008061; GO:0008270"
"g4638",95.8671393071245,4.25946081557495,1.09917503779469,3.87514332941989,0.000106561958238043,0.0175241451907135,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39067",127.543947320159,-0.364822629353549,0.0941791746307377,-3.87370807595165,0.0001071918037761,0.0175763306938059,6745,24934,"sp|Q96IR2|ZN845_HUMAN","Q96IR2","ZN845",1.22e-114,"Zinc finger protein 845","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872"
"g28103",546.69824354665,-0.438386030992397,0.113223823912421,-3.87185325352984,0.000108010976645537,0.0176591667107509,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64976",171.147346296281,0.523403224353927,0.135236035264008,3.87029406276321,0.000108704151259659,0.0177209822467993,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19215",83.2193258491378,0.505365144058386,0.130660952033846,3.86775954247966,0.000109839895151456,0.0178476314375656,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125769",34.1341046061658,0.627294112317373,0.162211053792037,3.86714775382444,0.000110115716170038,0.0178476314375656,0,3953,"sp|Q498P2|RT35_DANRE","Q498P2","RT35",8.96e-18,"28S ribosomal protein S35, mitochondrial (MRP-S35) (S35mt)","mitochondrial translation [GO:0032543]","GO:0003735; GO:0005763; GO:0032543"
"g3892",116.539103901715,-0.572947891711999,0.148413486763504,-3.86048400456348,0.000113162648838924,0.0179609207320683,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11801",660.385928904539,0.409985047513608,0.106101138496377,3.86409659051499,0.000111501096733115,0.0179609207320683,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15055",134.163936148388,-0.442928993007041,0.114704543816218,-3.86147730744399,0.000112703481682856,0.0179609207320683,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49350",2707.54816966893,-0.704188748765739,0.182410968877846,-3.8604517759966,0.000113177576426118,0.0179609207320683,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68959",310.898215430775,0.382274613826387,0.0989497421608891,3.86332096959708,0.000111855879401369,0.0179609207320683,100,4131,"sp|A7YW45|ANM5_BOVIN","A7YW45","ANM5",4.9e-17,"Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (Histone-arginine N-methyltransferase PRMT5) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog)","chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; peptidyl-arginine methylation [GO:0018216]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0003714; GO:0005634; GO:0005794; GO:0005829; GO:0006325; GO:0006353; GO:0006355; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035243; GO:0042118; GO:0043985; GO:0044020; GO:0070888; GO:0090161"
"g84103",93.8853388636272,-0.54473650927106,0.141122066302382,-3.86003779241619,0.000113369490058751,0.0179609207320683,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137707",146.501157827107,0.370649936391721,0.0959411704885582,3.86330429891851,0.000111863516540498,0.0179609207320683,0,2664,"sp|Q14746|COG2_HUMAN","Q14746","COG2",6.7e-11,"Conserved oligomeric Golgi complex subunit 2 (COG complex subunit 2) (Component of oligomeric Golgi complex 2) (Low density lipoprotein receptor defect C-complementing protein)","glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]","GO:0000139; GO:0000301; GO:0005795; GO:0005829; GO:0006891; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0044877; GO:0070085"
"g148463",256.319686343532,-0.416543107105743,0.107835361412064,-3.86276914781262,0.00011210894043015,0.0179609207320683,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44751",141.503667976552,1.46803586773729,0.380666676825839,3.85648641477736,0.000115028487699537,0.0180207025214411,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55089",459.778876959222,1.26827278868462,0.328784967674823,3.85745369581184,0.000114574375391529,0.0180207025214411,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137545",18.5421503848749,1.82578197421193,0.473260968847629,3.85787566352162,0.000114376803123208,0.0180207025214411,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g149135",106.432795155886,0.855297232740928,0.221775345715669,3.85659294084689,0.000114978393534791,0.0180207025214411,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25703",171.860587083392,-0.911659558339852,0.236448704297308,-3.85563355506293,0.00011543028997502,0.0180334176910419,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94306",40.1533406434643,0.678889587581231,0.17611560684971,3.85479515259865,0.000115826571043427,0.0180452022399568,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32416",52.6929742117786,1.59296368050535,0.413746592394399,3.85009498516154,0.000118072026318171,0.0181437347108923,22096,32145,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.19e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g53304",167.618296469058,0.533800937201953,0.138616119868722,3.85092973102619,0.00011767026067451,0.0181437347108923,2128,15634,"sp|Q16U49|MED14_AEDAE","Q16U49","MED14",4.95e-12,"Mediator of RNA polymerase II transcription subunit 14 (Mediator complex subunit 14)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003712; GO:0006357; GO:0016592"
"g69555",888.057393994437,0.5739428357344,0.149004044860596,3.85186077513108,0.000117223667356185,0.0181437347108923,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92689",29.5221945623786,1.7902012310927,0.464900019535135,3.85072307134504,0.000117769606341336,0.0181437347108923,0,6631,"sp|Q8CHN6|SGPL1_RAT","Q8CHN6","SGPL1",2.81e-15,"Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL) (SPL 1) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase)","androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570]","GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0006807; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0008585; GO:0009791; GO:0010761; GO:0016021; GO:0030097; GO:0030149; GO:0030170; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190"
"g111725",49.8437048733515,0.590945471822216,0.153466702101487,3.85064293250679,0.000117808152048952,0.0181437347108923,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42349",24.8361218768574,-0.728895615032589,0.189432564990551,-3.84778411815807,0.000119191011228429,0.0182161436236666,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95295",142.682494528708,0.829424914656385,0.215541856058724,3.84809210527728,0.000119041300031196,0.0182161436236666,0,4768,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.9e-22,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g1504",147.035974275231,-0.648173392146476,0.168517645128321,-3.8463235802572,0.00011990339271641,0.0182753566752204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70052",214.844627367723,0.437642077434665,0.113836739768491,3.84447128690346,0.00012081262898989,0.018364172647701,425,10902,"sp|Q91VD9|NDUS1_MOUSE","Q91VD9","NDUS1",1.04e-52,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0009060; GO:0032981; GO:0042776; GO:0043209; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g116613",25.1122994972169,0.658106693239109,0.171265613440609,3.84260844905289,0.000121733594778331,0.0184542879717598,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20414",328.524660508418,-0.447971773902956,0.1166034794199,-3.84183882103352,0.000122116018931623,0.0184624976794417,21735,43649,"sp|Q24210|CSKP_DROME","Q24210","CSKP",6.88e-24,"Peripheral plasma membrane protein CASK (dCASK) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase) (CAKI) (Camguk)","adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; anesthesia-resistant memory [GO:0007615]; behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; cellular protein localization [GO:0034613]; locomotion [GO:0040011]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; medium-term memory [GO:0072375]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; regulation of locomotion [GO:0040012]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of terminal button organization [GO:2000331]; synaptic vesicle docking [GO:0016081]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]","GO:0004674; GO:0004683; GO:0004712; GO:0005102; GO:0005516; GO:0005524; GO:0005886; GO:0005911; GO:0007269; GO:0007274; GO:0007298; GO:0007615; GO:0007616; GO:0007628; GO:0008049; GO:0008344; GO:0008582; GO:0016080; GO:0016081; GO:0031594; GO:0034613; GO:0040011; GO:0040012; GO:0042043; GO:0046928; GO:0048149; GO:0048488; GO:0061174; GO:0072375; GO:0106310; GO:1900073; GO:1900244; GO:2000331"
"g68509",143.185988623825,1.55850108542822,0.405741130630435,3.8411217591045,0.000122473342248288,0.0184654949342912,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103969",86.6937722222748,1.18033869102354,0.307341211609382,3.84048297604715,0.000122792487916946,0.0184654949342912,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41854",285.653572019953,-0.751984580178655,0.195878380046682,-3.83903818277158,0.000123517222863139,0.0185249483953832,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8261",533.952595476356,0.763889617168031,0.199108120609285,3.83655681561594,0.000124771340574769,0.0185645231127147,6445,16804,"sp|Q24319|OST48_DROME","Q24319","OST48",1.99e-14,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit) (DmOST50) (DrOST) (OST5OP)","protein N-linked glycosylation via asparagine [GO:0018279]","GO:0008250; GO:0012505; GO:0016021; GO:0018279"
"g86841",31.4584984779566,-0.516197091868564,0.134528644796325,-3.83707940156597,0.000124506224711255,0.0185645231127147,0,8114,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.27e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g101476",1267.29909684255,0.480255358393403,0.125170505706466,3.8368092841267,0.000124643193057206,0.0185645231127147,0,6329,"sp|P12261|EF1G_ARTSA","P12261","EF1G",1.31e-16,"Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","glutathione metabolic process [GO:0006749]","GO:0003746; GO:0006749"
"g55718",3283.41678777807,0.282763251397085,0.0737310907868613,3.83506127984035,0.000125532992361887,0.0186285661119189,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3881",428.808863721154,0.384671659171502,0.100485155463669,3.82814414125658,0.000129113138857255,0.0189103675927337,105965,115318,"sp|Q5R664|COPB2_PONAB","Q5R664","COPB2",7.35e-29,"Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP)","intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005198; GO:0005829; GO:0006886; GO:0016192; GO:0030117; GO:0030663"
"g27191",352.28624069831,-0.582907758319665,0.152234338070864,-3.82901627652709,0.000128656498694895,0.0189103675927337,10036,28194,"sp|P21328|RTJK_DROME","P21328","RTJK",4.28e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g32170",106.562606715732,0.630528221344266,0.164637191657043,3.82980428054023,0.000128245218006365,0.0189103675927337,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47305",30.7741724598227,2.74589825522722,0.717252586220017,3.82835601848206,0.000129002062085835,0.0189103675927337,2322,4874,"sp|Q9VZ49|ENDOU_DROME","Q9VZ49","ENDOU",8.24e-17,"Endoribonuclease CG2145 (EC 4.6.1.-) (Poly(U)-specific endoribonuclease homolog) (Uridylate-specific endoribonuclease homolog)","RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]","GO:0003723; GO:0004521; GO:0005576; GO:0016829; GO:0046872; GO:0090502"
"g123940",92.0557962941835,0.571896704745466,0.149367471528977,3.82879015686168,0.000128774746017597,0.0189103675927337,0,4138,"sp|P48605|TCPG_DROME","P48605","TCPG",2.9e-20,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (Chaperonin containing TCP1 subunit 3)","lumen formation, open tracheal system [GO:0035149]; protein folding [GO:0006457]; terminal branching, open tracheal system [GO:0007430]","GO:0005524; GO:0005832; GO:0006457; GO:0007430; GO:0016887; GO:0035149; GO:0051082"
"g2860",184.700784373832,0.467831699025176,0.122351942253388,3.82365568056377,0.000131487504069546,0.0190105917837517,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13396",644.127550531823,0.57230010591124,0.149664042653187,3.82389848467089,0.000131358016699768,0.0190105917837517,0,2024,"sp|P12261|EF1G_ARTSA","P12261","EF1G",1.17e-28,"Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","glutathione metabolic process [GO:0006749]","GO:0003746; GO:0006749"
"g33590",263.039801471028,0.408934263663091,0.106942801484731,3.82385965194188,0.000131378718109171,0.0190105917837517,6934,19994,"sp|Q0P5L5|SUMF1_BOVIN","Q0P5L5","SUMF1",3.56e-19,"Formylglycine-generating enzyme (FGE) (EC 1.8.3.7) (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)","post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158]","GO:0005783; GO:0005788; GO:0018158; GO:0042802; GO:0043687; GO:0120147; GO:1903135"
"g87617",26.0931962323453,3.82849894416974,1.00109091921302,3.82432691246408,0.000131129829286789,0.0190105917837517,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141291",61.4951458414186,0.986151656967491,0.257806562218265,3.82516119249358,0.000130686550050858,0.0190105917837517,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9950",424.488255775908,-0.437371702672297,0.114502195166076,-3.81976696637059,0.000133577813986042,0.0192035360215123,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22016",97.7170444197853,0.777433872809239,0.203647767088912,3.81754184650506,0.000134787930656365,0.0192035360215123,0,13202,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.21e-30,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g41209",123.778632393257,1.40561887899323,0.367928615707503,3.82035758836075,0.000133258331509874,0.0192035360215123,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45625",237.982058777727,-0.667329088517024,0.174777868246009,-3.81815555489968,0.000134453141926197,0.0192035360215123,16286,19654,"sp|Q9NJB5|ONEC_DROME","Q9NJB5","ONEC",3.61e-19,"Homeobox protein onecut","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0045944"
"g46920",182.049834204706,-0.788393603430574,0.206526848168508,-3.81739038009874,0.000134870679003189,0.0192035360215123,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63839",286.339434876675,0.516139343240442,0.135181592638918,3.81811852608584,0.000134473319566169,0.0192035360215123,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44",127.934349541739,0.386459289923529,0.101437541484658,3.8098250831718,0.000139065144238674,0.0193442743994161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12402",61.6375276963794,-0.888475743702898,0.233343631035135,-3.80758514711344,0.000140330428415806,0.0193442743994161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28331",443.22813411699,-0.385442982386027,0.101226194270164,-3.80773953980048,0.000140242869056834,0.0193442743994161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29610",79.7764661918441,0.862060926775441,0.226184340632404,3.81132011334272,0.000138226627042727,0.0193442743994161,25796,33754,"sp|P11586|C1TC_HUMAN","P11586","C1TC",1.69e-26,"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) (Epididymis secretory sperm binding protein) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]","10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]","GO:0000105; GO:0001843; GO:0004329; GO:0004477; GO:0004486; GO:0004487; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0006730; GO:0007507; GO:0009069; GO:0009070; GO:0009086; GO:0009257; GO:0016020; GO:0035999; GO:0048702; GO:0048703; GO:0061053; GO:0070062"
"g30332",2738.36540701942,-1.00607569669303,0.26407640762256,-3.80979015032268,0.000139084794183109,0.0193442743994161,9354,31614,"sp|A2SXS5|MEN1_CANLF","A2SXS5","MEN1",3.4e-25,"Menin","chromatin organization [GO:0006325]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000403; GO:0000785; GO:0000976; GO:0003682; GO:0006325; GO:0006357; GO:0008285; GO:0035097; GO:0045786"
"g33314",238.440837972216,0.505376228196777,0.132676272677902,3.80909274881181,0.000139477634582904,0.0193442743994161,6495,10395,"sp|P80313|TCPH_MOUSE","P80313","TCPH",1.25e-20,"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0005524; GO:0005739; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:1901998; GO:1904851"
"g34468",35.2828461542338,1.25663248606477,0.329957746008991,3.80846487547083,0.00013983220415756,0.0193442743994161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41347",155.657488765535,0.552572041359862,0.145107156713509,3.8080274872371,0.000140079705437254,0.0193442743994161,5510,11304,"sp|Q28104|COPE_BOVIN","Q28104","COPE",4.17e-11,"Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005198; GO:0005654; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0099612"
"g55172",1308.41499164858,0.48426729241465,0.127114636395986,3.80968947514484,0.000139141439226308,0.0193442743994161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96285",722.225677166688,0.265448351046086,0.0697067400943455,3.80807294512427,0.000140053963356308,0.0193442743994161,0,2323,"sp|Q8MQI6|ELOF1_DROME","Q8MQI6","ELOF1",1.96e-15,"Transcription elongation factor 1 homolog","transcription elongation from RNA polymerase II promoter [GO:0006368]","GO:0000993; GO:0006368; GO:0008023; GO:0046872"
"g121833",629.978894849106,0.182951404518251,0.048020565862939,3.80985524078233,0.000139048182498825,0.0193442743994161,0,4324,"sp|Q3KNM2|MARH5_MOUSE","Q3KNM2","MARH5",4.68e-17,"E3 ubiquitin-protein ligase MARCHF5 (EC 2.3.2.27) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) (RING-type E3 ubiquitin transferase MARCHF5)","negative regulation of cell aging [GO:0090344]; positive regulation of mitochondrial fission [GO:0090141]; protein autoubiquitination [GO:0051865]; protein localization to mitochondrion [GO:0070585]; protein polyubiquitination [GO:0000209]; regulation of mitochondrial fission [GO:0090140]","GO:0000209; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0051020; GO:0051865; GO:0061630; GO:0070585; GO:0090140; GO:0090141; GO:0090344"
"g156417",152.197030999778,1.03539293326601,0.27167353257278,3.81116601039753,0.000138312838057901,0.0193442743994161,0,1340,"sp|P42860|GSTT1_LUCCU","P42860","GSTT1",3.51e-19,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749"
"g157688",38.5658665440703,1.54958191077571,0.40665768643375,3.81053146779301,0.000138668359132326,0.0193442743994161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9302",172.383217853817,-0.523476543797785,0.1375171132949,-3.80662836250211,0.000140874190507294,0.0193717511552842,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132716",52.9866074675864,3.18134961287252,0.836028445260353,3.80531264325796,0.000141625184695848,0.0194275210674729,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2359",1769.81584478524,-0.406005667826045,0.106736080925805,-3.80382776193807,0.000142477262702543,0.019496852089821,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2637",452.313751217034,-0.531981362070205,0.139908224623194,-3.80235946459157,0.000143324569936563,0.0195178219427897,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64376",52.8791516000363,0.561986394776397,0.147781643443799,3.80281597687145,0.000143060624353791,0.0195178219427897,10477,11614,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.52e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g15100",151.61776623466,0.560270541851974,0.147398975492867,3.8010477344131,0.00014408553850443,0.0195740552090969,36305,43009,"sp|Q27640|ALDH_ENCBU","Q27640","ALDH",4.29e-16,"Aldehyde dehydrogenase (EC 1.2.1.3) (Aldehyde dehydrogenase [NAD(+)])","ethanol catabolic process [GO:0006068]","GO:0004029; GO:0006068; GO:0043878"
"g95785",301.888268913669,-0.357974142806492,0.0941944700624343,-3.80037323389811,0.000144478313347066,0.0195801187934113,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28589",51.888890711238,-0.573633714101083,0.151037609257869,-3.79795282062302,0.000145896083967173,0.0195835025166628,0,4650,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.52e-27,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g69950",189.776573982403,0.738968770942402,0.194527630062089,3.7987856568578,0.000145406773640318,0.0195835025166628,0,3160,"sp|Q3T0R7|THIM_BOVIN","Q3T0R7","THIM",2.55e-17,"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-) (EC 3.1.2.1) (EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase)","fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]","GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0006635; GO:0016290; GO:0047617; GO:0102991; GO:1901029"
"g85684",2602.93722450664,-0.379352605709592,0.0998731042470684,-3.79834599684756,0.000145664891057886,0.0195835025166628,1745,8145,"sp|P48613|TIPE_DROME","P48613","TIPE",2.29e-16,"Protein tipE (Temperature-induced paralytic E)","cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]","GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433"
"g85988",2151.68888626002,0.297130396398197,0.0782166718360612,3.79881155031717,0.00014539158543874,0.0195835025166628,1975,4788,"sp|Q567C6|ZN367_DANRE","Q567C6","ZN367",5.46e-20,"Zinc finger protein 367","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872"
"g10731",1002.26778366814,0.373102998346239,0.0983509473301724,3.79358825181115,0.000148485822681261,0.0198580225196251,34875,57870,"sp|P21328|RTJK_DROME","P21328","RTJK",7.78e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g45973",24.0225593248879,-0.558923565862991,0.147367108227748,-3.79272941285652,0.000149000489016781,0.0198580225196251,0,11714,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.85e-21,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g81364",28.6260427853373,-0.632735169165659,0.166804724845394,-3.79326886424903,0.000148677022521387,0.0198580225196251,0,3326,"sp|P97471|SMAD4_MOUSE","P97471","SMAD4",1.13e-27,"Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4 homolog) (SMAD family member 4) (SMAD 4) (Smad4)","adrenal gland development [GO:0030325]; aging [GO:0007568]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac septum development [GO:0003279]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; cellular response to glucose stimulus [GO:0071333]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; female gonad development [GO:0008585]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; male gonad development [GO:0008584]; mesendoderm development [GO:0048382]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of binding [GO:0051098]; regulation of cell population proliferation [GO:0042127]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; tissue morphogenesis [GO:0048729]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]; wound healing [GO:0042060]","GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0001822; GO:0003148; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003279; GO:0003360; GO:0003677; GO:0003682; GO:0003700; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006357; GO:0006879; GO:0007179; GO:0007183; GO:0007283; GO:0007338; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0007568; GO:0008283; GO:0008285; GO:0008584; GO:0008585; GO:0009653; GO:0009952; GO:0010614; GO:0010666; GO:0010718; GO:0010862; GO:0014033; GO:0017015; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0030513; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032991; GO:0033686; GO:0035556; GO:0036302; GO:0042060; GO:0042118; GO:0042127; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0046881; GO:0048382; GO:0048589; GO:0048663; GO:0048729; GO:0048733; GO:0048859; GO:0051098; GO:0051571; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060548; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0072133; GO:0072134; GO:0072520; GO:0090575; GO:1902895; GO:1905305; GO:2000617"
"g21025",25.8786886003242,-0.65430069186222,0.17256590084457,-3.79159896978457,0.000149680476877242,0.0199014878972336,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4290",253.847528591173,0.634346260373193,0.167359264970474,3.79032651992769,0.000150449379939304,0.0199095859448149,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64675",475.635065504289,0.436628443756368,0.11519162163547,3.7904531384939,0.000150372701883898,0.0199095859448149,0,5904,"sp|Q963B6|RL10A_SPOFR","Q963B6","RL10A",1.38e-20,"60S ribosomal protein L10a","translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015934"
"g22384",247.633780790679,0.694989381505135,0.18345150950772,3.78840917346548,0.000151615000730492,0.0200167391340008,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9181",35.4678788261254,0.528963476296851,0.139684580447236,3.78684228855639,0.000152573870958392,0.0200472679000399,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57008",193.72772713414,-0.357173498805724,0.0943337405664812,-3.78627516157921,0.000152922334580374,0.0200472679000399,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103853",29.3321027273828,0.810062430527492,0.213979152316513,3.7857072605338,0.000153272024412666,0.0200472679000399,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146918",34.8671987347287,0.522925938509112,0.138120019281873,3.78602566976142,0.000153075868665618,0.0200472679000399,0,2257,"sp|Q71U00|SKP1_XENLA","Q71U00","SKP1",1.23e-11,"S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (S-phase kinase-associated protein 1A) (p19A) (p19skp1)","protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0006511; GO:0016567; GO:0019005; GO:0031467"
"g18128",95.3741588316538,0.721599675400934,0.190672856234658,3.78449082712053,0.00015402358797529,0.0200581829834931,9862,56101,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.99e-28,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g34302",110.174294162783,-0.500026737286912,0.132167908441807,-3.78326889773753,0.00015478203859813,0.0200581829834931,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69532",413.054053941556,-0.596091131077498,0.157554936740959,-3.78338593133105,0.000154709243997241,0.0200581829834931,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136703",28.1209337122379,0.560509241885077,0.148149151363019,3.78341176259341,0.000154693181358714,0.0200581829834931,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28255",24.9407291733793,1.88177711945841,0.497622568119604,3.78153492227893,0.000155864351377813,0.020105786353649,28044,33514,"sp|P04069|CBPB_ASTAS","P04069","CBPB",2.75e-12,"Carboxypeptidase B (EC 3.4.17.2)",NA,"GO:0004181; GO:0005576; GO:0008270"
"g61803",117.469108956002,0.667326603594344,0.176464962093064,3.78163798455587,0.000155799823372793,0.020105786353649,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41714",536.255883438119,-0.784805387721333,0.207855286225118,-3.77572974916476,0.000159539894252847,0.0205328208983264,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25704",984.026414965938,-0.709770798610442,0.188061882675177,-3.77413428236475,0.000160564262243427,0.0206174777102622,13205,20660,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",7.44e-48,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g87800",108.061049035991,0.69192517754969,0.183424137469114,3.77226894506291,0.000161769747914405,0.0207249525334896,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104685",83.2460821947546,-1.1843120091019,0.314068140239456,-3.77087598951916,0.000162675502703085,0.0207936264159702,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43508",55.8577192639194,0.98513493064323,0.26130338907006,3.77008095512721,0.000163194602262105,0.0208126775973363,0,16314,"sp|Q9W3Z3|AGT_DROME","Q9W3Z3","AGT",7.06e-18,"Alanine--glyoxylate aminotransferase (AGT) (EC 2.6.1.44)","glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]","GO:0004760; GO:0005777; GO:0008453; GO:0009436; GO:0019265"
"g22734",188.148649509568,1.40579174393643,0.373039512138837,3.76847947252629,0.000164244989084221,0.0208992458734723,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15413",156.930175103743,-0.385474464685478,0.102359173610541,-3.76590051568939,0.000165949865025943,0.0210685153697271,47084,51764,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.27e-20,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g18111",710.075839759503,0.262243725057501,0.0696991650617114,3.76250884533998,0.000168217356920859,0.0211356908481434,2566,16454,"sp|A2AKG8|FOCAD_MOUSE","A2AKG8","FOCAD",9.63e-27,"Focadhesin","regulation of posttranscriptional gene silencing [GO:0060147]","GO:0005925; GO:0016021; GO:0060147"
"g22402",39.7922461699537,1.17851829476993,0.313156449981566,3.76335309344354,0.000167650228375224,0.0211356908481434,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30756",123.574236298815,0.413907670315947,0.110008318000177,3.76251248851275,0.000168214905725989,0.0211356908481434,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53749",67.1496820443553,-1.15425630450489,0.306795398568233,-3.76229992330925,0.000168357979801007,0.0211356908481434,11533,14844,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.25e-39,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g83170",48.8962343405801,0.66034644202858,0.175451820599858,3.76369102224702,0.000167423727211732,0.0211356908481434,1076,8384,"sp|P21439|MDR3_HUMAN","P21439","MDR3",2.91e-19,"Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3)","bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557]; transmembrane transport [GO:0055085]","GO:0005524; GO:0005548; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0006629; GO:0015629; GO:0016020; GO:0016021; GO:0016324; GO:0030136; GO:0032376; GO:0032782; GO:0042626; GO:0042910; GO:0045121; GO:0045332; GO:0046581; GO:0055085; GO:0055088; GO:0061092; GO:0070062; GO:0090554; GO:0090555; GO:0140359; GO:1901557; GO:1903413; GO:2001140"
"g78621",175.389443996521,0.431824081966026,0.114834945907073,3.7603891268035,0.000169649254387698,0.0212503638424786,2455,7480,"sp|Q2TBL4|RPC3_BOVIN","Q2TBL4","RPC3",9.16e-47,"DNA-directed RNA polymerase III subunit RPC3 (RNA polymerase III subunit C3) (DNA-directed RNA polymerase III subunit C)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]","GO:0003697; GO:0003899; GO:0005654; GO:0005666; GO:0006351; GO:0032728; GO:0045087; GO:0045089; GO:0051607"
"g5120",64.4042199179105,0.934056674935971,0.2486985504675,3.75577852456376,0.000172803461067158,0.0215973605718647,13311,40384,"sp|A7NF38|ARLY_ROSCS","A7NF38","ARLY",1.77e-21,"Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)","arginine biosynthetic process via ornithine [GO:0042450]","GO:0004056; GO:0005737; GO:0042450"
"g19221",89.6835848110685,0.390750615770638,0.104078555909967,3.7543816048779,0.000173769956634609,0.021622057303194,0,31074,"sp|P11369|LORF2_MOUSE","P11369","LORF2",7.53e-17,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g28131",634.377312987985,-0.641366991527552,0.170811111226929,-3.75483179589806,0.000173457926339884,0.021622057303194,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10775",1289.00614308622,-0.632195966206965,0.168467003663874,-3.75263970069964,0.00017498226143438,0.0216557347763607,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24983",648.840919448557,0.508616016823928,0.135546569081095,3.75233412599056,0.000175195749141995,0.0216557347763607,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72884",18.4012146557799,1.08376178150719,0.288821652435807,3.75235641915063,0.000175180165896782,0.0216557347763607,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146181",21.0278864178713,2.659140899685,0.708910238594844,3.75102623000026,0.000176112272717185,0.0217212860573682,1014,2326,"sp|O61866|LIPL5_CAEEL","O61866","LIPL5",4.16e-17,"Lipase lipl-5 (EC 3.1.1.-) (Lipase-like 5)","defense response to Gram-negative bacterium [GO:0050829]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; triglyceride catabolic process [GO:0019433]","GO:0005576; GO:0005764; GO:0006629; GO:0016788; GO:0019433; GO:0043202; GO:0050829; GO:0055088"
"g130772",12687.4150253399,0.816121502802515,0.217695002829675,3.74892162058975,0.000177596573805107,0.021856425610387,0,1214,"sp|Q5UPS7|COLL4_MIMIV","Q5UPS7","COLL4",3.13e-12,"Collagen-like protein 4",NA,NA
"g42038",43.6799409516653,0.441532771097845,0.117822716863358,3.74743328665473,0.000178653331401321,0.0219384730669718,0,21784,"sp|P21328|RTJK_DROME","P21328","RTJK",1.82e-39,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g68472",21.3545926133717,0.747568575909867,0.199726413663191,3.74296299722545,0.000181863018217656,0.0222597115372451,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127988",262.273976144484,0.540194342907147,0.144333183037315,3.74268987587897,0.000182060867450175,0.0222597115372451,0,3790,"sp|Q90YV8|RL10A_ICTPU","Q90YV8","RL10A",1.36e-19,"60S ribosomal protein L10a","hemoglobin biosynthetic process [GO:0042541]; translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015934; GO:0042541"
"g113463",71.9861945238447,0.550658341539976,0.14718106742342,3.74136667969532,0.000183022259704843,0.0223287156839909,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23737",275.100938112982,-0.408547758324929,0.109248589958258,-3.73961584749999,0.000184301695702786,0.0224361384625889,2324,21644,"sp|Q9UQ26|RIMS2_HUMAN","Q9UQ26","RIMS2",1.3e-17,"Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 3)","adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; spontaneous neurotransmitter secretion [GO:0061669]","GO:0006886; GO:0007188; GO:0017156; GO:0017157; GO:0030073; GO:0030154; GO:0031267; GO:0042391; GO:0042734; GO:0042995; GO:0044325; GO:0046872; GO:0048167; GO:0048786; GO:0048788; GO:0048791; GO:0050806; GO:0061669; GO:0070062; GO:0097151; GO:1903861; GO:2000463"
"g92129",212.106522883938,-0.355837253874747,0.0951786645357862,-3.73862415080383,0.000185030111900454,0.0224761631825169,0,7363,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.19e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g115718",48.866554308516,1.31118497177825,0.35094109347466,3.73619674685638,0.000186824512486058,0.022596525228475,406,4834,"sp|Q6TLF6|RGN_DANRE","Q6TLF6","RGN",7.61e-14,"Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17)","cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]","GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0019853; GO:0030234; GO:0032781; GO:0050848"
"g116298",102.667233567142,1.04689798949601,0.280179321153761,3.7365283961177,0.000186578387539062,0.022596525228475,0,3054,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.38e-20,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g98919",31.7636178364297,2.41206919332965,0.645852979722301,3.73470320500305,0.000187936692705902,0.0226822649595823,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145678",177.784090364766,-1.00375538921975,0.268822967469832,-3.73388999707548,0.000188544869464494,0.0227069390758503,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90591",174.254053386902,0.78323864627467,0.209884555913266,3.73175931343104,0.000190147136153828,0.0228509727170162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5498",58344.0461523193,0.299701571047559,0.0803711575323115,3.72896920051289,0.000192264647357062,0.0230561797370062,56627,94494,"sp|P13607|ATNA_DROME","P13607","ATNA",0,"Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha)","adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic assembly at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]","GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0016887; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0045202; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573"
"g46846",20.6698619304183,-0.747354247558396,0.20048205220522,-3.72778629976005,0.000193169063256748,0.0231153499057149,0,14444,"sp|P21328|RTJK_DROME","P21328","RTJK",1.54e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g15593",57.1324681018982,0.507012640952619,0.136085252554721,3.72569864430199,0.000194774993510977,0.0231917093641909,31524,44598,"sp|P55786|PSA_HUMAN","P55786","PSA",1.1e-16,"Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)","cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]","GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955"
"g87119",181.895827587105,-0.822223682082869,0.220710439588115,-3.72535020825152,0.000195044246813099,0.0231917093641909,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89184",296.305457612888,2.46201387549502,0.660746950174738,3.72610705935749,0.000194459836193277,0.0231917093641909,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73030",71.3764653639039,1.49401698264045,0.401219934320446,3.72368582625609,0.000196335227384208,0.0232469175969319,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112406",26.1261759796071,-0.7363186070716,0.197715307803561,-3.72413555253479,0.000195985607069118,0.0232469175969319,1306,5212,"sp|Q9VS29|DSCL_DROME","Q9VS29","DSCL",8.45e-19,"Down syndrome cell adhesion molecule-like protein Dscam2","axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]","GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632"
"g38678",84.4803740858738,-0.327730224232008,0.0880500628698846,-3.72208961072872,0.000197580873472149,0.0232987063292505,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63142",152.924485918276,1.39326637098638,0.374379486012156,3.72153502807348,0.00019801539108463,0.0232987063292505,1399,8094,"sp|Q9CPP7|LIPG_MOUSE","Q9CPP7","LIPG",3.19e-13,"Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3)","lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]","GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0016042; GO:0016615; GO:0043231"
"g113371",1035.35958424192,0.392461813283311,0.105444994740404,3.7219577301845,0.000197684121112593,0.0232987063292505,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8169",86.271702571424,0.445445855809524,0.119760942165139,3.71945851256993,0.00019965033642832,0.0233089220331142,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41311",21.3473094866619,-0.642027667649749,0.17258215252186,-3.72012782473799,0.000199121973121927,0.0233089220331142,13517,14374,"sp|B3LYS5|FOXO_DROAN","B3LYS5","FOXO",3.37e-34,"Forkhead box protein O","cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]","GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0007049; GO:0008285; GO:0010259; GO:0019216; GO:0030154; GO:0030308; GO:0042593; GO:0043565; GO:0046627"
"g107688",54.1026713546862,2.0094983364671,0.540242940471138,3.71961979681705,0.000199522896322371,0.0233089220331142,0,5676,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.54e-21,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g109418",20.1312913313291,-1.01063631725587,0.271726111648791,-3.71931983688828,0.000199759973328847,0.0233089220331142,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114579",65.2711839313877,0.628319127007798,0.16899230756923,3.71803389187048,0.000200779338314039,0.0233793613777602,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48146",623.107028109084,2.38838883254805,0.642518280667757,3.71723094020896,0.000201418312077723,0.0234053072476763,15250,18064,"sp|P55115|NAS15_CAEEL","P55115","NAS15",1.27e-13,"Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)",NA,"GO:0004222; GO:0005576; GO:0008270"
"g17462",160.606230482897,0.622215350189944,0.167504567246422,3.71461722159838,0.00020351151553449,0.023590186201938,482,13744,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.67e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g28675",40.8691972795234,-0.477251099486728,0.128511662965623,-3.71367927605446,0.000204267641270648,0.023590186201938,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116543",173.80259928985,1.23011760062217,0.331207855153166,3.71403510358564,0.000203980480415077,0.023590186201938,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53609",127.511124920468,0.460574128080173,0.124057614786739,3.71258248735413,0.000205155165587937,0.0236196328524624,3834,9714,"sp|A7YW45|ANM5_BOVIN","A7YW45","ANM5",5.08e-14,"Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (Histone-arginine N-methyltransferase PRMT5) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog)","chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; peptidyl-arginine methylation [GO:0018216]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0003714; GO:0005634; GO:0005794; GO:0005829; GO:0006325; GO:0006353; GO:0006355; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035243; GO:0042118; GO:0043985; GO:0044020; GO:0070888; GO:0090161"
"g71374",37.2626887057869,-0.667849740465948,0.179900576547529,-3.71232684898875,0.000205362548715446,0.0236196328524624,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31152",25.5189937896827,-1.03786978222275,0.279846119944361,-3.70871599873923,0.000208312915554867,0.0239100714217079,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g313",10993.668213702,-0.444554514341224,0.119902139752159,-3.70764454462722,0.000209196013449721,0.0239138255862586,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102578",231.030461986398,-0.710065136618594,0.191513117758332,-3.70765796583509,0.000209184929909516,0.0239138255862586,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14626",785.438510290891,-0.327436125486094,0.0883674314955925,-3.70539371739492,0.000211062620532205,0.0239492297628074,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27170",1310.24950645519,0.566088104801065,0.152781323394769,3.705217969204,0.000211209024614211,0.0239492297628074,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57575",54.5147899091101,0.926713849106988,0.250059306291103,3.70597624560378,0.000210578036369441,0.0239492297628074,889,11704,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.42e-52,"PiggyBac transposable element-derived protein 4",NA,NA
"g63943",73.9215806355638,1.46225092357734,0.394617057301635,3.70549345630449,0.000210979577103261,0.0239492297628074,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19281",1132.30356084924,0.787011986629748,0.212477950976421,3.70397014378722,0.000212251250353117,0.024018983545996,6098,10686,"sp|Q9CY50|SSRA_MOUSE","Q9CY50","SSRA",1.17e-26,"Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha)",NA,"GO:0005783; GO:0005789; GO:0016021"
"g3883",2647.97266600251,-0.384223804476499,0.103779877981772,-3.70229578169272,0.000213657323469509,0.0240811927586616,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4941",283.57037843666,-0.476203249199368,0.128618352094516,-3.7024517997978,0.000213525936076903,0.0240811927586616,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g945",143.013655478079,0.274158672875591,0.0741319289709769,3.6982535957337,0.000217087946223843,0.024099729909012,55990,61154,"sp|P21328|RTJK_DROME","P21328","RTJK",1.13e-23,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g8401",33.3067328713528,-0.792324431320417,0.214357398682578,-3.69627750751771,0.000218783821424606,0.024099729909012,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10917",892.833873153327,-0.449012631797622,0.121483845657114,-3.69606863668896,0.000218963799002616,0.024099729909012,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18849",116.87222711871,0.315194937992726,0.0852543756683946,3.69711156197669,0.000218066526024296,0.024099729909012,0,32014,"sp|P11369|LORF2_MOUSE","P11369","LORF2",7.76e-17,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g27178",39.433792941803,1.1748297835511,0.317854262002479,3.6961272004021,0.000218913322431441,0.024099729909012,35810,37004,"sp|Q5U3U0|PHYD1_DANRE","Q5U3U0","PHYD1",2.07e-11,"Phytanoyl-CoA dioxygenase domain-containing protein 1 (Protein PHYHD1) (EC 1.14.11.-)",NA,"GO:0046872; GO:0051213"
"g30496",362.572987744652,-0.592913510370775,0.160264097930039,-3.69960283075754,0.000215937134307177,0.024099729909012,1865,5553,"sp|Q641Z2|PTN9_RAT","Q641Z2","PTN9",1.76e-12,"Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48)","negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]","GO:0004725; GO:0005737; GO:0006470; GO:0010977; GO:0035335; GO:0044306; GO:1903078"
"g42491",679.531870580858,0.328006038993565,0.0887310703906901,3.69663115241739,0.0002184794130958,0.024099729909012,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43054",24.1438993716235,-0.806817890429427,0.218032206123849,-3.70045281278825,0.000215215097168398,0.024099729909012,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77463",64.688088327411,0.502564073628351,0.135796398775127,3.70086451600661,0.000214866181768104,0.024099729909012,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105377",149.508053257315,2.54438683938643,0.688012468021653,3.69816966646359,0.000217159722479307,0.024099729909012,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125421",75.6080060860018,0.592405565712848,0.160205579629458,3.69778360456003,0.000217490169430343,0.024099729909012,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131232",589.252570205769,2.99428924115246,0.809477153997503,3.6990410740631,0.000216415579405591,0.024099729909012,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65173",277.786091727319,1.0352340150972,0.280147943335483,3.69531185120101,0.000219617062705607,0.0241244196107202,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18404",263.874145917255,0.393124750318326,0.106423837118676,3.69395392011608,0.000220793830000983,0.0242064066021741,48225,55293,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.91e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g25873",133.484708468277,-0.342246478236745,0.092713894899509,-3.69142595732495,0.000223000316777374,0.0243873204738204,0,41218,"sp|P21329|RTJK_DROFU","P21329","RTJK",6.02e-30,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g107204",49.6279830868877,1.72652354564565,0.46775671544695,3.69107163751978,0.000223311227268189,0.0243873204738204,175,3899,"sp|P21328|RTJK_DROME","P21328","RTJK",2.16e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g38725",1806.63553327406,-0.403015459106318,0.109242547345222,-3.6891803505161,0.00022497769862765,0.0244806305823697,8941,25494,"sp|P21521|SY65_DROME","P21521","SY65",2.79e-28,"Synaptotagmin 1 (p65)","calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007268; GO:0007269; GO:0007317; GO:0008021; GO:0008345; GO:0014059; GO:0016021; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030285; GO:0030424; GO:0030672; GO:0031045; GO:0031340; GO:0031594; GO:0042803; GO:0043195; GO:0048488; GO:0048791; GO:0050803; GO:0060024; GO:0070382; GO:0071277; GO:0150007; GO:1900073"
"g111757",41.1831836905983,1.53370791993433,0.415738803080808,3.68911419518428,0.000225036200901197,0.0244806305823697,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144102",60.4300633683203,0.758570260985382,0.205670924730107,3.68827174760273,0.000225782441318187,0.024514393947138,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108963",437.2606391365,2.99766818895952,0.812991628174992,3.68720671292607,0.000226729174066366,0.0245697537723325,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122595",31.4384289356915,-1.01519728540907,0.275403593270681,-3.68621655713578,0.000227612686527066,0.0246180629147216,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28644",98.8280986405506,-0.623316051043009,0.169138668876159,-3.68523682481734,0.000228490077937838,0.0246655258414201,6188,17364,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.96e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g6438",181.826811191958,-0.392431898076183,0.106603236640272,-3.68123811662892,0.000232104111654534,0.0249909221597662,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64090",56.8389199406711,2.58599001866025,0.702559690330609,3.68081182887584,0.000232492539020173,0.0249909221597662,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103418",171.830037366037,0.714013636896638,0.194002571924823,3.6804338716361,0.000232837438421776,0.0249909221597662,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142209",19.8687761462302,3.15817859255206,0.858271507545931,3.67969641865694,0.000233511773275662,0.0250155602906091,0,2667,"sp|P04746|AMYP_HUMAN","P04746","AMYP",5.01e-14,"Pancreatic alpha-amylase (PA) (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate catabolic process [GO:0016052]; carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245]","GO:0004556; GO:0005509; GO:0005576; GO:0005615; GO:0005975; GO:0016052; GO:0031404; GO:0044245; GO:0070062"
"g79538",1133.38039954231,0.927021490249571,0.252123965354604,3.67684797018699,0.000236133673794409,0.0252004365873722,85,5342,"sp|Q93113|GST1D_ANOGA","Q93113","GST1D",4.02e-22,"Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g94956",95.663112775643,1.23443327630714,0.335729697385752,3.6768664968258,0.000236116531753122,0.0252004365873722,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147631",117.155667826267,-0.976095126488419,0.265563397209774,-3.6755634878303,0.000237325010915607,0.0252796084543856,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73664",430.246986496838,0.317971561379053,0.0865305285753985,3.67467489929855,0.000238152460416089,0.0253197933435193,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134850",182.667582694337,0.53429231132039,0.14547287395104,3.6727968370255,0.000239910217632907,0.0254391993855308,0,3243,"sp|Q91VD9|NDUS1_MOUSE","Q91VD9","NDUS1",1.66e-53,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0009060; GO:0032981; GO:0042776; GO:0043209; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g137244",22.1157674190859,2.6465886799264,0.720648555384787,3.67250951958582,0.000240180201161354,0.0254391993855308,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7372",18.5654072628552,1.54793518225263,0.421586537127697,3.67169026031721,0.000240951600412981,0.0254729321624566,67786,78254,"sp|P21328|RTJK_DROME","P21328","RTJK",6.07e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g95442",270.808951693811,0.308962840607977,0.0841671095605956,3.67082631470837,0.000241767593123456,0.0255112438507494,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111224",252.540483797171,0.563380007322737,0.153632038961914,3.66707368547261,0.000245342113155293,0.0257975137263713,0,5322,"sp|Q5ZIK9|COPE_CHICK","Q5ZIK9","COPE",6.62e-26,"Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005198; GO:0005654; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0099612"
"g116942",24.5091550881256,-0.941365103136512,0.256711514266762,-3.6670155050322,0.000245397920479511,0.0257975137263713,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20451",2227.53038965082,-0.626493279054907,0.170992339626219,-3.66386751841862,0.000248435319006316,0.0260680955439426,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4116",160.388215422715,-0.712892671908325,0.194630308119534,-3.66280400414562,0.000249469416270975,0.0261131356847661,0,14784,"sp|Q8MQJ9|BRAT_DROME","Q8MQJ9","BRAT",2.14e-109,"Brain tumor protein","asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]","GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0007400; GO:0007402; GO:0007405; GO:0007406; GO:0007419; GO:0007420; GO:0008270; GO:0008285; GO:0008356; GO:0008582; GO:0009303; GO:0010629; GO:0014016; GO:0014019; GO:0017148; GO:0030182; GO:0030371; GO:0035282; GO:0043025; GO:0045179; GO:0045180; GO:0045182; GO:0048477; GO:0050767; GO:0055060; GO:0099738; GO:1900242; GO:1902692"
"g23932",506.286044645104,0.766811265489976,0.209484857553664,3.66046154573984,0.000251761337550347,0.0261131356847661,28766,40034,"sp|A0A291PQH4|UGT2_DACCO","A0A291PQH4","UGT2",1.46e-13,"UDP-glucosyltransferase 2 (DcUGT2) (EC 2.4.1.-)","organic acid biosynthetic process [GO:0016053]","GO:0005783; GO:0005789; GO:0016021; GO:0016053; GO:0035251"
"g31292",31.1687054890043,0.462188637123362,0.126289532299223,3.65975412774733,0.0002524573664679,0.0261131356847661,1801,26226,"sp|P21328|RTJK_DROME","P21328","RTJK",8.92e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g50117",1597.73861321738,-0.337911705688062,0.092268199475196,-3.66227700995619,0.00024998332830451,0.0261131356847661,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51206",121.597302955587,-0.475966665717622,0.130020498193482,-3.66070482985952,0.000251522386362371,0.0261131356847661,2470,6444,"sp|P21328|RTJK_DROME","P21328","RTJK",9.99e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g108699",142.769305028564,0.43201277469837,0.118032890578112,3.66010501464821,0.000252111903411804,0.0261131356847661,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132516",81.3543114654569,1.07978574096597,0.294877641940747,3.66180946734153,0.000250440095662332,0.0261131356847661,0,3426,"sp|B2D0J5|EST6_APIME","B2D0J5","EST6",2.23e-18,"Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)",NA,"GO:0005576; GO:0080030"
"g132705",63.4471144256521,-1.63835314668955,0.447682639610857,-3.6596307333107,0.00025257895900773,0.0261131356847661,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9411",261.200549972483,0.36389512668553,0.0994690452607787,3.65837558540452,0.00025381890286054,0.0261798186390688,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31381",41.2102018734966,2.29112442083441,0.626374019268987,3.65775774593634,0.000254431352624797,0.0261798186390688,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56002",105.469638467783,0.431906470482688,0.11809694090898,3.65721979890715,0.000254965735251585,0.0261798186390688,0,3514,"sp|Q9GZR7|DDX24_HUMAN","Q9GZR7","DDX24",3.25e-16,"ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24)","RNA metabolic process [GO:0016070]","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016020; GO:0016070; GO:0016887"
"g146747",142.014420854893,0.352717188331679,0.0964472631009964,3.65709898851484,0.000255085889801389,0.0261798186390688,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4132",1845.23442108583,-0.3712122465532,0.10154912181881,-3.65549440413221,0.00025668680787206,0.0262483262697098,5397,14164,"sp|Q80T69|RSBN1_MOUSE","Q80T69","RSBN1",6.46e-19,"Lysine-specific demethylase 9 (KDM9) (EC 1.14.11.-) (Round spermatid basic protein 1) (Rosbin)","chromatin organization [GO:0006325]","GO:0005634; GO:0006325; GO:0035575; GO:0046872"
"g97861",7070.33438530528,0.473873692608717,0.129630135275625,3.65558279794391,0.000256598371382502,0.0262483262697098,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30501",276.841906762989,-0.505941650850132,0.138460680970678,-3.65404566338422,0.000258140327197371,0.0263184321984569,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34741",463.036197107569,-0.504160844996705,0.13800662455679,-3.65316408988209,0.000259028581794446,0.0263184321984569,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48064",68.8907264730872,0.871214500490329,0.238450077059137,3.65365577245867,0.000258532820114711,0.0263184321984569,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55724",59.6225916492108,-0.479884662409554,0.131369055687593,-3.65295053616555,0.000259244184736409,0.0263184321984569,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57552",157.493115353274,0.847147340342021,0.232016221374239,3.65124186285054,0.000260975323318913,0.0264464398812654,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7284",663.455277955028,0.47000678967306,0.128796610359792,3.64921707458062,0.000263040763944136,0.0264857277693192,0,10835,"sp|Q66X93|SND1_RAT","Q66X93","SND1",7.37e-18,"Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (SND p102) (p100 co-activator) (p105 coactivator)","gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; regulation of cell cycle process [GO:0010564]","GO:0003713; GO:0003723; GO:0004518; GO:0004519; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0010564; GO:0010587; GO:0016442; GO:0031047; GO:0042470; GO:0097433; GO:1905172"
"g16166",153.452823308834,-0.533008933192505,0.146069223623181,-3.64901599372859,0.00026324671638721,0.0264857277693192,21556,46034,"sp|Q95YM8|MBLK1_APIME","Q95YM8","MBLK1",4.32e-16,"Mushroom body large-type Kenyon cell-specific protein 1","memory [GO:0007613]; positive regulation of transcription, DNA-templated [GO:0045893]","GO:0005634; GO:0007613; GO:0043565; GO:0045893"
"g98731",1677.35787206633,0.711712902335649,0.195014240575394,3.64954323456443,0.000262707023281064,0.0264857277693192,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119460",87.3689104471988,1.58759720515744,0.435047728887982,3.64924834618829,0.000263008748294885,0.0264857277693192,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7179",14475.969436793,0.31030453607048,0.0851796585790198,3.64294176857513,0.000269539831889451,0.0266116450075056,1455,18689,"sp|P82013|VDAC2_MELGA","P82013","VDAC2",7.11e-36,"Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin 2)",NA,"GO:0000166; GO:0005741; GO:0008308; GO:0015288; GO:0046930"
"g15116",132.568147717088,1.0413290593343,0.2855961074427,3.64615984671018,0.000266188431582725,0.0266116450075056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17345",577.286933862901,0.772399348320846,0.211880566286813,3.64544687536508,0.000266927554579158,0.0266116450075056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41474",42.8144484669316,0.763570987368802,0.209570433653408,3.64350530777453,0.000268950103479144,0.0266116450075056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68625",76.1055531550578,3.73308431089984,1.02478824874727,3.6427860247844,0.000269703027173255,0.0266116450075056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70521",53.0126669041456,-0.412914826499945,0.113341610908516,-3.6431000335193,0.000269374089653357,0.0266116450075056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78298",145.649519489968,-1.26882718402758,0.348170203468381,-3.64427274760407,0.000268148943474708,0.0266116450075056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82311",284.055781586444,0.513841923614138,0.140992069340459,3.64447394820019,0.00026793927285985,0.0266116450075056,5855,8766,"sp|P80317|TCPZ_MOUSE","P80317","TCPZ",3.39e-15,"T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0001669; GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:0071987; GO:1901998; GO:1904851"
"g94365",25.8735993679464,0.814744821078001,0.223481834497411,3.64568701035716,0.000266678396881322,0.0266116450075056,0,4474,"sp|O96553|C1TC_DROME","O96553","C1TC",9.07e-23,"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]","cellular amino acid biosynthetic process [GO:0008652]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]","GO:0000105; GO:0004329; GO:0004477; GO:0004488; GO:0005524; GO:0005737; GO:0005829; GO:0006164; GO:0008652; GO:0009086; GO:0035999"
"g111412",524.248595550829,2.27117331356341,0.62277186523415,3.64687848046811,0.000265445380319935,0.0266116450075056,0,4944,"sp|Q95029|CATL_DROME","Q95029","CATL",2.01e-24,"Cathepsin L (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]","digestion [GO:0007586]; immune response [GO:0006955]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]","GO:0004197; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0007586; GO:0008233; GO:0008234; GO:0045169; GO:0051603"
"g137406",507.364120051427,-0.204899436053551,0.0561882938474566,-3.64665701738204,0.000265674160668226,0.0266116450075056,0,3045,"sp|E9Q5F9|SETD2_MOUSE","E9Q5F9","SETD2",1.68e-11,"Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2)","angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 methylation [GO:0010452]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]; vasculogenesis [GO:0001570]","GO:0001525; GO:0001570; GO:0001763; GO:0001843; GO:0005634; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010452; GO:0010468; GO:0010569; GO:0010793; GO:0016279; GO:0018023; GO:0018024; GO:0018026; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0046872; GO:0046975; GO:0048332; GO:0048568; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0097198; GO:0097676; GO:1902850; GO:1905634"
"g69921",124.621218125242,0.991091773781836,0.272136544278389,3.64189152327875,0.000270642120673998,0.0266575379175954,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31396",970.734391297305,0.36745732263445,0.100924733707184,3.64090455468098,0.000271681846998393,0.0267131651029434,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34301",130.812450313286,-0.465374726766485,0.127837209123444,-3.64036988884124,0.000272246655272218,0.0267219832213265,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17573",35.3520541989637,2.19899898785202,0.604734546590735,3.63630455751064,0.000276577309949965,0.0267288429637179,0,7989,"sp|Q04519|ASM_MOUSE","Q04519","ASM",1.48e-13,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g26579",106.696101583312,0.341363625403501,0.0938323207281382,3.63801750563688,0.000274744754940555,0.0267288429637179,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35214",199.881027413757,0.402217776638039,0.11059747839869,3.63677167383595,0.000276076444440255,0.0267288429637179,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40226",54.6199646275265,1.3564945607909,0.373134371753855,3.63540500012079,0.000277544260353672,0.0267288429637179,0,4642,"sp|P35502|ESTF_MYZPE","P35502","ESTF",1.98e-17,"Esterase FE4 (EC 3.1.1.1) (Carboxylic-ester hydrolase)",NA,"GO:0080030"
"g50521",111.418341896994,2.44532486616975,0.672586973645581,3.63570060376803,0.00027722616174961,0.0267288429637179,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53974",11943.7489716679,-0.475891921273869,0.13080218707424,-3.63825660654867,0.000274489865719413,0.0267288429637179,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67045",503.557860618833,0.690272606918573,0.189783010467712,3.63716754844086,0.000275652633467498,0.0267288429637179,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87001",21.8726883459762,0.991911469772725,0.272722926447593,3.63706668409975,0.000275760557753903,0.0267288429637179,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90287",35.3880424381296,1.36450818483309,0.375268264622963,3.63608733662578,0.000276810515022485,0.0267288429637179,0,7655,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.74e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g112759",36.3429570146849,0.620965108595191,0.170619761097023,3.63946769473015,0.000273202207702283,0.0267288429637179,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118271",57.5490041052222,0.724802549020773,0.199256108735125,3.63754242528277,0.000275251864188279,0.0267288429637179,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32412",42.661100424486,1.89867514257664,0.52250470249597,3.63379531994027,0.000279282445581708,0.0268502620588144,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42134",350.196598251052,-0.639768315810606,0.176089033815654,-3.63320930297326,0.000279917774801146,0.0268654189255394,0,14130,"sp|Q66KB0|UBE2Z_XENTR","Q66KB0","UBE2Z",1.03e-30,"Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z)","apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]","GO:0004869; GO:0005524; GO:0005634; GO:0005737; GO:0006915; GO:0043066; GO:0061631"
"g35215",48.9450559653291,0.46494238134482,0.127990807058963,3.63262324871995,0.000280554498708378,0.0268806577791424,6805,12034,"sp|A4FUY7|MOC2B_BOVIN","A4FUY7","MOC2B",2.2e-22,"Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B)","Mo-molybdopterin cofactor biosynthetic process [GO:0006777]","GO:0005829; GO:0006777; GO:0016607; GO:0019008; GO:0030366"
"g19117",105.788914993252,-0.471851322404534,0.129925110576223,-3.63171768961253,0.000281541020816224,0.0268835825004178,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142014",869.988952235401,0.559052317257451,0.153918785575021,3.6321253131572,0.000281096551430763,0.0268835825004178,0,2684,"sp|P35979|RL12_MOUSE","P35979","RL12",1.78e-13,"60S ribosomal protein L12","cytoplasmic translation [GO:0002181]; translation [GO:0006412]","GO:0002181; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0014069; GO:0015934; GO:0022625; GO:0022626; GO:0070180"
"g153583",44.8128170471619,0.519762237548326,0.143145446353964,3.63100783704345,0.000282316610577353,0.0269119505289687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27721",1134.76379792466,0.47013168714394,0.12950826421873,3.63012885687295,0.00028327976465424,0.0269580719520876,35909,38234,"sp|Q9TZH6|PHS_CAEEL","Q9TZH6","PHS",7.37e-21,"Putative pterin-4-alpha-carbinolamine dehydratase (PHS) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Pterin carbinolamine dehydratase) (PCD)","tetrahydrobiopterin biosynthetic process [GO:0006729]","GO:0006729; GO:0008124"
"g142349",399.108973749486,0.682025962677479,0.187931421493377,3.62912150218326,0.000284387372665181,0.0270177611713431,0,2544,"sp|A0A291PQF1|UGT5_DACCO","A0A291PQF1","UGT5",5e-15,"UDP-glycosyltransferase UGT5 (EC 2.4.1.-) (UDP-glucosyltransferase 5) (DcUGT5)",NA,"GO:0005783; GO:0008194; GO:0016021"
"g100360",27.7026813220298,1.62670704804199,0.448377514910744,3.62798533366647,0.000285641482817237,0.0270911438054081,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125773",24.5955615232438,0.765713857394531,0.211148420428205,3.62642474824902,0.000287372515183145,0.0272094360251354,0,3973,"sp|O88342|WDR1_MOUSE","O88342","WDR1",1.4e-22,"WD repeat-containing protein 1 (Actin-interacting protein 1) (AIP1)","actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; apical junction assembly [GO:0043297]; cortical cytoskeleton organization [GO:0030865]; establishment of planar polarity of follicular epithelium [GO:0042247]; locomotion [GO:0040011]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; platelet formation [GO:0030220]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of cell shape [GO:0008360]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605]","GO:0002102; GO:0002446; GO:0003779; GO:0005886; GO:0005911; GO:0007605; GO:0008360; GO:0015629; GO:0030036; GO:0030042; GO:0030043; GO:0030054; GO:0030220; GO:0030834; GO:0030836; GO:0030864; GO:0030865; GO:0040011; GO:0042247; GO:0042995; GO:0043209; GO:0043297; GO:0045199; GO:0045214; GO:0048713; GO:0051015; GO:0060307; GO:1990266"
"g49826",86.171374161664,0.373998880097146,0.103148780746931,3.62581968869537,0.000288046299347683,0.0272273949040544,7108,17442,"sp|P21328|RTJK_DROME","P21328","RTJK",1.36e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g35164",1360.0361164176,-0.387220864500852,0.106855281857459,-3.62378777885205,0.000290319846242354,0.0272464990679912,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45248",182.651199977563,0.490761823100368,0.135448072786985,3.62324699792645,0.000290927763750611,0.0272464990679912,10798,12764,"sp|P51688|SPHM_HUMAN","P51688","SPHM",0,"N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase)","glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]","GO:0005539; GO:0005764; GO:0006027; GO:0008449; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0070062"
"g54121",67.8027231089509,0.565506864463542,0.156028450795882,3.62438299924764,0.000289652106559256,0.0272464990679912,2470,13014,"sp|Q7ZUC7|PGES2_DANRE","Q7ZUC7","PGES2",8.6e-15,"Prostaglandin E synthase 2 (EC 5.3.99.3) (Microsomal prostaglandin E synthase 2) (mPGES-2)","prostaglandin biosynthetic process [GO:0001516]","GO:0000139; GO:0001516; GO:0004362; GO:0005739; GO:0016021; GO:0016829; GO:0020037; GO:0036134; GO:0043295; GO:0050220; GO:0097573"
"g82025",63.3253373043594,0.481753147214531,0.132938314570258,3.62388487300945,0.0002902108241793,0.0272464990679912,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83194",24.1099901076967,-0.59098266672495,0.163117670988995,-3.62304502719893,0.00029115511432493,0.0272464990679912,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159718",1930.57006882977,0.539508691528932,0.148855147683062,3.62438719739567,0.000289647402039301,0.0272464990679912,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3418",64.789675305268,1.18926673090297,0.328530663107441,3.61995656555819,0.00029465247240221,0.0272693337794966,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15756",44.3406050136999,-0.445051801096493,0.122881423241449,-3.62179888022631,0.000292561538833511,0.0272693337794966,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17816",78.592098529127,0.556927931465385,0.15390188086548,3.61872076113335,0.000296062882667668,0.0272693337794966,43296,47674,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.45e-21,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g28546",39.3162400476938,0.502574149548694,0.138799427399282,3.62086615892836,0.000293618386859581,0.0272693337794966,0,13604,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.17e-14,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g35076",651.366298581093,0.561856005368127,0.155221984450867,3.61969348192409,0.000294952198587452,0.0272693337794966,0,22254,"sp|P80147|GABT_PIG","P80147","GABT",1.12e-23,"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)","behavioral response to cocaine [GO:0048148]; gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]","GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042135; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0048148; GO:0051537"
"g41689",3055.62552617855,-0.33295993098365,0.0920252688152458,-3.61813592364632,0.000296732553484085,0.0272693337794966,3139,22741,"sp|P21328|RTJK_DROME","P21328","RTJK",6.48e-23,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g64959",176.243920379784,0.555226924671534,0.153453199158947,3.61821667918719,0.000296639999634492,0.0272693337794966,0,11564,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.5e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g100573",161.374659111096,0.877717834904543,0.242559036587913,3.6185740479985,0.000296230744066919,0.0272693337794966,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104222",185.293621079633,-0.569307350962932,0.157307653942622,-3.61906961736641,0.000295664097561819,0.0272693337794966,1949,4644,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.76e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g113123",35.4460606808792,0.84991972424238,0.23483156329256,3.61927379916781,0.000295430926396092,0.0272693337794966,0,2414,"sp|Q640T1|ALLC_XENTR","Q640T1","ALLC",4.1e-16,"Allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase)","allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]","GO:0000256; GO:0004037; GO:0006144"
"g131151",19.1517414943044,0.719223085157859,0.198696235518561,3.61971168341876,0.000294931452778493,0.0272693337794966,0,3461,"sp|P21328|RTJK_DROME","P21328","RTJK",2.15e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g14787",926.771746971409,-0.693076900637046,0.191667571719062,-3.61603631965938,0.000299148422079738,0.0272973438919641,9645,22910,"sp|Q28298|RRBP1_CANLF","Q28298","RRBP1",1.68e-19,"Ribosome-binding protein 1 (180 kDa ribosome receptor) (RRp)","protein transport [GO:0015031]; signal transduction [GO:0007165]","GO:0007165; GO:0015031; GO:0030176"
"g79157",27.1338903325561,-1.40282608796248,0.387975108050226,-3.61576312205287,0.000299464122565731,0.0272973438919641,0,2414,"sp|A2SXS5|MEN1_CANLF","A2SXS5","MEN1",3.63e-22,"Menin","chromatin organization [GO:0006325]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000403; GO:0000785; GO:0000976; GO:0003682; GO:0006325; GO:0006357; GO:0008285; GO:0035097; GO:0045786"
"g109848",69.3241859174837,1.27109201987415,0.351541360179089,3.61576805422443,0.000299458420303933,0.0272973438919641,3209,5014,"sp|Q6TLF6|RGN_DANRE","Q6TLF6","RGN",3.12e-14,"Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17)","cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]","GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0019853; GO:0030234; GO:0032781; GO:0050848"
"g126020",31.6653184355056,0.727523195387392,0.201189648919896,3.61610649103053,0.000299067384083498,0.0272973438919641,0,3953,"sp|Q9YH58|FTCD_CHICK","Q9YH58","FTCD",3.25e-15,"Formimidoyltransferase-cyclodeaminase (Formiminotransferase-cyclodeaminase) (FTCD) (p60) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)]","histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]","GO:0005542; GO:0005794; GO:0005814; GO:0005829; GO:0019556; GO:0019557; GO:0030409; GO:0030412; GO:0035999"
"g126094",122.693387584278,0.807193634583364,0.223205042989891,3.61637722773102,0.00029875491418676,0.0272973438919641,0,2861,"sp|Q2KJI2|STT3A_BOVIN","Q2KJI2","STT3A",1.15e-54,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18)","co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0004579; GO:0016021; GO:0018279; GO:0035000; GO:0043686; GO:0043687; GO:0046872"
"g5019",1118.11579838104,0.322418880395339,0.0892626581136231,3.61202419028268,0.000303816217049957,0.0275600510956833,4411,11874,"sp|G4WAW9|SELM_ERISI","G4WAW9","SELM",9.44e-11,"Selenoprotein M",NA,"GO:0005783"
"g21027",34.4074912238126,-0.635438334257012,0.175921299128471,-3.61206026447638,0.000303773945378574,0.0275600510956833,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111336",543.391140053365,0.687975581551386,0.190455823120179,3.61225805691048,0.000303542270451398,0.0275600510956833,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73581",440.542355752539,0.568720566959252,0.15752847579058,3.6102715023747,0.000305876661352586,0.0276942774836873,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124101",92.6619349061067,1.156905008973,0.320478596929046,3.60992908749265,0.000306280726056213,0.0276942774836873,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61199",334.324550970501,0.507625717458614,0.140721568569892,3.60730570741536,0.000309393054697511,0.0279307932300119,0,13063,"sp|Q4R963|TCPG_MACFA","Q4R963","TCPG",2.93e-34,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)","protein folding [GO:0006457]","GO:0005524; GO:0005832; GO:0006457; GO:0016887; GO:0051082"
"g55020",660.318930511589,0.914975014658304,0.25373371487558,3.60604429374696,0.000310900091730973,0.0279323369954207,6045,13768,"sp|P29413|CALR_DROME","P29413","CALR",7.44e-26,"Calreticulin","olfactory behavior [GO:0042048]; protein folding [GO:0006457]; sleep [GO:0030431]; ubiquitin-dependent ERAD pathway [GO:0030433]","GO:0005509; GO:0005615; GO:0005788; GO:0005789; GO:0006457; GO:0012505; GO:0030246; GO:0030431; GO:0030433; GO:0042048; GO:0045169; GO:0051082"
"g83162",172.631007337884,0.530354573757893,0.147070069676424,3.60613532668307,0.000310791103113807,0.0279323369954207,0,4510,"sp|Q18515|C1GLT_CAEEL","Q18515","C1GLT",6.95e-19,"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Ce-T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)","O-glycan processing, core 1 [GO:0016267]","GO:0016021; GO:0016263; GO:0016267; GO:0046872"
"g104668",22.7699806436417,2.22663133460963,0.617404932954023,3.60643593169257,0.000310431459674561,0.0279323369954207,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51992",13197.1766707264,0.457789332573584,0.126994885589335,3.6047855821056,0.00031241074920924,0.0280232940303446,11136,16394,"sp|A2I3Z2|RSSA_MACHI","A2I3Z2","RSSA",4.49e-24,"40S ribosomal protein SA","ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]","GO:0000028; GO:0003735; GO:0006412; GO:0022627"
"g26714",2224.69398408162,-0.25329782132332,0.0702990815301517,-3.60314552921547,0.000314389389522113,0.0281318959472832,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63233",71.024883361143,1.24293902137489,0.344977816058697,3.6029534756038,0.000314621858234792,0.0281318959472832,0,12502,"sp|Q4V8V2|NUD17_DANRE","Q4V8V2","NUD17",1.11e-13,"Nucleoside diphosphate-linked moiety X motif 17 (Nudix motif 17) (EC 3.6.1.-)","NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]","GO:0005777; GO:0006734; GO:0006742; GO:0019677; GO:0035529; GO:0046872"
"g9805",19.6971042690349,-2.49887648308089,0.694056949809653,-3.60039112606857,0.000317738855567249,0.0283423123650162,7465,8508,"sp|P20825|POL2_DROME","P20825","POL2",1.44e-28,"Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g15806",506.027732551688,-0.310567363481477,0.0862849093190801,-3.5993242147709,0.000319045215649016,0.0283423123650162,0,24344,"sp|O75182|SIN3B_HUMAN","O75182","SIN3B",3.57e-12,"Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b)","histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000118; GO:0000122; GO:0000785; GO:0000805; GO:0000806; GO:0001741; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0016575; GO:0016580; GO:0030336; GO:0030849"
"g27607",666.390077811127,-0.26817675569525,0.0745743098901013,-3.59610107140726,0.000323022336082916,0.0283423123650162,10892,38204,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.7e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g34419",201.607058018795,0.374277979434987,0.104062587100009,3.59666225744789,0.000322326554343327,0.0283423123650162,0,28565,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.62e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g35255",225.159458666831,-0.534119459688929,0.148525963171376,-3.59613530378279,0.000322979853135143,0.0283423123650162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48123",201.982032128282,0.270305668567056,0.075090331072501,3.59974000255867,0.000318535515139824,0.0283423123650162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65388",328.868562014179,0.49214157042315,0.136816031036538,3.59710456950561,0.000321779146281238,0.0283423123650162,4326,11975,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",8.22e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g88006",215.151881017904,0.935616691122793,0.260140131136214,3.5965872971475,0.000322419411993767,0.0283423123650162,1809,7804,"sp|P30039|PBLD_HUMAN","P30039","PBLD",7.36e-15,"Phenazine biosynthesis-like domain-containing protein (EC 5.1.-.-) (MAWD-binding protein) (MAWDBP) (Unknown protein 32 from 2D-page of liver tissue)","biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]","GO:0005737; GO:0009058; GO:0016853; GO:0030277; GO:0030512; GO:0042802; GO:0060392; GO:0070062"
"g93508",367.419718016937,0.772053094822094,0.214563449832926,3.59825075250826,0.00032036466964037,0.0283423123650162,0,3733,"sp|P54985|PPIA_BLAGE","P54985","PPIA",1.09e-17,"Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)","protein folding [GO:0006457]","GO:0003755; GO:0005737; GO:0006457"
"g99169",69.7819377689755,-0.482395873985052,0.134041743700714,-3.59884809512875,0.000319629812599106,0.0283423123650162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146288",6914.79824607093,0.99870091352313,0.27764670538124,3.59702058107191,0.000321883023897534,0.0283423123650162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147236",52.4094328380133,1.31680422117238,0.365796690390085,3.59982541058024,0.000318430910679915,0.0283423123650162,0,1489,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.38e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g11337",130.205970801339,-0.484219373061932,0.13468769843129,-3.59512693959169,0.000324233444163307,0.0283600892171581,15568,18984,"sp|Q9VSH9|PHAF1_DROME","Q9VSH9","PHAF1",4.24e-13,"PHAF1 protein CG7083","Golgi to plasma membrane protein transport [GO:0043001]","GO:0000407; GO:0005802; GO:0043001"
"g17414",364.431851992618,0.660334595062698,0.183667772610365,3.59526652758804,0.000324059638228422,0.0283600892171581,36066,42324,"sp|P28765|SODM_PALVU","P28765","SODM",1.42e-25,"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) (Fragment)",NA,"GO:0004784; GO:0005759; GO:0046872"
"g43008",1779.51463704831,0.335893163297844,0.0934880745095839,3.59289850667969,0.000327019985809085,0.0285151287470924,17605,19730,"sp|Q17237|SGF3_BOMMO","Q17237","SGF3",3.77e-108,"Silk gland factor 3 (SGF-3) (POU domain protein M1)","cell differentiation [GO:0030154]; nervous system development [GO:0007399]","GO:0000981; GO:0003677; GO:0005634; GO:0007399; GO:0030154"
"g80998",39.1447358479516,0.693236438779874,0.1929390593623,3.59303316327524,0.000326850970382789,0.0285151287470924,0,8000,"sp|Q55F21|AATM_DICDI","Q55F21","AATM",2.53e-13,"Aspartate aminotransferase, mitochondrial (EC 2.6.1.1) (EC 2.6.1.7) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Transaminase A)","2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; glutamate metabolic process [GO:0006536]","GO:0004069; GO:0005739; GO:0005759; GO:0005886; GO:0006103; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0016212; GO:0030170"
"g3911",2021.7443426716,0.261120345141107,0.0727151823788565,3.59100172204249,0.000329409459323789,0.0285365998537656,58846,71244,"sp|A6QL88|SAC1_BOVIN","A6QL88","SAC1",0,"Phosphatidylinositol-3-phosphatase SAC1 (EC 3.1.3.64) (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein)","phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000139; GO:0004438; GO:0005783; GO:0005789; GO:0005794; GO:0016021; GO:0016791; GO:0043812; GO:0046856; GO:0140268"
"g11411",42.0134301895534,1.6684577022103,0.464955565873319,3.58842397999141,0.000332682966308218,0.0285365998537656,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26429",103.282755486192,0.329981124223309,0.091860868669807,3.59218379927826,0.000327918427171084,0.0285365998537656,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45313",65.5242767659393,0.717089364061181,0.19973043515387,3.59028589462964,0.000330315461579214,0.0285365998537656,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45495",115.966132585184,0.303330505903945,0.0844877590228264,3.59023022284202,0.000330386021407382,0.0285365998537656,14692,19594,"sp|P30044|PRDX5_HUMAN","P30044","PRDX5",9.67e-11,"Peroxiredoxin-5, mitochondrial (EC 1.11.1.24) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin-dependent peroxiredoxin 5)","cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]","GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034599; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057"
"g52791",38.8684576483384,-0.633673884854434,0.176554272752177,-3.58911667770226,0.0003318003225913,0.0285365998537656,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89536",38711.677907686,0.683373894726748,0.1904157301719,3.58885210854074,0.000332137180825335,0.0285365998537656,3932,7064,"sp|H6VGI3|KARG0_SCYPA","H6VGI3","KARG0",0,"Arginine kinase Scy p 2.0101 (AK) (EC 2.7.3.3) (allergen Scy p 2.0101)","phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]","GO:0004054; GO:0004111; GO:0005524; GO:0016310; GO:0019863; GO:0046314"
"g95735",124.739118608569,-0.548135319857388,0.152750715943863,-3.58843044676027,0.000332674716123638,0.0285365998537656,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98071",229.327345144433,0.468036108212474,0.130397971081883,3.58928980511953,0.000331580064097932,0.0285365998537656,2707,6718,"sp|Q9YHT1|SDHA_CHICK","Q9YHT1","SDHA",4.81e-32,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp)","mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]","GO:0000104; GO:0005743; GO:0005749; GO:0006099; GO:0006105; GO:0006121; GO:0008177; GO:0009055; GO:0022904; GO:0050660"
"g101950",32.3304661632317,0.744044884356272,0.207353318593642,3.58829503864563,0.000332847507273395,0.0285365998537656,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158120",698.753284290252,3.19784615033349,0.890460926676513,3.59122568383644,0.00032912647525215,0.0285365998537656,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59417",1772.63101775344,0.419680434382486,0.11698936601252,3.58733830848841,0.000334070763379525,0.0285544192613849,0,9649,"sp|O16797|RL3_DROME","O16797","RL3",6.9e-26,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g64613",4615.43325841979,0.556311424861956,0.155059923223004,3.58771894954366,0.000333583580300448,0.0285544192613849,8105,12153,"sp|Q26365|ADT_DROME","Q26365","ADT",1.7e-16,"ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT) (Stress-sensitive protein B)","action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic assembly at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]","GO:0001508; GO:0005471; GO:0005739; GO:0005743; GO:0006839; GO:0007268; GO:0008340; GO:0010507; GO:0016021; GO:0034599; GO:0040011; GO:0045202; GO:0046716; GO:0048477; GO:0048489; GO:0051124; GO:0051480; GO:0051560; GO:0051900; GO:0070050; GO:0140021; GO:1990544; GO:2001171"
"g51107",99.7146808244364,-0.417979365961392,0.116561743613282,-3.58590522931886,0.000335910941699034,0.0286507858708059,10556,13894,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.35e-19,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g60596",156.750079930174,0.662250413750889,0.184693757071171,3.58566756263284,0.000336217038418475,0.0286507858708059,0,4147,"sp|P50143|TCPG_XENLA","P50143","TCPG",2.18e-13,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)","protein folding [GO:0006457]","GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g9806",33.5094890035598,-2.48039451246027,0.691945628905113,-3.58466678427476,0.000337508830733451,0.0287173550047061,8585,10271,"sp|Q09575|YRD6_CAEEL","Q09575","YRD6",6.37e-16,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0008270; GO:0015074"
"g20915",334.223004251113,-0.427233587670039,0.119244789699579,-3.5828281365282,0.000339894245571932,0.0288766346819586,0,49280,"sp|Q8K4P8|HECW1_MOUSE","Q8K4P8","HECW1",4.93e-66,"E3 ubiquitin-protein ligase HECW1 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECW1) (NEDD4-like E3 ubiquitin-protein ligase 1) (mNEDL1)","negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]","GO:0000209; GO:0005737; GO:0005829; GO:0016567; GO:0043161; GO:0045732; GO:0048814; GO:0061630; GO:2000650"
"g75451",158.045191250675,0.516805734128585,0.144332345812388,3.58066468898357,0.000342721244177228,0.0290291087575537,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86709",49.9531716932524,0.62498858847531,0.174529839126059,3.58098415494382,0.000342302415088631,0.0290291087575537,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148584",72.277610931542,2.62899612821074,0.734373769796341,3.57991561836395,0.000343705178032633,0.0290686716134005,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67159",151.900118629714,0.673729892178117,0.188221386255157,3.57945452205307,0.000344312159566454,0.0290762830005053,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1798",120.580480550687,-0.595186330966196,0.166358505207273,-3.57773310252233,0.000346587086208001,0.0291430601788008,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55699",214.171889973672,0.542858467831554,0.15173477268529,3.57768004145948,0.000346657431450121,0.0291430601788008,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79416",51.4410262408871,0.824781889026037,0.230521758419072,3.57789171261934,0.000346376889857263,0.0291430601788008,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15081",429.223475135142,-0.635593081118269,0.177690534830804,-3.57696644744458,0.000347604770991396,0.029179085865818,15285,44351,"sp|Q9P281|BAHC1_HUMAN","Q9P281","BAHC1",4.43e-18,"BAH and coiled-coil domain-containing protein 1 (Bromo adjacent homology domain-containing protein 2) (BAH domain-containing protein 2)",NA,"GO:0003682"
"g53816",1243.13656561793,-0.36897985695568,0.103167215343015,-3.57652240325456,0.000348195488412175,0.0291851127560023,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68362",28.5461159439887,0.661647029855587,0.185044691860469,3.57560664509357,0.000349416698975949,0.0292004368258623,3126,8804,"sp|Q5PRA2|DHTK1_DANRE","Q5PRA2","DHTK1",9.92e-17,"2-oxoadipate dehydrogenase complex component E1 (E1a) (OADC-E1) (OADH-E1) (EC 1.2.4.-) (2-oxoadipate dehydrogenase, mitochondrial) (Alpha-ketoadipate dehydrogenase) (Alpha-KADH-E1) (Dehydrogenase E1 and transketolase domain-containing protein 1) (Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial)","glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]","GO:0004591; GO:0005739; GO:0006096; GO:0006099; GO:0030976"
"g124038",23.2340783963695,1.81807672591834,0.50845798024747,3.57566759997251,0.000349335288219037,0.0292004368258623,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29311",116.688905851928,0.498511643369441,0.139468948302939,3.57435579342455,0.000351091248167768,0.0292968456668421,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17568",624.096070957378,-0.442444263960079,0.123873761653601,-3.5717351120516,0.000354623991580502,0.0293748274499143,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20349",307.22060959346,-0.446381138120453,0.124983070204486,-3.57153282752715,0.000354898053641999,0.0293748274499143,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28958",91.7667990094373,-0.399351897427082,0.111821305586484,-3.57133996363706,0.000355159536750858,0.0293748274499143,28715,33252,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.12e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g65099",8705.3847084006,1.16832042342755,0.32708312362,3.57193734270707,0.000354350200363694,0.0293748274499143,0,5129,"sp|H9J9M0|CDA1_BOMMO","H9J9M0","CDA1",1.38e-117,"Chitin deacetylase 1 (BmCDA1) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0008061; GO:0008270"
"g102625",40.6834489175522,2.10319117239609,0.588802355787161,3.57198158554301,0.000354290328290093,0.0293748274499143,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114308",134.962495374685,1.54587551823077,0.432787085043774,3.57190769238046,0.000354390330269288,0.0293748274499143,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1849",319.761208426331,-0.380566665078103,0.106618615960175,-3.5694204211041,0.00035777187385911,0.0294193506641126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9293",7031.31095754271,0.243437763006372,0.0681799349420359,3.57051914486769,0.000356274411847684,0.0294193506641126,57916,72634,"sp|Q5REX3|ZFR_PONAB","Q5REX3","ZFR",6.75e-26,"Zinc finger RNA-binding protein",NA,"GO:0003677; GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0008270"
"g24123",41.6456802297926,-0.418938905359492,0.117427413794872,-3.5676414205231,0.000360208978574281,0.0294193506641126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48892",215.067669388252,0.32428123213687,0.0908876518421984,3.567934978669,0.000359805758145693,0.0294193506641126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85683",152.781787207738,-0.602616324707695,0.168909801667628,-3.56768120475029,0.00036015430771458,0.0294193506641126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86473",116.943870055605,2.58824042952631,0.72552026530059,3.56742678780168,0.000360504057377896,0.0294193506641126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87745",256.138742190266,1.25623503628693,0.352067503832991,3.56816525981575,0.000359489748080446,0.0294193506641126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114888",109.050535696206,-0.806257041768921,0.226024761779032,-3.56711820166474,0.000360928700228258,0.0294193506641126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119056",23.60549098578,0.94093111132763,0.263650201822611,3.56886171458616,0.000358535596295944,0.0294193506641126,0,4575,"sp|Q27712|CP2L1_PANAR","Q27712","CP2L1",2.3e-17,"Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)",NA,"GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"g155444",291.296918661482,0.455332147320975,0.127547349686372,3.56990677141154,0.000357108297383327,0.0294193506641126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26658",638.601405787929,0.930748640602366,0.261078869848457,3.56500945918226,0.000363843066127569,0.0296045997173658,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36598",21.9546695739874,0.609651574238539,0.171025460189505,3.56468313877369,0.000364296014956056,0.0296045997173658,23361,24474,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.45e-15,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g87009",88.2174403169471,0.73251931367957,0.205535441793057,3.56395620769436,0.000365306927275912,0.0296045997173658,0,2227,"sp|P61166|TM258_MOUSE","P61166","TM258",4.59e-19,"Transmembrane protein 258 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258) (Oligosaccharyl transferase subunit TMEM258)","protein N-linked glycosylation [GO:0006487]","GO:0005737; GO:0005783; GO:0005789; GO:0006487; GO:0008250; GO:0016020; GO:0016021; GO:0032991; GO:0034998; GO:0043227"
"g95498",79.9849754028232,0.791950458918201,0.222203114914754,3.56408351530997,0.000365129696717371,0.0296045997173658,0,5243,"sp|P08548|LIN1_NYCCO","P08548","LIN1",6.13e-19,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g9079",188.861543165413,-0.501376860119122,0.140735758725446,-3.56254064112611,0.000367283027044928,0.029721916556922,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109289",59.6352929713142,-0.756489107988552,0.21238470409666,-3.56188130970233,0.000368206846768938,0.0297538641896245,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26983",46.001485666149,0.593217039430869,0.166576746710269,3.56122358700322,0.000369130576590836,0.0297857128961575,32730,36234,"sp|P51659|DHB4_HUMAN","P51659","DHB4",4.89e-15,"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]","androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]","GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0008209; GO:0008210; GO:0016020; GO:0016508; GO:0016853; GO:0033989; GO:0036111; GO:0036112; GO:0042803; GO:0044594; GO:0060009; GO:0106386"
"g94751",401.793735664288,-0.491702490184047,0.138087683688924,-3.56079903035905,0.000369727989597717,0.0297911770644051,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6683",4148.1591956251,-0.583993402389669,0.164232951342446,-3.55588447760384,0.000376709591552507,0.0301264204429826,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9921",268.314073519377,1.08466759869794,0.305067905905926,3.55549560507496,0.000377267251724057,0.0301264204429826,89,22211,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.06e-54,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g35163",3231.70269604941,-0.298241340772716,0.0838562149436299,-3.55658004565553,0.000375714037853205,0.0301264204429826,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48218",176.816748902113,-0.514567438619222,0.144691879738616,-3.55629797296697,0.000376117466465174,0.0301264204429826,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75090",122.845338547218,1.66752135068662,0.469032369949811,3.55523724485167,0.000377638178092933,0.0301264204429826,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95860",113.086732559703,0.42021527178949,0.118128133130508,3.55728360936032,0.000374709542477752,0.0301264204429826,0,6976,"sp|Q7ZVF3|SDHA_DANRE","Q7ZVF3","SDHA",1.57e-18,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp)","mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; tricarboxylic acid cycle [GO:0006099]","GO:0000104; GO:0005749; GO:0006099; GO:0006121; GO:0008177; GO:0009055; GO:0050660"
"g107245",370.811023191204,0.836130162144658,0.235177391396663,3.5553169340772,0.000377523732364088,0.0301264204429826,201,5723,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.03e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g136814",33.0704386039833,0.759015726787664,0.213536193188432,3.55450621955166,0.00037868955480485,0.030167504166196,0,3086,"sp|P04069|CBPB_ASTAS","P04069","CBPB",1.83e-25,"Carboxypeptidase B (EC 3.4.17.2)",NA,"GO:0004181; GO:0005576; GO:0008270"
"g60890",432.82325027741,-0.33961419045051,0.0955981784846036,-3.55251737882439,0.000381563813250618,0.0303154828566506,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69696",179.539054683962,0.507651641861423,0.142900830928325,3.55247508753847,0.000381625153133043,0.0303154828566506,0,10980,"sp|O62742|SCP2_RABIT","O62742","SCP2",2.52e-23,"Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X) (SCP-X)","bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; regulation of phospholipid biosynthetic process [GO:0071071]","GO:0003988; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0006635; GO:0006869; GO:0008206; GO:0008289; GO:0032367; GO:0033814; GO:0050632; GO:0050633; GO:0071071; GO:0120019; GO:0120020"
"g8055",145.58412564132,0.395453032700017,0.111434173995327,3.54875904331288,0.000387051084440435,0.0304073013063139,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31954",35.6771769701226,2.07232832045866,0.583964759986222,3.54872153673718,0.000387106214845147,0.0304073013063139,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37542",52.6333103984313,0.752757910978832,0.212010790053723,3.55056415189097,0.000384406437653316,0.0304073013063139,17028,26464,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",5.89e-70,"PiggyBac transposable element-derived protein 4",NA,NA
"g90460",124.853302297217,1.29702978210832,0.365304372029998,3.55054546678628,0.000384433726303328,0.0304073013063139,1128,7574,"sp|P08548|LIN1_NYCCO","P08548","LIN1",4.4e-22,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g101830",31.0569496453784,-0.892104765041491,0.251378141117903,-3.54885576396665,0.000386908949924784,0.0304073013063139,0,6287,"sp|Q9M2U3|ALPL_ARATH","Q9M2U3","ALPL",7.14e-25,"Protein ALP1-like (EC 3.1.-.-)",NA,"GO:0000118; GO:0004518; GO:0046872"
"g102393",424.475273507406,0.310257244391913,0.0874051141498618,3.54964634975428,0.000385748982884604,0.0304073013063139,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126175",57.8420856080442,2.08080245294,0.586243762300932,3.54938096871703,0.000386137993651443,0.0304073013063139,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144250",107.281040686212,-0.663278189450408,0.186801984976799,-3.55070204169827,0.000384205112534101,0.0304073013063139,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5683",69.1635561521728,-0.704093261503082,0.198472710780802,-3.54755703559014,0.00038882155461838,0.0304767149185051,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18256",130.761899740313,-0.623012218116237,0.175632429902297,-3.54725046201784,0.000389274324975903,0.0304767149185051,44555,55668,"sp|Q99315|YG31B_YEAST","Q99315","YG31B",1.9e-43,"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g38276",107.504698668878,-0.442121458322988,0.12464590107076,-3.54701963341739,0.000389615554681647,0.0304767149185051,14560,18224,"sp|P21328|RTJK_DROME","P21328","RTJK",6.48e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g13983",739.267412491017,-0.507121307750888,0.142987917639904,-3.54660251104576,0.000390232888094356,0.0304826084613927,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74970",86.7811562698462,0.443454524394651,0.125053771435002,3.54611075944352,0.000390961845328319,0.0304971929333638,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36879",112.136418867935,-0.687968829086405,0.194056540733858,-3.54519784020025,0.000392318503252809,0.0305606333240228,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104480",48.7392055571367,2.67522718564292,0.755423781037338,3.54135950283341,0.000398070795591141,0.0309658335900926,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8262",163.80736460668,0.816081867410769,0.23065963923159,3.53803495977637,0.000403116681448188,0.0310069438607525,2466,10744,"sp|P45971|OST48_CAEEL","P45971","OST48",7.64e-14,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (Oligosaccharyl transferase 48 kDa subunit) (Oligosaccharyl transferase beta subunit 1)","protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0006487; GO:0008250; GO:0016021; GO:0018279"
"g13368",165.471552859178,-0.453512041579611,0.128177749424775,-3.53814951202407,0.000402941828272012,0.0310069438607525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22202",29.6974615037605,0.507529778629964,0.14335047677603,3.54048197148954,0.000399396921522809,0.0310069438607525,4785,6984,"sp|O16129|SYFM_DROME","O16129","SYFM",4.92e-11,"Probable phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS)","phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]","GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006432; GO:0008033"
"g32447",1976.01563593794,0.979343255877995,0.276703229817664,3.53932715755917,0.000401148367353586,0.0310069438607525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51338",400.084136045139,-0.623032276958994,0.176110050176782,-3.53774402047802,0.000403561091463156,0.0310069438607525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77718",345.320625825685,0.359368312197615,0.101545425508113,3.53899065762349,0.000401660067627988,0.0310069438607525,0,8661,"sp|Q5R922|COPB_PONAB","Q5R922","COPB",1.17e-33,"Coatomer subunit beta (Beta-coat protein) (Beta-COP)","intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005198; GO:0005793; GO:0005886; GO:0006886; GO:0016192; GO:0030126"
"g83424",336.878268955358,0.481342476199639,0.136044592167608,3.53812282083672,0.000402982563513814,0.0310069438607525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91849",226.706474673958,2.11724149536198,0.598242609615501,3.53910179805273,0.000401490993987786,0.0310069438607525,0,1650,"sp|P80067|CATC_RAT","P80067","CATC",3.7e-11,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0005813; GO:0006508; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0043621; GO:0051087; GO:0051603; GO:1903052; GO:1903980; GO:2001235"
"g132828",169.702153295976,0.392031405095721,0.110754650935307,3.53963830669929,0.000400675758870339,0.0310069438607525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1700",390.63344484705,0.403090872108716,0.114001266517835,3.5358455605022,0.000406472246662454,0.0310187409725776,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2464",235.258936222856,0.912409362937157,0.258015154664887,3.53626268240795,0.000405830942950821,0.0310187409725776,48821,69124,"sp|O00370|LORF2_HUMAN","O00370","LORF2",6.22e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g79766",186.874184632595,-0.549736949180319,0.155462265890705,-3.53614393840627,0.000406013409513181,0.0310187409725776,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83627",69.8326122738921,2.74389109725562,0.775839114191479,3.53667538419367,0.00040519736524085,0.0310187409725776,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87840",51.2973988591745,0.866933392858756,0.245177086389592,3.53594785558866,0.000406314885618611,0.0310187409725776,0,1974,"sp|P42860|GSTT1_LUCCU","P42860","GSTT1",1.1e-16,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749"
"g86924",206.950294197818,1.4764204622125,0.417752054244915,3.53420275785626,0.000409007189353845,0.0311698947745785,0,3784,"sp|P04040|CATA_HUMAN","P04040","CATA",1.91e-27,"Catalase (EC 1.11.1.6)","aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular detoxification of hydrogen peroxide [GO:0061692]; cellular response to growth factor stimulus [GO:0071363]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650]","GO:0000268; GO:0000302; GO:0001649; GO:0001657; GO:0001666; GO:0004046; GO:0004096; GO:0005576; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005778; GO:0005782; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006641; GO:0007568; GO:0008203; GO:0009060; GO:0009410; GO:0009642; GO:0009650; GO:0010193; GO:0010288; GO:0014068; GO:0014823; GO:0014854; GO:0016020; GO:0016209; GO:0016684; GO:0019899; GO:0020027; GO:0020037; GO:0032088; GO:0032355; GO:0032868; GO:0032991; GO:0033189; GO:0033197; GO:0033591; GO:0034774; GO:0042542; GO:0042744; GO:0042802; GO:0042803; GO:0043066; GO:0043231; GO:0045471; GO:0046686; GO:0046872; GO:0050661; GO:0051092; GO:0051781; GO:0055093; GO:0061692; GO:0062151; GO:0070062; GO:0070542; GO:0071363; GO:0080184; GO:1904813"
"g10048",94.7052104082273,-0.615791351924594,0.174559248585638,-3.52769249933204,0.000419198829258989,0.031244033664839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14151",354.920719328921,0.720166896189557,0.204110701700628,3.52831522398976,0.000418213808273016,0.031244033664839,33745,56447,"sp|Q9GMB0|RPN1_PIG","Q9GMB0","RPN1",9.43e-29,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1)","protein N-linked glycosylation via asparagine [GO:0018279]","GO:0008250; GO:0016021; GO:0018279; GO:0042470"
"g16506",473.509972372428,-0.355522677204931,0.100644697004581,-3.53245315238765,0.000411723168381582,0.031244033664839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31803",4662.6761603074,0.4816006245776,0.136341584736548,3.53230913010285,0.000411947488406729,0.031244033664839,23519,32887,"sp|Q7PQV7|ADT2_ANOGA","Q7PQV7","ADT2",5.54e-70,"ADP,ATP carrier protein 2 (ADP/ATP translocase 2) (Adenine nucleotide translocator 2) (ANT 2)","mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]","GO:0005471; GO:0005743; GO:0016021; GO:0140021; GO:1990544"
"g32261",4251.17528782328,0.423870819936274,0.120185193047027,3.52681398756349,0.000420592137010179,0.031244033664839,24369,27074,"sp|P60868|RS20_RAT","P60868","RS20",2.12e-43,"40S ribosomal protein S20","positive regulation of signal transduction by p53 class mediator [GO:1901798]; translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015935; GO:0022626; GO:0022627; GO:0045202; GO:0097371; GO:1901798; GO:1990948"
"g33793",185.946549887783,-0.336424375938178,0.095304348965148,-3.53000025278181,0.000415559269919989,0.031244033664839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35295",139.801107275574,0.401390057280065,0.113819070151254,3.5265624358612,0.000420991890319158,0.031244033664839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36533",81.0186885942937,-0.724457543789428,0.205264477091989,-3.52938586380323,0.000416525329787406,0.031244033664839,4109,17324,"sp|A6NP11|ZN716_HUMAN","A6NP11","ZN716",4.85e-45,"Zinc finger protein 716","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g51514",74.0223206735552,1.47030586654878,0.416386948161882,3.53110459643215,0.00041382806876924,0.031244033664839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61710",32.1529942805509,-1.47703726303338,0.41851846111738,-3.52920456385583,0.000416810804775096,0.031244033664839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75525",152.062089287293,0.271076405994539,0.0767826695498216,3.53043737061847,0.000414873224115277,0.031244033664839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76938",2147.07950363225,0.641172449522148,0.18157636558757,3.53114485713684,0.000413765082362782,0.031244033664839,5325,9603,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.26e-13,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g83623",85.0884462724766,2.65374742312879,0.751913035617554,3.52932759165325,0.000416617065224398,0.031244033664839,2180,8566,"sp|Q04519|ASM_MOUSE","Q04519","ASM",1.08e-12,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g84127",21.015636782525,1.71854184875732,0.487369623991503,3.52615707700996,0.000421636812826519,0.031244033664839,0,6481,"sp|O97396|AMY_PHACE","O97396","AMY",1.28e-17,"Alpha-amylase (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate metabolic process [GO:0005975]; digestion [GO:0007586]","GO:0004556; GO:0005576; GO:0005975; GO:0007586; GO:0046872"
"g109022",173.383232822144,0.348408868222011,0.0987650641516146,3.52765293289505,0.000419261488284866,0.031244033664839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117081",163.417358185591,0.614290386228417,0.174209881211579,3.526151226074,0.000421646128366929,0.031244033664839,0,4761,"sp|Q94572|TBA3_HOMAM","Q94572","TBA3",1.29e-154,"Tubulin alpha-3 chain (Alpha-III tubulin)","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g121505",175.321997122604,-0.35843144841693,0.101487797124188,-3.53176892763105,0.000412789891162544,0.031244033664839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136687",29.5609785691965,0.533491386525323,0.151252162308619,3.52716535342332,0.000420034357392703,0.031244033664839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142735",269.374752855216,0.561500938023171,0.159171458676667,3.52764837799077,0.000419268702178723,0.031244033664839,0,2625,"sp|O16797|RL3_DROME","O16797","RL3",1.2e-20,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g143740",120.937570031673,0.859897096237499,0.243379830871479,3.53314854874552,0.000410641667333083,0.031244033664839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154620",41.3383520195802,0.659195811405253,0.186850433455714,3.52793300616823,0.000418818140910003,0.031244033664839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8314",108.029586800222,-0.682712894235694,0.193834854048617,-3.52213691178811,0.000428082998574794,0.0315616227794573,0,65240,"sp|G5ECJ6|CSK1_CAEEL","G5ECJ6","CSK1",2.07e-16,"Tyrosine-protein kinase csk-1 (EC 2.7.10.2) (C-terminal src kinase)","embryo development ending in birth or egg hatching [GO:0009792]; larval feeding behavior [GO:0030536]; muscle cell development [GO:0055001]; nematode larval development [GO:0002119]; pharyngeal pumping [GO:0043050]","GO:0002119; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005886; GO:0005911; GO:0009792; GO:0030536; GO:0043050; GO:0046872; GO:0055001"
"g25614",307.615089042332,-0.989575452946764,0.280963458268592,-3.52207884628456,0.000428176775020908,0.0315616227794573,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88315",67.6126937496241,0.58422093177122,0.165854051222888,3.52250021909984,0.000427496688366195,0.0315616227794573,0,7494,"sp|Q9VUL9|FUCTA_DROME","Q9VUL9","FUCTA",3.76e-11,"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)","fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]","GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0036065; GO:0036071; GO:0046920"
"g143303",54.2690426241493,1.32535668934364,0.376220629371024,3.52281769226587,0.000426984959864863,0.0315616227794573,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9883",18.9003846187561,0.971687931349539,0.276163170322128,3.51852830417656,0.00043394752226883,0.0319033680358739,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106122",42.9103577545195,-0.767121862857871,0.218006711180015,-3.51879930074461,0.000433504520997178,0.0319033680358739,0,5393,"sp|Q62101|KPCD1_MOUSE","Q62101","KPCD1",7.82e-29,"Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu)","angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; nervous system development [GO:0007399]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","GO:0000421; GO:0001525; GO:0001938; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0006468; GO:0006915; GO:0006954; GO:0007030; GO:0007265; GO:0007399; GO:0010508; GO:0010595; GO:0010837; GO:0010976; GO:0016301; GO:0018105; GO:0018107; GO:0030154; GO:0031647; GO:0032793; GO:0033138; GO:0034198; GO:0034599; GO:0035556; GO:0035924; GO:0038033; GO:0042307; GO:0042802; GO:0043123; GO:0043536; GO:0045087; GO:0045669; GO:0045766; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0048193; GO:0050829; GO:0051092; GO:0051279; GO:0060548; GO:0071447; GO:0089700; GO:0106310; GO:1901727; GO:2001028"
"g35569",30.3140711349003,1.16934919314209,0.332408447216702,3.51780829558694,0.000435126582777112,0.0319482888623373,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41432",35.9285969534484,0.863413320232972,0.245538489769854,3.51640722822014,0.000437429497756624,0.0320238064719967,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66062",155.691005164986,-0.679938441139889,0.193406280996908,-3.5155964823643,0.000438767301228615,0.0320238064719967,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97119",38.3904880710682,-0.460275032440202,0.130929027892175,-3.51545444008991,0.00043900207656039,0.0320238064719967,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121585",1296.14908931828,2.74404732927292,0.780565491621909,3.51546072523802,0.000438991685640625,0.0320238064719967,1436,4284,"sp|P04069|CBPB_ASTAS","P04069","CBPB",3.01e-12,"Carboxypeptidase B (EC 3.4.17.2)",NA,"GO:0004181; GO:0005576; GO:0008270"
"g140532",808.548967509141,-0.713045043375794,0.202806463642467,-3.51588914164412,0.000438283947244462,0.0320238064719967,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5619",114.925034004798,0.50896500605616,0.144822816172641,3.514397934711,0.000440752010524282,0.0321098116268221,66756,79944,"sp|Q96EZ8|MCRS1_HUMAN","Q96EZ8","MCRS1",2.53e-23,"Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2)","cellular protein modification process [GO:0006464]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]","GO:0000123; GO:0000723; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005844; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0006464; GO:0008266; GO:0010521; GO:0030425; GO:0031011; GO:0033044; GO:0034046; GO:0042766; GO:0043204; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051571; GO:0051726; GO:0051974; GO:0060382; GO:0071339; GO:1900095; GO:1904357; GO:1904507; GO:1904751"
"g110926",38.6561809235982,0.467412933751869,0.133015912754111,3.51396253330918,0.000441475076901393,0.0321208813390532,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33792",278.906368124426,-0.339900839356381,0.0967606243959289,-3.5128012192807,0.000443409077306757,0.0321691251038161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133688",1375.79826457035,1.02988660048715,0.293203254926104,3.51253467751138,0.000443854078456692,0.0321691251038161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140395",41.0637285723472,0.97162045428614,0.27659652453579,3.5127717382451,0.000443458276474109,0.0321691251038161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75936",21.3088333986755,-0.741324065575744,0.211318397747588,-3.50809050928556,0.000451335469311692,0.0326692528507441,0,6411,"sp|P21328|RTJK_DROME","P21328","RTJK",9.63e-41,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g4131",1284.7638900796,-0.365958566532174,0.104375594478011,-3.50616988925769,0.000454604954739177,0.0327003699163048,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60469",154.68288821226,0.471737346580374,0.134546436634741,3.50613036197324,0.000454672473854954,0.0327003699163048,3297,5864,"sp|A9URZ4|PESC_MONBE","A9URZ4","PESC",2.7e-16,"Pescadillo homolog","maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]","GO:0000463; GO:0000466; GO:0003723; GO:0005654; GO:0030687; GO:0043021; GO:0070545"
"g81248",266.778686453898,2.36764365185341,0.675230079239144,3.50642503148156,0.000454169354845482,0.0327003699163048,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119470",128.810447034257,0.662997419134343,0.189035486919711,3.50726432342271,0.000452739192748711,0.0327003699163048,0,1994,"sp|P15857|HM17_APIME","P15857","HM17",9.01e-36,"Homeobox protein H17 (Fragment)",NA,"GO:0000981; GO:0003677; GO:0005634"
"g156625",24.7802012555366,-0.93360824815139,0.26624537266088,-3.50657079528116,0.000453920669697919,0.0327003699163048,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94305",311.426692174958,0.464907391677875,0.132660332805419,3.50449438687738,0.000457475211806916,0.0328599244731093,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7501",23.7423765266215,0.563967550002831,0.16105413076376,3.50172670100638,0.000462253523719736,0.0331607942360273,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5151",74.6694479037829,1.60622181626675,0.459217831388392,3.49773398696327,0.000469228900663987,0.0333104396502866,109046,124074,"sp|Q93113|GST1D_ANOGA","Q93113","GST1D",1.57e-19,"Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g22739",65.432115287847,0.425270233582686,0.1215553539501,3.49857262360706,0.000467755683976082,0.0333104396502866,20136,39984,"sp|P53034|RFC2_DROME","P53034","RFC2",4.42e-32,"Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40) (Replication factor C subunit 4) (DmRfc4)","DNA damage checkpoint signaling [GO:0000077]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA strand elongation involved in DNA replication [GO:0006271]; leading strand elongation [GO:0006272]; sister chromatid cohesion [GO:0007062]","GO:0000076; GO:0000077; GO:0003677; GO:0005524; GO:0005634; GO:0005663; GO:0006260; GO:0006261; GO:0006271; GO:0006272; GO:0006281; GO:0007062; GO:0016887; GO:0031391"
"g33297",263.409768045584,0.40028414057551,0.114403904719362,3.49886781886883,0.000467238147806516,0.0333104396502866,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55280",5120.9297822444,0.391621294021757,0.111889087877887,3.50008478439973,0.000465110200268299,0.0333104396502866,4125,8400,"sp|B4LYI3|EI3D1_DROVI","B4LYI3","EI3D1",1.95e-119,"Eukaryotic translation initiation factor 3 subunit D-1 (eIF3d-1) (Eukaryotic translation initiation factor 3 subunit 7-1) (Eukaryotic translation initiation factor 3 subunit p66)","cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]","GO:0001732; GO:0002191; GO:0003743; GO:0005634; GO:0005852; GO:0006446; GO:0016282; GO:0033290; GO:0098808"
"g80419",37.2649680011429,0.635817849742933,0.181714443622081,3.49899456019725,0.000467016108943618,0.0333104396502866,0,5669,"sp|Q6NT04|TIGD7_HUMAN","Q6NT04","TIGD7",3.2e-69,"Tigger transposable element-derived protein 7",NA,"GO:0003677; GO:0005634"
"g112760",30.7366665437007,0.880724357294159,0.251794682940667,3.49778774916265,0.000469134327950927,0.0333104396502866,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117162",3054.48203817601,0.523959387162192,0.14971944800853,3.49960806115408,0.0004659427039681,0.0333104396502866,95,4282,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",3.12e-52,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g139384",90.9502886707885,0.42752981607919,0.122239270189562,3.4974833817005,0.000469669973377143,0.0333104396502866,157,2891,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.71e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g142416",1522.28826435045,0.74761997490541,0.213702038213318,3.49842229468645,0.00046801944603336,0.0333104396502866,0,2649,"sp|Q5UPS7|COLL4_MIMIV","Q5UPS7","COLL4",1.55e-16,"Collagen-like protein 4",NA,NA
"g5684",1668.88181628278,-0.354884591739757,0.101496809997756,-3.4965098090039,0.000471387162965855,0.0333598649982764,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113851",23.8379801412739,1.7894739907259,0.511802387311384,3.49641587278719,0.000471553157313569,0.0333598649982764,0,5074,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.83e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g99034",20.2391597175354,1.60954597790802,0.460447742208706,3.49561053375404,0.000472978508371527,0.0333852320198597,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124965",2372.96930671287,0.321792831846718,0.0920580489966432,3.49554259897961,0.000473098928200067,0.0333852320198597,796,3854,"sp|O57592|RL7A_TAKRU","O57592","RL7A",6.23e-12,"60S ribosomal protein L7a (Surfeit locus protein 3)","ribosome biogenesis [GO:0042254]","GO:0005840; GO:0042254; GO:1990904"
"g90811",43.9316046334075,0.747324312772706,0.213857720438386,3.49449302667573,0.000474963017153035,0.033474774449525,3478,7345,"sp|Q4FAT7|BGLR_PIG","Q4FAT7","BGLR",9.77e-11,"Beta-glucuronidase (EC 3.2.1.31)","glucuronoside catabolic process [GO:0019391]","GO:0004566; GO:0005102; GO:0005615; GO:0005764; GO:0019391; GO:0019904; GO:0030246"
"g7863",298.017330295863,0.90954736724778,0.260588571234484,3.49035785774867,0.000482374142896338,0.0339545513701825,58975,62999,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.7e-37,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g7593",977.078505628788,0.485666600529056,0.139240006003618,3.48798175516047,0.000486681287429778,0.0341201460751781,32771,36564,"sp|P55216|CGL2_CAEEL","P55216","CGL2",6.32e-30,"Putative cystathionine gamma-lyase 2 (EC 4.4.1.1) (Gamma-cystathionase)","cysteine biosynthetic process via cystathionine [GO:0019343]; transsulfuration [GO:0019346]","GO:0004123; GO:0005737; GO:0005783; GO:0016846; GO:0019343; GO:0019346; GO:0030170; GO:0044540; GO:0080146"
"g21717",34.3202070599659,0.712129077785724,0.204181688539641,3.48772254201174,0.000487153324888305,0.0341201460751781,46085,48446,"sp|Q9GKZ4|TRAM1_BOVIN","Q9GKZ4","TRAM1",2.37e-13,"Translocating chain-associated membrane protein 1 (Protein TRAM1)","cotranslational protein targeting to membrane [GO:0006613]; protein insertion into ER membrane [GO:0045048]; response to unfolded protein [GO:0006986]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0006613; GO:0006616; GO:0006986; GO:0030176; GO:0045048"
"g80553",33.2539698571522,0.59772885742458,0.171374104674117,3.48785984067554,0.000486903245400463,0.0341201460751781,0,9032,"sp|P08548|LIN1_NYCCO","P08548","LIN1",8.56e-17,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g128648",747.44576966722,2.98959790933793,0.85695494740937,3.48862903280467,0.00048550443091951,0.0341201460751781,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86270",25.351440231824,0.736035129437687,0.211099213758182,3.48667868692694,0.000489058551661279,0.0341684857919672,3724,8087,"sp|P0C2X9|AL4A1_RAT","P0C2X9","AL4A1",8.73e-30,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)","proline catabolic process to glutamate [GO:0010133]","GO:0003842; GO:0004029; GO:0005759; GO:0010133; GO:0042802"
"g123676",88.5731906691882,-0.474807321636206,0.136170426738437,-3.48686078915095,0.000488725682155556,0.0341684857919672,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94469",3669.81459449227,-1.17682909090398,0.337595353081198,-3.48591614239706,0.000490454724759463,0.0341811085872636,3865,5762,"sp|Q24133|DNAJ1_DROME","Q24133","DNAJ1",7.77e-121,"DnaJ protein homolog 1 (DROJ1)","chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]","GO:0000122; GO:0005829; GO:0006457; GO:0008134; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087"
"g135363",2949.42538134731,0.83182939866428,0.23860534649994,3.4862144158387,0.000489908162044932,0.0341811085872636,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73930",40.5026711709398,0.558719068054356,0.160297610223389,3.48551090235052,0.000491198206511019,0.0341905563497435,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103595",395.405377954151,1.15169122978806,0.330456200115399,3.48515545898631,0.000491851192856349,0.0341936894791431,0,3215,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.68e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g6614",21.2169493874348,0.669282752554671,0.19215911218908,3.48296130706574,0.000495900032594427,0.0343259772048386,101676,105144,"sp|Q3SYU1|NOC2L_BOVIN","Q3SYU1","NOC2L",8.16e-14,"Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)","apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]","GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0140297; GO:2001243"
"g18736",42.1386167099684,0.876754357448957,0.251738220648601,3.48280191696758,0.000496195360540767,0.0343259772048386,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22306",158.961324181915,-0.375883256607944,0.107903615514598,-3.48350937839605,0.000494885782005697,0.0343259772048386,16322,33184,"sp|P11369|LORF2_MOUSE","P11369","LORF2",6.41e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g85707",1112.77158326082,0.49902803289337,0.143270787671495,3.48311083511029,0.000495623126686834,0.0343259772048386,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56551",20.4908006936058,0.553059054448303,0.158818719115512,3.48232914563461,0.000497072305755841,0.0343443987964619,0,9034,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.85e-14,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g23999",181.521968043357,0.44536764069449,0.127933813435741,3.48123477862396,0.000499107798224869,0.0344427248929609,33015,35277,"sp|Q6NV04|HACL2_DANRE","Q6NV04","HACL2",1.06e-22,"2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein)","embryonic cranial skeleton morphogenesis [GO:0048701]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]","GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016021; GO:0016829; GO:0030976; GO:0048701; GO:0050660"
"g15142",28.2293392216725,1.27424854041681,0.366202141503843,3.47963159140465,0.000502103717732571,0.0345646478491007,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140552",194.497089266033,-0.532811781133852,0.153122903884025,-3.47963477454296,0.000502097752738985,0.0345646478491007,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95397",51.3212299711857,-0.734093060171858,0.211059246845964,-3.47813740047892,0.000504911040183549,0.0347154116405906,215,4252,"sp|Q8N8E2|ZN513_HUMAN","Q8N8E2","ZN513",5.65e-23,"Zinc finger protein 513","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]","GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041"
"g6379",3340.41688450354,-0.796960333256335,0.229177681850781,-3.47747794122136,0.000506154696823315,0.0347584279105457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51339",327.889263988077,-0.573163002568341,0.164869705552514,-3.47646040033581,0.000508079254027247,0.0348480407378054,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21591",760.143754595351,-0.525770816268466,0.151275923725718,-3.47557498456762,0.000509759460757413,0.0349206962142734,5617,13164,"sp|P80363|CCB23_FAXLI","P80363","CCB23",2.93e-19,"Crustacean calcium-binding protein 23 (CCBP-23)",NA,"GO:0005509"
"g8065",924.692352546779,-0.328393127854,0.0945837186175561,-3.47198368444192,0.000516627734021525,0.0350496707078873,40375,52312,"sp|P21328|RTJK_DROME","P21328","RTJK",1.94e-27,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g17239",3479.38510593224,-0.234451935340834,0.067505587579212,-3.47307450758391,0.000514532494450267,0.0350496707078873,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31589",70.460364539516,0.535195980731003,0.15413102419994,3.47234428311294,0.000515934222227307,0.0350496707078873,714,5232,"sp|Q9W3K5|GSH1_DROME","Q9W3K5","GSH1",1.28e-12,"Glutamate--cysteine ligase (EC 6.3.2.2) (Gamma-ECS) (GCS) (Gamma-glutamylcysteine synthetase)","axonogenesis [GO:0007409]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; imaginal disc-derived wing morphogenesis [GO:0007476]; response to copper ion [GO:0046688]","GO:0004357; GO:0005524; GO:0005634; GO:0006749; GO:0006750; GO:0007409; GO:0007476; GO:0017109; GO:0046688; GO:0048471"
"g58642",24.7343963652646,-0.663701633896706,0.19106013561158,-3.47378395693172,0.000513174046729199,0.0350496707078873,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70278",537.328980839667,0.592901841691484,0.170708370951256,3.47318551742715,0.000514319712748606,0.0350496707078873,0,374,"sp|Q6DIY9|MDHC_XENTR","Q6DIY9","MDHC",1.88e-20,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase)","malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]","GO:0005829; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0030060"
"g74862",24.0989503328079,1.52631299763345,0.439547647124649,3.47246312798624,0.000515705847175241,0.0350496707078873,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131223",373.62294508975,0.626120575709707,0.180273658132925,3.47316730682881,0.000514354612876119,0.0350496707078873,0,1034,"sp|P38377|S61A1_CANLF","P38377","S61A1",3.26e-26,"Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1)","cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein insertion into ER membrane [GO:0045048]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0005048; GO:0005784; GO:0005789; GO:0006613; GO:0006616; GO:0008320; GO:0030176; GO:0031204; GO:0039019; GO:0043022; GO:0045047; GO:0045048"
"g140450",30.1778603676891,-0.866668917615988,0.249611515795388,-3.47207104950404,0.000516459631781264,0.0350496707078873,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15718",91.5999839756282,0.902603854942792,0.25999985299303,3.4715552510985,0.000517452836471308,0.0350633523238787,55349,57004,"sp|P08548|LIN1_NYCCO","P08548","LIN1",9e-24,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g41895",31.6769600817113,0.756417164945799,0.21799148065751,3.46993911259412,0.000520576360287955,0.0350637792279224,0,15346,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.03e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g43303",56.1251070640661,-0.365943066340958,0.105441508592455,-3.47057881877787,0.000519337899666319,0.0350637792279224,2368,15854,"sp|Q8I7P9|POL5_DROME","Q8I7P9","POL5",1.67e-70,"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]","GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074"
"g85383",52.3916378284773,-0.438728989949908,0.126422427463254,-3.47034144774218,0.000519797125293786,0.0350637792279224,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91319",185.485932052502,0.515978333254681,0.148650539164378,3.47108282388476,0.000518364088754736,0.0350637792279224,6995,7523,"sp|B3NQ53|KAD2_DROER","B3NQ53","KAD2",5.79e-86,"Adenylate kinase (EC 2.7.4.3) (ATP-AMP transphosphorylase) (ATP:AMP phosphotransferase) (Adenylate kinase cytosolic and mitochondrial) (Adenylate monophosphate kinase)","ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]","GO:0004017; GO:0005524; GO:0005758; GO:0005829; GO:0006172; GO:0046033; GO:0046034"
"g98418",52.0467923819676,0.432772807969088,0.124713415093042,3.4701383780263,0.00052019029084256,0.0350637792279224,0,4964,"sp|P21328|RTJK_DROME","P21328","RTJK",3.21e-13,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g130746",77.8150535469124,-0.769824191452426,0.221959369009132,-3.46831131701745,0.000523740170166596,0.0352346825963035,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8834",51.0684665593395,-0.353807125734662,0.102043521391011,-3.46721791752896,0.000525875370328231,0.0352938932911699,76572,85724,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.21e-38,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g48875",49.4083245666513,0.399038767148656,0.115086517458734,3.46729378870758,0.000525726946893021,0.0352938932911699,0,8214,"sp|B1P1W2|SDHF2_ARTSF","B1P1W2","SDHF2",1.01e-18,"Succinate dehydrogenase assembly factor 2, mitochondrial (SDH assembly factor 2) (SDHAF2)","mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; protein-FAD linkage [GO:0018293]","GO:0005739; GO:0005759; GO:0006121; GO:0018293"
"g14067",670.509850393731,-0.464020788930984,0.133864251879751,-3.46635328263598,0.000527569577897733,0.0353255329782139,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20655",183.476064944767,-0.443054324463951,0.127816314408674,-3.46633625381617,0.000527602996011871,0.0353255329782139,0,13589,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.24e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g10838",104.900017893829,-0.549634144655194,0.158618015512634,-3.46514324289612,0.000529949130028499,0.0353339389027332,63365,69712,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.11e-36,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g40052",34.4781985393135,0.476459451973599,0.137519177057344,3.4646764339996,0.000530869783663624,0.0353339389027332,13622,14614,"sp|Q86AQ5|RPC1_DICDI","Q86AQ5","RPC1",3.74e-39,"DNA-directed RNA polymerase III subunit rpc1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)","transcription by RNA polymerase III [GO:0006383]","GO:0003677; GO:0003899; GO:0005666; GO:0006383; GO:0046872"
"g60337",97.2361711548333,0.372919878371475,0.107621085384971,3.46511909852521,0.000529996711725751,0.0353339389027332,0,5644,"sp|Q7YU24|MARF_DROME","Q7YU24","MARF",3.66e-33,"Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin)","adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]","GO:0003924; GO:0005525; GO:0005740; GO:0005741; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115"
"g67368",81.6456820418433,-0.46772391482317,0.134996149989395,-3.46472040024781,0.000530783008658566,0.0353339389027332,0,9500,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.61e-22,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g120826",28.0893396113202,-0.642135060506052,0.185281647204152,-3.46572404874249,0.000528805725597819,0.0353339389027332,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g818",533.517011810299,-0.455526939647785,0.131520645752316,-3.46353940890504,0.000533118496452158,0.0353705426585746,88745,155139,"sp|Q9VX32|RG190_DROME","Q9VX32","RG190",3.93e-17,"Rho GTPase-activating protein 190 (Rho GTPase-activating protein of 190 kDa)","defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266]","GO:0003924; GO:0005096; GO:0005525; GO:0005829; GO:0007266; GO:0007415; GO:0016319; GO:0030215; GO:0045792; GO:0050770"
"g13719",1570.71006362526,0.301567411392052,0.0870689811329171,3.46354588589578,0.00053310566170517,0.0353705426585746,0,8843,"sp|Q26250|VATL_NEPNO","Q26250","VATL",2.97e-15,"V-type proton ATPase 16 kDa proteolipid subunit c (V-ATPase 16 kDa proteolipid subunit c) (Vacuolar proton pump 16 kDa proteolipid subunit c)",NA,"GO:0005774; GO:0016021; GO:0033179; GO:0046961"
"g88981",624.381530902533,0.500981102490933,0.144648222310921,3.4634445863709,0.000533306428904933,0.0353705426585746,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27569",453.616591867351,-0.269622255920805,0.0779121598409225,-3.46059275562772,0.000538987513497779,0.0357052246574111,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80319",125.325745146124,-0.60094576274042,0.17368685425934,-3.45993808974811,0.000540299595832413,0.0357460640203101,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130275",26.1813454615756,0.690743218643698,0.199656885233624,3.45965138059446,0.000540875155244904,0.0357460640203101,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22595",524.615728440894,-0.364306103323402,0.105317696362402,-3.45911576027842,0.000541951926493985,0.0357751880867074,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101322",836.932593795205,2.40760767367648,0.696134830487645,3.45853643322219,0.000543118810553202,0.0358101853964047,0,1363,"sp|P25784|CYSP3_HOMAM","P25784","CYSP3",3.78e-29,"Digestive cysteine proteinase 3 (EC 3.4.22.-)",NA,"GO:0008234"
"g4102",582.7692937963,-0.547851212146047,0.158574470163993,-3.45485128583105,0.000550596429545833,0.0358491586862057,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19173",35.0132580090759,0.626780349556416,0.181430331314609,3.45466132930964,0.000550984461845107,0.0358491586862057,48075,53406,"sp|Q5RBL1|GARS_PONAB","Q5RBL1","GARS",7.56e-18,"Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1)","diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; tRNA aminoacylation for protein translation [GO:0006418]","GO:0004081; GO:0004820; GO:0005524; GO:0005739; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030424; GO:0046983; GO:0070062"
"g28943",37.2524315169675,1.47424326447925,0.426762938933854,3.45447818913758,0.000551358811272145,0.0358491586862057,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29023",1462.72791067465,2.52193449465404,0.729339842660715,3.45783179135496,0.00054454125933534,0.0358491586862057,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33404",20.5642245383026,-0.572602709327247,0.165755768742997,-3.45449641764844,0.000551321540495156,0.0358491586862057,27535,31040,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.91e-19,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g54323",58.1491963251629,-0.612658298336239,0.177238463984193,-3.45668927931399,0.00054685500728863,0.0358491586862057,3259,6264,"sp|Q09575|YRD6_CAEEL","Q09575","YRD6",2.72e-16,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0008270; GO:0015074"
"g68935",257.182886872484,0.562209790855455,0.162747422161131,3.45449275564457,0.000551329027793307,0.0358491586862057,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120709",23.9317526985537,1.94205226305388,0.56210852414906,3.45494184773986,0.000550411524490568,0.0358491586862057,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128260",149.879584960335,1.08366100401956,0.313597823054081,3.45557565886761,0.000549119056826943,0.0358491586862057,1716,3324,"sp|Q924Z4|CERS2_MOUSE","Q924Z4","CERS2",1.54e-53,"Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (Sphingosine N-acyltransferase CERS2) (EC 2.3.1.24) (Translocating chain-associating membrane protein homolog 3) (TRAM homolog 3) (Tumor metastasis-suppressor gene 1 protein) (Very-long-chain ceramide synthase CERS2) (EC 2.3.1.297)","ceramide biosynthetic process [GO:0046513]; negative regulation of axon regeneration [GO:0048681]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation involved in axon regeneration [GO:1905045]; regulation of lipid metabolic process [GO:0019216]; sphingolipid biosynthetic process [GO:0030148]","GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0016410; GO:0019216; GO:0030148; GO:0046513; GO:0048681; GO:0050291; GO:1900148; GO:1905045"
"g144190",33.8445439962286,0.771145439359421,0.223103758791775,3.45644306279546,0.000547354828477406,0.0358491586862057,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152522",86.0192527269041,0.517928805800627,0.149834264938897,3.45667799025703,0.000546877914846574,0.0358491586862057,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153196",19.5106455979347,-0.6925983251377,0.200452273584022,-3.45517819655655,0.000549929231003012,0.0358491586862057,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95950",206.478603652782,-0.593627643455695,0.171860642317789,-3.4541221041058,0.000552087348545075,0.035855076970984,1526,6966,"sp|Q96GN5|CDA7L_HUMAN","Q96GN5","CDA7L",1.64e-38,"Cell division cycle-associated 7-like protein (Protein JPO2) (Transcription factor RAM2)","positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]","GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0008284"
"g37575",816.067685029227,-0.371116258504786,0.107456593424701,-3.45363878266661,0.000553077641597595,0.035877961613301,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2498",211.007033076582,0.448805909277225,0.129968208049916,3.45319763972475,0.000553982957818794,0.0358952874581159,13655,15709,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.22e-13,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g6043",86.6667081213217,0.34757157167772,0.100694276981004,3.45175100411407,0.000556961446442741,0.0359460307404106,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55974",1845.18314259603,0.445497131365788,0.129049475824573,3.45214212238557,0.000556154702391609,0.0359460307404106,0,12200,"sp|Q9M888|TCPZA_ARATH","Q9M888","TCPZA",6.91e-35,"T-complex protein 1 subunit zeta 1 (TCP-1-zeta 1) (CCT-zeta 1) (Chaperonin CCT6A)","protein folding [GO:0006457]; response to zinc ion [GO:0010043]","GO:0005524; GO:0005737; GO:0005829; GO:0005832; GO:0006457; GO:0010043; GO:0016887; GO:0051082"
"g76736",154.994725040331,2.17630142456158,0.630464061289635,3.45190401513115,0.000556645707012776,0.0359460307404106,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89937",42.4494230800997,1.08143987882799,0.313317700552883,3.45157607412434,0.000557322620206216,0.0359460307404106,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134025",39.0915495664746,0.476712541699096,0.138144115166518,3.45083495684539,0.000558855208537671,0.0360035906512895,0,2564,"sp|Q9VBX1|NEMF_DROME","Q9VBX1","NEMF",5.23e-20,"Ribosome quality control complex subunit NEMF homolog (Protein Caliban)","CAT tailing [GO:0140708]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein export from nucleus [GO:0006611]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]","GO:0000049; GO:0005634; GO:0006611; GO:0032473; GO:0043023; GO:0072344; GO:0140708; GO:1902167; GO:1902231; GO:1990112; GO:1990116"
"g49628",28.597923638276,0.650171193602429,0.188442145231419,3.45024300590496,0.00056008214813446,0.0360194521038544,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127726",56.0219107529932,0.598189512274475,0.173396248922751,3.44984113549638,0.000560916536136833,0.0360194521038544,3460,3811,"sp|P11217|PYGM_HUMAN","P11217","PYGM",2.02e-15,"Glycogen phosphorylase, muscle form (EC 2.4.1.1) (Myophosphorylase)","glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]","GO:0000166; GO:0005737; GO:0005829; GO:0005977; GO:0005980; GO:0008184; GO:0030170; GO:0070062; GO:0102250; GO:0102499"
"g140076",69.5947273933014,0.584382619093889,0.169396575945591,3.44979003165677,0.000561022723995883,0.0360194521038544,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34290",102.564792557656,-0.702939746934207,0.20380707689992,-3.44904483998554,0.000562573274510132,0.0360778176795882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9628",1571.00680336935,-0.678707167784807,0.196802053411135,-3.4486792999407,0.000563335326691769,0.0360855415077432,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25702",568.407605080922,-0.731041104312804,0.212002545449414,-3.44826569305149,0.000564198744496187,0.036099733547161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68114",28.4748476644338,-0.512140339817487,0.148548073045272,-3.44764041241656,0.000565506378320019,0.0361379701185668,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88193",103.634814419212,0.482220004492769,0.13989315212147,3.44705939626018,0.000566723972201841,0.0361379701185668,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108434",41.8058949085029,0.492752354400619,0.142944555969224,3.44715719363743,0.00056651885451608,0.0361379701185668,2288,5304,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.37e-59,"PiggyBac transposable element-derived protein 4",NA,NA
"g6027",65.4023565347213,0.517682646697411,0.150266439255253,3.44509824857192,0.000570851860222907,0.0361959981089704,51719,71298,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",8.71e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g7864",454.500104328198,0.695000401024105,0.201708555685138,3.44556728723487,0.000569862072709433,0.0361959981089704,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15692",104.876227021747,-0.55254441271915,0.160383831705867,-3.44513787232918,0.000570768182434478,0.0361959981089704,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41343",30.5754457194289,1.43958177078794,0.417737310063256,3.44614123782708,0.000568653069394349,0.0361959981089704,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46559",38.9848572577802,-0.657793936377848,0.190922020350953,-3.4453539469606,0.000570312075119185,0.0361959981089704,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28697",470.15778459935,0.404457720651657,0.117417010132331,3.44462629559233,0.000571849413294039,0.0362184174577515,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25600",136.091135545818,-0.733694904212243,0.213058103027694,-3.44363764525245,0.000573944358283103,0.0363102121468597,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g135831",51.5347272705367,0.75241497202382,0.218609077565754,3.44182858462273,0.000577796261920254,0.0365128284976617,0,3164,"sp|Q8VCW8|ACSF2_MOUSE","Q8VCW8","ACSF2",2.96e-12,"Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2)","fatty acid metabolic process [GO:0006631]","GO:0005524; GO:0005739; GO:0006631; GO:0031956; GO:0047760"
"g77598",30.9189491797492,2.012605885796,0.585007533800961,3.44030763624448,0.000581053319400293,0.0366571283976715,0,3464,"sp|Q9GV46|LUCB_OPLGR","Q9GV46","LUCB",5.94e-22,"Oplophorus-luciferin 2-monooxygenase non-catalytic subunit",NA,"GO:0005576"
"g117210",26.3459220457319,0.583001232149059,0.169469515809773,3.44015399680182,0.000581383281724031,0.0366571283976715,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49815",28.5079475091415,0.486929687553159,0.141626807851054,3.4381180720055,0.00058577222122259,0.0368924986181421,0,17446,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.11e-30,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g8446",39.2556626937072,-0.635570581318445,0.185228804329981,-3.43127292549053,0.000600755851411454,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13982",266.230242763665,-0.633614266806966,0.184684204017233,-3.4307983737897,0.00060180772874513,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25355",30.4138201728823,-0.774665297486044,0.225702525137167,-3.43224027739722,0.000598616944890463,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28975",110.195441206129,-0.306149863736158,0.0891903524996791,-3.4325446099931,0.000597945503861048,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36397",525.916540525315,0.433927890857464,0.126290574652179,3.4359483441465,0.000590483546104627,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38277",68.2565193810282,-0.43853324636792,0.127758402432771,-3.43251980313925,0.000598000208320505,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40784",65.9388852445155,-0.488754460440403,0.142288491845853,-3.43495425455693,0.000592653863907976,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43117",370.448206933095,-0.440046477063989,0.128075583815298,-3.43583424689748,0.000590732269292105,0.0369507317468162,2915,11501,"sp|P17019|ZN708_HUMAN","P17019","ZN708",1.53e-61,"Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g49698",61.2684314197928,-0.606488875458111,0.176771728608315,-3.43091556683223,0.000601547802824846,0.0369507317468162,5050,14734,"sp|Q29397|SV2A_BOVIN","Q29397","SV2A",1.8e-11,"Synaptic vesicle glycoprotein 2A (p87)","cellular calcium ion homeostasis [GO:0006874]; synaptic vesicle priming [GO:0016082]","GO:0005783; GO:0005911; GO:0006874; GO:0016021; GO:0016082; GO:0019901; GO:0022857; GO:0030672; GO:0031594; GO:0043005; GO:0048786; GO:0098978; GO:0098982"
"g53690",45.3523046068906,-0.647330253823728,0.188577125668563,-3.43270824353032,0.000597584773324328,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63602",69.8574515906083,-1.21658737565447,0.354269372258645,-3.43407438215196,0.000594581012692173,0.0369507317468162,0,12409,"sp|P04323|POL3_DROME","P04323","POL3",2.6e-31,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g71365",616.264404672246,-0.368292128996363,0.1072627561397,-3.43355086379373,0.000595730419860525,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87382",609.864448574104,0.491722386174686,0.143242838686877,3.43278861744404,0.000597407663024192,0.0369507317468162,4459,8041,"sp|Q2NKZ1|TCPH_BOVIN","Q2NKZ1","TCPH",3.8e-22,"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0005524; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:1901998; GO:1904851"
"g92677",412.334689983496,0.585211390480609,0.170446120162606,3.43340986537162,0.000596040341325921,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99918",157.355500947751,-0.53204155971225,0.154829427756135,-3.43630773182372,0.00058970074572189,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101291",1089.28999276721,0.389765981177179,0.113410083888595,3.43678417132689,0.000588664478066434,0.0369507317468162,382,4391,"sp|Q9NB32|TCPD_OCHTR","Q9NB32","TCPD",1.62e-19,"T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","protein folding [GO:0006457]","GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g119636",104.903645060042,0.604623550897182,0.176048389771853,3.434416819607,0.000593830293564886,0.0369507317468162,0,4522,"sp|P40301|PSA2_DROME","P40301","PSA2",6.37e-24,"Proteasome subunit alpha type-2 (PROS-Dm25) (Proteasome 25 kDa subunit)","proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","GO:0000502; GO:0005654; GO:0005829; GO:0005839; GO:0010498; GO:0019773; GO:0043161"
"g121506",101.424676577138,-0.476367418382755,0.138609947390548,-3.43674770354353,0.000588743736442249,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122495",329.257773652301,0.555262386080355,0.161836120207954,3.43101642183996,0.000601324197171967,0.0369507317468162,455,4140,"sp|O88989|MDHC_RAT","O88989","MDHC",2.06e-21,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase)","malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; NAD metabolic process [GO:0019674]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]","GO:0005829; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0016615; GO:0019674; GO:0030060; GO:0051287"
"g137887",103.801759917825,-0.973920996844134,0.283591175239944,-3.43424295914747,0.00059421133421635,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138715",40.2656106467554,0.49151954805944,0.143266667131397,3.4308018599235,0.000601799995237436,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147015",69.2532931513863,0.743722658479684,0.216415008179396,3.43655768024729,0.000589156890174463,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150436",25.2594809804663,1.69884355046095,0.495008315050657,3.43194952247841,0.000599259085290948,0.0369507317468162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7876",154.948734107995,-0.635222295213053,0.18525642357239,-3.42888134707424,0.000606074426806992,0.0370787493496943,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10726",374.493184899264,-0.395532695389942,0.115331289718096,-3.42953500612662,0.000604616434483368,0.0370787493496943,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120902",76.8873199046155,-1.24577843572574,0.363340804250514,-3.42867748722988,0.000606529806936432,0.0370787493496943,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137528",736.762377495422,0.806503265040446,0.235200158033911,3.42900817661937,0.000605791276786689,0.0370787493496943,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2452",33.8332704184687,-0.682745933549781,0.199145561595638,-3.42837634983844,0.000607203067324961,0.0370796035966237,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2250",54.3253414492761,-0.902543843095213,0.263279829413887,-3.42807819765173,0.000607870338749005,0.0370800906636893,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6558",3912.97151135909,-0.482531994305426,0.140789717518803,-3.42732411719615,0.000609561034881875,0.0371288338101397,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42618",52.7578277515117,-0.546626459432387,0.15949962381195,-3.42713322055768,0.000609989730816277,0.0371288338101397,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45954",94.2145540049854,0.726855007142522,0.212132937923279,3.42641276860738,0.000611610176176717,0.0371763938091246,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100759",835.003223038283,-1.83553749876575,0.535735904575585,-3.4261983994145,0.000612093109548903,0.0371763938091246,1853,5104,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.9e-20,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g67890",1008.96440571866,-0.380808298124327,0.111161762283665,-3.42571303568012,0.000613187854090921,0.0372027090504656,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32118",734.57902387509,-0.311945725443516,0.0910773123065842,-3.42506511823104,0.000614652080369825,0.0372029827687554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44465",117.866869316297,-0.344408536552575,0.100562132131546,-3.42483327722261,0.000615176806922629,0.0372029827687554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88067",19.7811734578402,-1.32324040694597,0.386341130438197,-3.42505703559216,0.000614670366825313,0.0372029827687554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29144",40.5163579529894,-0.52820676147227,0.154251543164327,-3.42432075969289,0.000616338269207725,0.0372331868279064,4386,31434,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.16e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g28406",3087.09059064767,0.341091330779309,0.0996354953302213,3.42339173051564,0.000618448829354969,0.0372406842190387,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44297",427.363263932945,0.439389984551248,0.128338646392691,3.42367631965512,0.000617801588896857,0.0372406842190387,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57002",333.224623751862,2.45294703129817,0.716463084546093,3.42368934870135,0.000617771972059109,0.0372406842190387,4396,14144,"sp|P81182|BGBP_PENVA","P81182","BGBP",0,"Beta-1,3-glucan-binding protein (BGBP) (Beta-1,3-glucan recognition protein) (BetaGRP) (BetaGBP-HDL) (High density lipoprotein)","cell surface pattern recognition receptor signaling pathway [GO:0002752]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; regulation of innate immune response [GO:0045088]","GO:0002752; GO:0005576; GO:0006869; GO:0038187; GO:0045087; GO:0045088"
"g5635",52.1815993640165,0.479768570489149,0.140178781689654,3.42254772588424,0.000620372059360999,0.0373165404947394,67415,79560,"sp|Q99J83|ATG5_MOUSE","Q99J83","ATG5",2.29e-12,"Autophagy protein 5 (APG5-like)","aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; blood vessel remodeling [GO:0001974]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; cellular response to starvation [GO:0009267]; chaperone-mediated autophagy [GO:0061684]; C-terminal protein lipidation [GO:0006501]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of defense response to virus [GO:0050687]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of innate immune response [GO:0045824]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of type I interferon production [GO:0032480]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation of mucus secretion [GO:0070257]; positive regulation of viral translation [GO:1904973]; post-translational protein modification [GO:0043687]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of autophagosome maturation [GO:1901096]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to fluoride [GO:1902617]; response to fungus [GO:0009620]; response to iron(II) ion [GO:0010040]; response to xenobiotic stimulus [GO:0009410]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015]","GO:0000045; GO:0000422; GO:0001974; GO:0002718; GO:0005737; GO:0005776; GO:0005829; GO:0005930; GO:0006497; GO:0006501; GO:0006914; GO:0006915; GO:0006995; GO:0009267; GO:0009410; GO:0009620; GO:0010040; GO:0016020; GO:0016236; GO:0019883; GO:0030424; GO:0031397; GO:0032480; GO:0032991; GO:0034045; GO:0034274; GO:0035973; GO:0039689; GO:0042311; GO:0043066; GO:0043687; GO:0044233; GO:0044804; GO:0045060; GO:0045824; GO:0048840; GO:0050687; GO:0050765; GO:0051279; GO:0055015; GO:0060047; GO:0060548; GO:0061684; GO:0061739; GO:0070257; GO:0071500; GO:1901096; GO:1902017; GO:1902617; GO:1904973; GO:1990234; GO:2000377; GO:2000378; GO:2000619"
"g45765",36.1470818701048,1.5055963162864,0.439981706539771,3.42195208097887,0.000621732700886007,0.0373584300889218,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12557",310.767474749494,-0.333387481218656,0.0974425589556241,-3.4213744465648,0.000623054852232491,0.037390712021223,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51831",48.0104912165431,-0.581229650214121,0.169893718346799,-3.4211367899293,0.000623599585290479,0.037390712021223,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120270",139.097734043643,0.471110502053,0.137750609218387,3.42002481677674,0.000626154232188298,0.0375039045013144,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22677",163.959317289581,0.384316587690081,0.112440797824623,3.41794611142398,0.000630955981648557,0.0376711532058154,38695,43923,"sp|Q92665|RT31_HUMAN","Q92665","RT31",2.97e-18,"28S ribosomal protein S31, mitochondrial (MRP-S31) (S31mt) (Imogen 38) (Mitochondrial small ribosomal subunit protein mS31)","mitochondrial translation [GO:0032543]","GO:0003723; GO:0003735; GO:0005730; GO:0005739; GO:0005743; GO:0005763; GO:0019904; GO:0032543"
"g78291",67.6713443657057,-0.362720865514446,0.106118654238295,-3.41806884112889,0.000630671530708694,0.0376711532058154,0,7944,"sp|P08548|LIN1_NYCCO","P08548","LIN1",3.02e-32,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g96994",98.5901741545218,-0.614798003565951,0.179867083186355,-3.41806845741184,0.000630672419864708,0.0376711532058154,0,6840,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.65e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g54424",83.5756489388196,0.752076655644801,0.220074960448171,3.41736585622116,0.000632302457362842,0.0377115109300116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29753",251.233838304231,-0.226079632347193,0.066164278135151,-3.41694398728858,0.00063328307714778,0.0377299860433744,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19650",628.755183495255,0.500718164368646,0.146583845762781,3.41591641127335,0.000635677565048871,0.037792576758434,0,5931,"sp|Q5EA68|S61A1_BOVIN","Q5EA68","S61A1",1.22e-37,"Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1)","cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein insertion into ER membrane [GO:0045048]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0005048; GO:0005784; GO:0005789; GO:0006613; GO:0006616; GO:0008320; GO:0030176; GO:0031204; GO:0039019; GO:0043022; GO:0045047; GO:0045048"
"g130975",63.21006948977,2.27678197921124,0.666467073774347,3.41619574139999,0.000635025829594597,0.037792576758434,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94706",145.672907246566,0.982773604391316,0.287770551469625,3.41512916930643,0.000637517714171484,0.0378619548895803,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25685",2718.11156154933,-0.582462605056614,0.170592537475078,-3.41434985186093,0.000639344219384358,0.037890408415822,0,20200,"sp|A6QQJ8|ZC12A_BOVIN","A6QQJ8","ZC12A",4.02e-64,"Ribonuclease ZC3H12A (EC 3.1.-.-) (Zinc finger CCCH domain-containing protein 12A)","3'-UTR-mediated mRNA destabilization [GO:0061158]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to chemokine [GO:1990869]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to sodium arsenite [GO:1903936]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; immune response-activating signal transduction [GO:0002757]; miRNA catabolic process [GO:0010587]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of tumor necrosis factor production [GO:0032720]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of cell death [GO:0010942]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of lipid storage [GO:0010884]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]; protein deubiquitination [GO:0016579]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; T cell receptor signaling pathway [GO:0050852]","GO:0000294; GO:0000932; GO:0001525; GO:0001933; GO:0002230; GO:0002757; GO:0003677; GO:0003682; GO:0003729; GO:0003730; GO:0004518; GO:0004521; GO:0004532; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005791; GO:0005856; GO:0006915; GO:0006974; GO:0010508; GO:0010587; GO:0010595; GO:0010656; GO:0010884; GO:0010942; GO:0016579; GO:0030154; GO:0030867; GO:0032088; GO:0032689; GO:0032691; GO:0032715; GO:0032720; GO:0032991; GO:0034599; GO:0035198; GO:0035613; GO:0035925; GO:0036464; GO:0042149; GO:0042307; GO:0042406; GO:0043022; GO:0043124; GO:0044828; GO:0045019; GO:0045600; GO:0045766; GO:0045944; GO:0046872; GO:0050852; GO:0051259; GO:0055118; GO:0061014; GO:0061158; GO:0071222; GO:0071347; GO:0071356; GO:0090501; GO:0090502; GO:0098586; GO:1900016; GO:1900119; GO:1900745; GO:1901223; GO:1903003; GO:1903799; GO:1903936; GO:1904637; GO:1990869; GO:2000320; GO:2000379; GO:2000627"
"g92576",956.588202075139,-0.331972530081711,0.0972206525898449,-3.41462972360656,0.000638687717770011,0.037890408415822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37965",302.842005171208,0.496196361371641,0.145378678722606,3.41313021779777,0.000642212477563948,0.0380164482384661,18374,21904,"sp|Q25008|TBA1_HOMAM","Q25008","TBA1",1.04e-27,"Tubulin alpha-1 chain (Alpha-I tubulin)","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g89993",70.7684640730087,-0.858234276349795,0.251469859937904,-3.41287133401085,0.000642822841911405,0.0380164482384661,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56664",155.630760073206,0.39848359789333,0.11678916510296,3.41199115125132,0.000644902066572886,0.0380593725374525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143666",48.4410524140106,0.808297630346752,0.236895881873715,3.41203749070505,0.000644792444714264,0.0380593725374525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1566",40.0980281813039,-0.487808027530914,0.14298135677614,-3.41168973724773,0.000645615522813927,0.0380615390294558,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89158",82.2187468209924,0.401232294761091,0.117635317843746,3.41081489909386,0.000647690451323097,0.0381438810087053,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6058",1303.08993655849,-0.546580833440163,0.160310737618612,-3.40950856791957,0.000650800336284438,0.0382469305259241,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121440",52.7512733037508,1.04975064449711,0.307872527592877,3.40969248768202,0.000650361653901224,0.0382469305259241,2135,4360,"sp|P08548|LIN1_NYCCO","P08548","LIN1",6.28e-28,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g30674",10804.1930340342,0.319136457663555,0.0936210816847718,3.40880976720722,0.000652469614532541,0.0383050063262413,23345,34333,"sp|P62083|RS7_RAT","P62083","RS7",1.01e-22,"40S ribosomal protein S7 (S8)","cell differentiation [GO:0030154]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]","GO:0001843; GO:0003730; GO:0003735; GO:0005634; GO:0005730; GO:0005815; GO:0006364; GO:0006412; GO:0008266; GO:0010628; GO:0019901; GO:0022626; GO:0022627; GO:0030154; GO:0032040; GO:0032991; GO:0042274; GO:0045202; GO:0048027; GO:0050821; GO:1902255; GO:1904667; GO:1990904; GO:1990948; GO:2000059"
"g35476",496.290140662624,-0.690225697371059,0.202567380257516,-3.40738818112571,0.000655877761452675,0.0383392687078948,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52342",37.5404460426663,-0.554984312545461,0.162901903674303,-3.40686204413586,0.000657143327662789,0.0383392687078948,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69128",179.180103235428,1.20811215691189,0.354592475865513,3.40704397058356,0.000656705466440685,0.0383392687078948,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95074",55.2543015353562,1.46617290543708,0.430274499093379,3.40752916690722,0.00065553902049708,0.0383392687078948,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107455",325.116052327679,0.472504926997639,0.138688290394805,3.40695617238164,0.000656916745582757,0.0383392687078948,0,2834,"sp|Q9NJH0|EF1G_DROME","Q9NJH0","EF1G",4.68e-13,"Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","glutathione metabolic process [GO:0006749]; translational elongation [GO:0006414]","GO:0003746; GO:0005634; GO:0005737; GO:0005853; GO:0006414; GO:0006749"
"g112723",26556.9557680205,0.31408387791112,0.0921801065860321,3.40728482037482,0.000656126205639817,0.0383392687078948,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38662",79.2191705455343,0.364721920423797,0.107091120323139,3.40571579906232,0.00065990836418812,0.0384599023447665,16354,24624,"sp|P10394|POL4_DROME","P10394","POL4",2.03e-39,"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g48548",44.6294346006976,1.15261437278557,0.338462826549978,3.40543859582574,0.000660578671900794,0.0384599023447665,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34681",61.3448768265596,-0.630745628735795,0.185237013826069,-3.40507340141017,0.000661462718375409,0.0384715472666699,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15714",107.574353169383,0.418452925060372,0.122908664992472,3.40458441303549,0.000662648162537498,0.0384786189966075,59275,62016,"sp|Q9VE51|CPSF3_DROME","Q9VE51","CPSF3",6.24e-30,"Cleavage and polyadenylation specificity factor 73 (EC 3.1.27.-)","mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]","GO:0003723; GO:0004521; GO:0005847; GO:0006378; GO:0006398; GO:0008409; GO:0046872"
"g131143",40.3502272857829,-0.978797953433051,0.287504700987193,-3.40445895344386,0.00066295262984447,0.0384786189966075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27727",5405.73051133229,0.268086747172412,0.0788017400021548,3.40204095956614,0.000668846127148702,0.038542258076944,5341,17844,"sp|Q6GPM1|ZFR_XENLA","Q6GPM1","ZFR",4.17e-30,"Zinc finger RNA-binding protein",NA,"GO:0003677; GO:0003723; GO:0005634; GO:0005737; GO:0008270"
"g31638",36.1007851441096,1.33522113527967,0.392419058248126,3.40253896240538,0.000667628351390686,0.038542258076944,0,2914,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.89e-67,"PiggyBac transposable element-derived protein 4",NA,NA
"g63894",397.093545600262,0.481871646457132,0.141589260807577,3.40330646341891,0.000665755602751847,0.038542258076944,3526,12284,"sp|Q5XGB9|AMPL_XENTR","Q5XGB9","AMPL",2.27e-20,"Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)",NA,"GO:0004180; GO:0005737; GO:0008233; GO:0030145; GO:0070006"
"g105162",25.533749982064,0.608170757717459,0.178740338899078,3.40253779008917,0.000667631215655439,0.038542258076944,3024,4554,"sp|P41894|DEI_DROME","P41894","DEI",7.28e-18,"Helix-loop-helix protein delilah (Protein taxi)","cell adhesion mediated by integrin [GO:0033627]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; neuron differentiation [GO:0030182]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic muscle development [GO:0007525]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007474; GO:0007498; GO:0007525; GO:0016203; GO:0030182; GO:0033627; GO:0043425; GO:0046983"
"g106450",40.3973854413228,0.618590689334402,0.181765145216888,3.40324152133941,0.000665913875972243,0.038542258076944,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113594",341.822592999967,-0.937224072231613,0.275425640188375,-3.40282070903277,0.000666940304416691,0.038542258076944,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127546",56.1836765488744,-0.638530369810236,0.187678924495698,-3.40224866231516,0.000668337976856639,0.038542258076944,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5315",455.025632563608,-0.975397594721215,0.286808259278627,-3.40086996509274,0.000671717723985533,0.0385741482166783,76195,96875,"sp|Q6C5V7|YNG2_YARLI","Q6C5V7","YNG2",3.53e-12,"Chromatin modification-related protein YNG2 (ING1 homolog 2)","chromatin organization [GO:0006325]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of transcription, DNA-templated [GO:0006355]","GO:0005634; GO:0006281; GO:0006325; GO:0006355; GO:0035064; GO:0046872; GO:0051321"
"g8626",3564.80147688279,-0.503644863132622,0.148070073373229,-3.40139537760018,0.000670427854902274,0.0385741482166783,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82374",49.4126809763298,0.889262206954095,0.261483264830943,3.40083793710098,0.000671796426129036,0.0385741482166783,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143783",48.7018042166067,0.622504640466228,0.183052077182101,3.40069694946405,0.000672142975931595,0.0385741482166783,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g161323",220.936199178894,2.25780390689322,0.664003054117643,3.40029144879988,0.00067314062952076,0.0385920237365001,559,1107,"sp|P80067|CATC_RAT","P80067","CATC",7.5e-13,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0005813; GO:0006508; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0043621; GO:0051087; GO:0051603; GO:1903052; GO:1903980; GO:2001235"
"g9417",197.776643381306,-0.442394691225622,0.130163512329268,-3.39876116823368,0.000676917993817546,0.0387296254407797,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155933",107.054874288255,0.561754403733665,0.165273063098284,3.39894713150928,0.00067645791013722,0.0387296254407797,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92714",301.074392726103,-0.535965407659833,0.157715284964392,-3.3983098580511,0.00067803577070319,0.0387541542844399,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5437",42.858739405432,-0.851509783583868,0.250638552359986,-3.39736156136453,0.000680390045413058,0.0388492354661129,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73628",189.003200156144,2.60068375205149,0.765914226571036,3.39552871826736,0.000684961877292288,0.0390706145057534,0,5254,"sp|H2N0D4|AMY_ORYLA","H2N0D4","AMY",1.01e-26,"Alpha-amylase (EC 3.2.1.1)","carbohydrate metabolic process [GO:0005975]","GO:0004556; GO:0005576; GO:0005975; GO:0046872"
"g128451",57.6452676179286,-0.582612205457237,0.171615441469489,-3.39487053419269,0.000686610603883971,0.0391249783015626,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69997",149.47548866422,-0.597937121129589,0.176172821944055,-3.39403725575485,0.000688703226615358,0.0392045008818836,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125713",26.7124328513569,1.43667965093679,0.423384347047441,3.39332254712716,0.00069050280459274,0.0392275340766716,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151012",41.1307397265978,-0.704860889056452,0.207703049252626,-3.39359913873551,0.000689805851720155,0.0392275340766716,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142289",89.33040475216,0.552543401848993,0.162896906261248,3.39198217161255,0.000693889550350314,0.0393801575083777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34568",109.299537670272,-0.534291346468041,0.157580231656984,-3.39059881337825,0.000697401085152562,0.0394997299407355,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110234",2366.88637491412,0.481590739708834,0.142037073334778,3.390598865507,0.000697400952517653,0.0394997299407355,0,2975,"sp|Q5UAP0|RS4_BOMMO","Q5UAP0","RS4",2.78e-20,"40S ribosomal protein S4","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412; GO:0019843"
"g15564",446.945646997051,-0.401945571256411,0.118584860232294,-3.38951844669756,0.00070015497990065,0.0396158112470547,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2494",170.689814669034,0.403582787767215,0.119099425583934,3.38862077452083,0.000702450862923639,0.03964665219142,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34752",29.4558294776581,0.845553558169378,0.249638901143895,3.38710655388596,0.000706339488208151,0.03964665219142,18052,20594,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.38e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g40515",114.842693459154,0.503397116032165,0.148598502290041,3.38763250150134,0.000704986556022127,0.03964665219142,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46997",1203.13549464198,-0.45854147669172,0.135358839492047,-3.38759905457567,0.000705072522159825,0.03964665219142,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102091",52.2855786276306,0.524940498305414,0.154974026888107,3.38728049368186,0.000705891783807564,0.03964665219142,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105330",287.265457707023,0.678539474689616,0.200302388300303,3.38757555737337,0.000705132921091171,0.03964665219142,0,5919,"sp|Q04820|MDHC_ECHGR","Q04820","MDHC",1.13e-18,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37)","malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]","GO:0005737; GO:0006099; GO:0006108; GO:0030060"
"g112131",304.965343086821,0.414539124647854,0.122333494700624,3.388598728928,0.000702507334566266,0.03964665219142,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162655",163.455630934966,0.468057206556168,0.138174814325995,3.3874277945609,0.000705512851652728,0.03964665219142,0,1019,"sp|P46471|PRS7_MOUSE","P46471","PRS7",3.17e-34,"26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0008540; GO:0016887; GO:0017025; GO:0022624; GO:0036402; GO:0036464; GO:0043161; GO:0043197; GO:0140296"
"g100350",248.748684799351,-0.618483681267513,0.182629388876358,-3.38655068098724,0.000707772021498863,0.0396874516781047,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26539",1023.93126007946,0.813079672904945,0.240139315489717,3.38586653854172,0.000709538822604752,0.0397016513271144,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48748",64.8288944773988,-0.383666803083277,0.113322030919025,-3.38563296096792,0.00071014297562457,0.0397016513271144,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147451",327.677233930043,0.273621595046311,0.0808121426003306,3.38589704766956,0.000709459945415182,0.0397016513271144,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13487",58.8168219964781,-0.467301034458254,0.138086213106531,-3.38412520660364,0.000714054327564293,0.0397804055166969,28505,43538,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.63e-33,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g15085",810.154474611128,-0.382234888939345,0.112939743741785,-3.38441434587678,0.000713302707103933,0.0397804055166969,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37824",377.256020080826,-0.436793586104462,0.129086496328516,-3.38372795395155,0.000715088189918221,0.0397804055166969,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134738",54.4140658754079,0.866779681493634,0.256149260148083,3.38388516520616,0.000714678876571157,0.0397804055166969,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155557",66.4183317530832,0.495554805686308,0.146411245289121,3.38467721319989,0.000712620018849589,0.0397804055166969,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6376",94.0111092529152,0.412408067013204,0.121915985974764,3.38272346908281,0.000717708600718966,0.0398080543605879,32035,39627,"sp|Q9VZU4|NDUS3_DROME","Q9VZU4","NDUS3",7.57e-26,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 7.1.1.2) (NADH dehydrogenase (Ubiquinone) 30 kDa subunit)","reactive oxygen species metabolic process [GO:0072593]","GO:0005739; GO:0005747; GO:0008137; GO:0072593"
"g8243",67.0629578613755,-0.475013481086741,0.140414753344238,-3.3829314211891,0.000717165382574629,0.0398080543605879,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98021",19.1917972606847,0.940001555391134,0.277852942276939,3.38309016160867,0.000716750973654248,0.0398080543605879,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32954",1402.80815587215,-0.772550669629939,0.228479649174161,-3.38126687616302,0.000721524282148454,0.0398233254922408,18500,31555,"sp|Q80U96|XPO1_RAT","Q80U96","XPO1",3.14e-35,"Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)","mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to xenobiotic stimulus [GO:0009410]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]","GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005730; GO:0005737; GO:0006611; GO:0006913; GO:0009410; GO:0010824; GO:0015030; GO:0019904; GO:0031267; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0046825; GO:0051028; GO:1990904"
"g73585",584.943864705406,0.546844550474636,0.161707379456899,3.38169199396611,0.000720408703257046,0.0398233254922408,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130829",37.4657055519368,-0.733311325197424,0.216861350340896,-3.38147541756377,0.000720976834895655,0.0398233254922408,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132026",61.8955945621721,0.432664621761021,0.127931744214698,3.3819958010962,0.000719612445497115,0.0398233254922408,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150244",187.263204783442,0.556876349732837,0.164665474015839,3.38186467479681,0.000719956018234498,0.0398233254922408,0,1204,"sp|Q3T084|TCPW_BOVIN","Q3T084","TCPW",2.91e-23,"T-complex protein 1 subunit zeta-2 (TCP-1-zeta-2) (CCT-zeta-2)","protein folding [GO:0006457]","GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g69741",337.604454631985,0.58004217150911,0.17157405668631,3.38071024671058,0.000722987395676234,0.0398649579486498,3075,7330,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",8.56e-68,"PiggyBac transposable element-derived protein 4",NA,NA
"g17338",1571.90640922034,0.537609431304908,0.159082980932798,3.37942769334963,0.000726369115568515,0.0398949724587934,18597,55264,"sp|P28765|SODM_PALVU","P28765","SODM",8.59e-25,"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) (Fragment)",NA,"GO:0004784; GO:0005759; GO:0046872"
"g33553",41.0808970713371,-0.549387381761133,0.162550619537003,-3.37979260445741,0.000725405458600994,0.0398949724587934,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44065",41.0779192879021,0.417626433353102,0.123556008895466,3.38005765228651,0.000724706265248471,0.0398949724587934,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152891",4628.07553758314,-1.78425764312174,0.527971078140054,-3.37946095344343,0.000726281233107343,0.0398949724587934,885,1732,"sp|Q61696|HS71A_MOUSE","Q61696","HS71A",2.62e-82,"Heat shock 70 kDa protein 1A (Heat shock 70 kDa protein 3) (HSP70.3) (Hsp68)","ATP metabolic process [GO:0046034]; cellular heat acclimation [GO:0070370]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; DNA repair [GO:0006281]; lysosomal transport [GO:0007041]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein folding [GO:0006457]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein ubiquitination [GO:0031396]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; telomere maintenance [GO:0000723]; vesicle-mediated transport [GO:0016192]","GO:0000723; GO:0001664; GO:0003714; GO:0005102; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006402; GO:0006457; GO:0006986; GO:0007041; GO:0008285; GO:0009408; GO:0010628; GO:0016192; GO:0016234; GO:0016235; GO:0016607; GO:0016887; GO:0019899; GO:0030308; GO:0031072; GO:0031249; GO:0031396; GO:0031397; GO:0031625; GO:0032436; GO:0032757; GO:0032991; GO:0034605; GO:0034620; GO:0042026; GO:0042826; GO:0043066; GO:0044183; GO:0045121; GO:0045648; GO:0045666; GO:0046034; GO:0047485; GO:0048471; GO:0050821; GO:0051082; GO:0051085; GO:0051092; GO:0051787; GO:0055131; GO:0060548; GO:0070370; GO:0070434; GO:0090063; GO:0090084; GO:0097201; GO:0097718; GO:0140545; GO:1901673; GO:1903265; GO:1990904; GO:2001240"
"g18713",38.4041595278402,2.18586889476289,0.647081605762364,3.37804208201466,0.000730039078194244,0.0399613343286054,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29719",33.029044315161,-0.509578337097247,0.150856601115526,-3.37789883458272,0.000730419467476377,0.0399613343286054,33141,35835,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.25e-17,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g55207",25.3086800313558,0.562867188955558,0.166621598826087,3.37811660025575,0.000729841269998378,0.0399613343286054,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71918",23.99747655196,0.482241667745012,0.142749306420511,3.37824175708724,0.000729509154015372,0.0399613343286054,0,9204,"sp|P21328|RTJK_DROME","P21328","RTJK",3.21e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g31891",33.9708083952025,2.24256427369655,0.664007307856385,3.37731866376022,0.000731961977451792,0.039966864413567,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72757",458.431427260543,1.78099566987789,0.527378734231247,3.37707145600783,0.000732620151760078,0.039966864413567,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99007",26.3946628158638,0.831277397105322,0.246154216650137,3.37705934278928,0.000732652416528352,0.039966864413567,0,6618,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.06e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g5170",92.9117507265007,0.708720354388778,0.209942311452507,3.37578618376364,0.000736050972150308,0.0399970809426837,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13866",270.508842276878,-0.469752197960332,0.13912403746308,-3.37649917675075,0.000734145917390444,0.0399970809426837,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69215",34.4963288882907,0.631007929793149,0.186916261103493,3.37588568307477,0.00073578484331713,0.0399970809426837,4345,11096,"sp|Q5R8G6|MCM3_PONAB","Q5R8G6","MCM3",7.13e-20,"DNA replication licensing factor MCM3 (EC 3.6.4.12)","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]","GO:0003677; GO:0003678; GO:0005524; GO:0006270; GO:0007049; GO:0016887; GO:0042555; GO:0071162"
"g127082",170.682922820713,0.359727168635236,0.106546658716864,3.37624072840398,0.000734835938907927,0.0399970809426837,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5792",3077.85523061696,-0.372821343662497,0.110455266154466,-3.37531524428294,0.000737311798106026,0.0400269209933196,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66006",23.6076012476113,1.45982046425303,0.432577355455108,3.3747038439337,0.000738951666643343,0.0400386509011126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118463",144.592225483431,0.976816409788207,0.289433370752286,3.37492669642515,0.000738353550488981,0.0400386509011126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32908",737.670286498503,-0.480098216462446,0.142416239980104,-3.3710917837005,0.000748709086897437,0.0402768969526655,0,19481,"sp|Q9CXP4|RHG08_MOUSE","Q9CXP4","RHG08",2.56e-23,"Rho GTPase-activating protein 8 (Rho-type GTPase-activating protein 8)","positive regulation of ERK1 and ERK2 cascade [GO:0070374]; signal transduction [GO:0007165]","GO:0005096; GO:0007165; GO:0070374"
"g48697",1393.42506829558,0.596660451627969,0.177000360050595,3.37095614640227,0.00074907781039949,0.0402768969526655,0,7584,"sp|Q8VEM8|MPCP_MOUSE","Q8VEM8","MPCP",3.54e-53,"Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3)","mitochondrial phosphate ion transmembrane transport [GO:1990547]; phosphate ion transmembrane transport [GO:0035435]","GO:0005315; GO:0005739; GO:0005743; GO:0015293; GO:0031305; GO:0035435; GO:0043209; GO:0044877; GO:1990547"
"g53091",505.178033722151,0.748291613624921,0.221953897257462,3.37138307941905,0.000747917783054474,0.0402768969526655,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81548",277.876801958647,-0.660166662597776,0.19580402372361,-3.37156841847971,0.000747414714482779,0.0402768969526655,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97015",40.8279032738637,0.737566550149472,0.218753706883277,3.37167566510323,0.000747123756924127,0.0402768969526655,156,6838,"sp|P31335|PUR9_CHICK","P31335","PUR9",1.28e-21,"Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase) (ATIC) [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (IMP synthase) (Inosinicase)]","'de novo' IMP biosynthetic process [GO:0006189]","GO:0003937; GO:0004643; GO:0005829; GO:0006189; GO:0042803"
"g104011",97.6119082969973,1.42506546597963,0.422574307691139,3.37234289932556,0.000745315927916182,0.0402768969526655,0,2914,"sp|P50903|LIPP_CAVPO","P50903","LIPP",4.31e-17,"Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3)","lipid catabolic process [GO:0016042]","GO:0004806; GO:0005576; GO:0016042; GO:0046872; GO:0047376"
"g109645",122.568040949935,-0.511521901603285,0.151684027165347,-3.37228587058602,0.000745470284764,0.0402768969526655,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111770",20.541386379927,0.828908219667514,0.245856146269478,3.37151717475863,0.000747553774637558,0.0402768969526655,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4786",84.2655790201924,-0.422528053498384,0.125395470148009,-3.36956393241046,0.000752872238404397,0.0403081902434126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8820",267.202945832641,-0.25517205876554,0.0757374542902486,-3.36916603755448,0.000753959961169056,0.0403081902434126,30158,74504,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.74e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g28038",2207.98175500751,0.233350050111874,0.0692549224871788,3.36943630476339,0.000753220974487095,0.0403081902434126,0,3470,"sp|P31410|VATB_HELVI","P31410","VATB",4.19e-85,"V-type proton ATPase subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B)","ATP metabolic process [GO:0046034]","GO:0005524; GO:0016787; GO:0033180; GO:0046034; GO:0046961"
"g52514",358.647284780749,0.732713215136587,0.217460002096546,3.36941602167043,0.000753276410823547,0.0403081902434126,715,16145,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.53e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g65981",1092.77159538662,0.386858646401778,0.114806598744585,3.36965514728328,0.000752623090262386,0.0403081902434126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87527",168.136551311744,0.486726653917283,0.144449320701438,3.36953231454301,0.000752958618652099,0.0403081902434126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3937",21.7289159950771,-0.786208227413622,0.233424951660336,-3.36814133117036,0.000756767916767488,0.0403815381165437,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12517",195.098614815284,-0.216716803385438,0.064340897028096,-3.36825896739989,0.000756445070947503,0.0403815381165437,38735,57230,"sp|P21328|RTJK_DROME","P21328","RTJK",3.08e-29,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g107812",128.259464128326,0.573701799392974,0.170359410392975,3.36759676538909,0.000758264113770623,0.0404230239684241,955,5663,"sp|Q8JJC0|ZIC1_CHICK","Q8JJC0","ZIC1",8.29e-66,"Zinc finger protein ZIC 1 (Zinc finger protein of the cerebellum 1)","cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; pattern specification process [GO:0007389]; regulation of smoothened signaling pathway [GO:0008589]; spinal cord development [GO:0021510]","GO:0003677; GO:0005634; GO:0005737; GO:0007389; GO:0008589; GO:0021510; GO:0030154; GO:0042472; GO:0046872"
"g55019",10005.2794266836,0.816512192977793,0.242492882906733,3.36715941181596,0.000759467733062037,0.0404488487148438,3658,5934,"sp|Q7Z1E6|CALR_BOMMO","Q7Z1E6","CALR",8.63e-101,"Calreticulin","protein folding [GO:0006457]","GO:0005509; GO:0005788; GO:0006457; GO:0030246; GO:0051082"
"g80510",78.4675018273955,0.416338364010499,0.123675618110791,3.36637382832835,0.000761634154965228,0.0404493183602969,4335,9039,"sp|P08548|LIN1_NYCCO","P08548","LIN1",3.07e-27,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g85389",69.3730278282454,0.423699588426507,0.125857343613338,3.36650668337803,0.000761267374816882,0.0404493183602969,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124869",38.3588643386249,0.526650100230146,0.156430687760196,3.36666742166017,0.000760823835161701,0.0404493183602969,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15197",429.354891539351,0.552541601902712,0.164158166791953,3.36590991907811,0.000762916181600681,0.0404791810241373,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37773",106360.608323974,0.538507860239911,0.160044241697701,3.36474373915351,0.000766147808076343,0.0405503142491221,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77706",45.8727220482477,-0.795313570663171,0.236373639765276,-3.36464578475389,0.000766419829430261,0.0405503142491221,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93861",53.3831322046207,-0.61760868928959,0.183545980902493,-3.36487176811399,0.000765792404202364,0.0405503142491221,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64326",38.3080694036376,0.968201491279956,0.287818777386237,3.36392746877902,0.000768417348937319,0.0406177899801999,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39260",1059.09482680648,-0.769217959862744,0.228698045720996,-3.36346538265204,0.00076970488866903,0.0406476453976747,2425,23731,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.29e-15,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g99546",145.019455928051,0.379059696883444,0.112712003307085,3.36308188801056,0.000770774964574379,0.0406659714423942,1685,6556,"sp|P21328|RTJK_DROME","P21328","RTJK",1.15e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g32889",615.005349415024,-0.362393118182944,0.10777562902555,-3.36247741218967,0.000772464455046107,0.0406791475434047,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51515",60.8794868863798,1.42583972090996,0.424044708742022,3.36247497378255,0.000772471277272435,0.0406791475434047,3485,10490,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.95e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g49492",1730.96905221644,-0.444271220170479,0.132155383230185,-3.36173381145327,0.000774547511071467,0.0407122440352163,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59545",2242.20712600597,0.852929593764927,0.253715751857904,3.36175262087242,0.00077449475583884,0.0407122440352163,2732,13264,"sp|Q86TX2|ACOT1_HUMAN","Q86TX2","ACOT1",8.46e-37,"Acyl-coenzyme A thioesterase 1 (Acyl-CoA thioesterase 1) (EC 3.1.2.-) (CTE-I) (CTE-Ib) (Inducible cytosolic acyl-coenzyme A thioester hydrolase) (Long chain acyl-CoA thioester hydrolase) (Long chain acyl-CoA hydrolase) (Palmitoyl-coenzyme A thioesterase) (EC 3.1.2.2)","acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0047617; GO:0052689; GO:0102991"
"g100134",23.6268756955031,-0.516434865808796,0.153670092595196,-3.36067257517186,0.000777529395585591,0.0408308200434405,0,6486,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.43e-35,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g27600",48.0578396834638,0.393510712837517,0.117163845626932,3.35863602574566,0.000783281605493639,0.040837988605307,28649,38621,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.53e-17,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g37455",77.4917597842621,0.493281621710871,0.146872607975813,3.35856786714174,0.000783474800062697,0.040837988605307,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51045",655.813419871464,-0.49420720210475,0.147125874715537,-3.35907740946507,0.000782031579788414,0.040837988605307,0,6362,"sp|Q92519|TRIB2_HUMAN","Q92519","TRIB2",1.24e-15,"Tribbles homolog 2 (TRB-2)","negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405]","GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0006469; GO:0031434; GO:0031625; GO:0032436; GO:0032693; GO:0043405; GO:0045599; GO:0055106; GO:0061629"
"g55027",65.568351631956,-0.540145877303261,0.160782369799443,-3.35948448811291,0.000780880349856793,0.040837988605307,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80029",19.9208716095499,1.11513196944967,0.331884117913637,3.36000401724511,0.000779413391770513,0.040837988605307,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84395",8541.00432863413,0.934168535521107,0.278138574500895,3.3586442915997,0.000783258179057679,0.040837988605307,4076,7935,"sp|H9J9M0|CDA1_BOMMO","H9J9M0","CDA1",5.47e-119,"Chitin deacetylase 1 (BmCDA1) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0008061; GO:0008270"
"g101236",288.642309317317,1.28006396026994,0.381019688047706,3.35957432233703,0.00078062650810836,0.040837988605307,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136924",125.573645429981,-0.610070650081941,0.181627630545168,-3.35890881938378,0.000782508818486584,0.040837988605307,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19146",38.1527382284706,1.38672034969035,0.413003029728649,3.35765176008866,0.000786075788327351,0.0408701351995054,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44756",193.990536106162,0.474633643905708,0.141375561812511,3.35725381261548,0.000787208125882001,0.0408701351995054,0,3307,"sp|Q8CIE6|COPA_MOUSE","Q8CIE6","COPA",2.77e-12,"Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030137; GO:0030157; GO:0030424; GO:0030426; GO:0044297; GO:0099612; GO:1902463"
"g70772",51.7535496407241,2.629500912719,0.783272039632493,3.3570723575844,0.000787724948548483,0.0408701351995054,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119235",1343.2563988139,1.00393260433799,0.299000898720936,3.35762403602331,0.000786154626603785,0.0408701351995054,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145194",65.5261608081618,0.688451322290492,0.205051859038952,3.35744979595485,0.000786650277043847,0.0408701351995054,0,1674,"sp|P18422|PSA3_RAT","P18422","PSA3",6.98e-14,"Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8) (Proteasome subunit K)","proteasomal protein catabolic process [GO:0010498]; regulation of endopeptidase activity [GO:0052548]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000502; GO:0005634; GO:0005737; GO:0005839; GO:0006511; GO:0010498; GO:0019773; GO:0031625; GO:0045202; GO:0052548"
"g10730",422.960869407293,-0.375317636619568,0.111827394143896,-3.35622268132817,0.000790149200669631,0.0409581302710243,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29686",691.479749497669,-0.250903343253484,0.0747711776469254,-3.35561577534952,0.000791885030791206,0.0409725831662916,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56555",314.158953079364,1.32021984668113,0.393433305025445,3.35563824876429,0.000791820690847336,0.0409725831662916,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148232",3754.828772162,0.319629340007033,0.095313659421086,3.35344736471552,0.000798115922041159,0.0412570180950725,0,308,"sp|P31009|RS2_DROME","P31009","RS2",9.82e-13,"40S ribosomal protein S2 (Protein strings of pearls)","cytoplasmic translation [GO:0002181]; oogenesis [GO:0048477]; translation [GO:0006412]","GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0006412; GO:0022626; GO:0022627; GO:0048477"
"g18893",774.409133277899,-0.320064582027589,0.0954830081631885,-3.35205800680863,0.000802132101900185,0.0413242749388553,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38387",516.346421631252,0.371930349985973,0.110946929098848,3.35232667552791,0.00080135400870525,0.0413242749388553,2174,5474,"sp|Q9NQP4|PFD4_HUMAN","Q9NQP4","PFD4",5.23e-23,"Prefoldin subunit 4 (Protein C-1)","negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821]","GO:0001540; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0050821; GO:0051082; GO:0051087; GO:1905907"
"g52980",925.00764505908,-0.433216627257834,0.129255552334031,-3.35162876514802,0.000803376686420547,0.0413242749388553,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74760",71.6492570813764,-0.560185367236399,0.167162236846797,-3.3511478298164,0.000804773285149149,0.0413242749388553,0,9971,"sp|P21328|RTJK_DROME","P21328","RTJK",2.45e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g76888",93.0464310822554,0.478076636739112,0.142657722549392,3.35121455884444,0.000804579374730905,0.0413242749388553,5271,9414,"sp|P37227|MDHM_SCHMA","P37227","MDHM",3.72e-19,"Malate dehydrogenase, mitochondrial (EC 1.1.1.37) (Fragment)","tricarboxylic acid cycle [GO:0006099]","GO:0005759; GO:0006099; GO:0030060"
"g100619",1035.47599148522,0.414179897038329,0.123618688743204,3.35046343921926,0.00080676458665878,0.0413242749388553,2426,6427,"sp|Q66LN0|PGES2_BOVIN","Q66LN0","PGES2",7.37e-14,"Prostaglandin E synthase 2 (EC 5.3.99.3) (Membrane-associated prostaglandin E synthase-2) (mPGE synthase-2) (Microsomal prostaglandin E synthase 2) (mPGES-2) [Cleaved into: Prostaglandin E synthase 2 truncated form]","glutathione metabolic process [GO:0006749]; prostaglandin biosynthetic process [GO:0001516]","GO:0001516; GO:0005739; GO:0005783; GO:0006749; GO:0016021; GO:0016829; GO:0020037; GO:0036134; GO:0043295; GO:0050220"
"g118044",181.885043483952,0.342759389415667,0.102239260869103,3.35252217692087,0.000800788256218265,0.0413242749388553,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121232",279.069713541131,0.297540822918379,0.0887993138975448,3.35071083163634,0.000806044247117891,0.0413242749388553,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131415",20.5822803491014,-0.854309718117714,0.254943216585199,-3.35098038520359,0.000805260059776651,0.0413242749388553,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134456",612.985912658512,0.480709529472196,0.14347096147218,3.35057020974525,0.000806453626638993,0.0413242749388553,688,3224,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.85e-14,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g17274",599.848333503822,-0.521796417489627,0.155808306417621,-3.34896405388703,0.000811143186653664,0.0413471699900651,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73485",4043.91553694989,-0.526436268755845,0.157171471092923,-3.34943908773752,0.000809753582078818,0.0413471699900651,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82313",28.8550957591922,0.662910997366193,0.197954767811713,3.34880035825522,0.000811622553768213,0.0413471699900651,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100480",125.229394115386,-0.724514241977425,0.216322492126786,-3.34923213418229,0.000810358706338224,0.0413471699900651,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140741",7615.18920911577,-2.14918349768057,0.64172953491645,-3.34904875145006,0.0008108952610251,0.0413471699900651,1445,2786,"sp|Q9I8F9|HSP71_ORYLA","Q9I8F9","HSP71",0,"Heat shock 70 kDa protein 1 (HSP70-1)","cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; vesicle-mediated transport [GO:0016192]","GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016192; GO:0016887; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787"
"g161980",23.5591578557692,0.999156032803343,0.298360724782508,3.34881889542158,0.0008115682562415,0.0413471699900651,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33515",69.4270883228948,-0.801626345555612,0.239402829414797,-3.34844140111096,0.000812674646028436,0.0413534115786342,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110314",67.4661294002384,-0.505641078086695,0.151016208966714,-3.3482569953676,0.000813215625439519,0.0413534115786342,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110840",20.390681375518,1.17927106334454,0.35244474039101,3.34597435625292,0.000819939783672597,0.0415906395474643,0,5355,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.17e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g130292",87.7763324274268,0.427418291105247,0.127743112087916,3.3459204501851,0.000820099200919915,0.0415906395474643,0,3608,"sp|Q6DEU3|VPS29_XENTR","Q6DEU3","VPS29",1.34e-29,"Vacuolar protein sorting-associated protein 29 (Vesicle protein sorting 29)","endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0005768; GO:0005829; GO:0006886; GO:0010008; GO:0030904; GO:0032456; GO:0042147; GO:0046872"
"g140691",293.327072125435,-0.607418033588087,0.181516780775288,-3.34634644242645,0.000818840191373581,0.0415906395474643,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2638",4243.52016473239,-0.368658363341955,0.110196483199532,-3.34546396253342,0.000821450332185033,0.0416181694127025,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17630",171.706342607137,2.21133650743278,0.661040253748746,3.34523729060724,0.000822122012330864,0.0416181694127025,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1039",199.458459509915,0.495014307408522,0.147987422763989,3.34497552672413,0.000822898311831932,0.041619062625075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12270",138.875093154031,-0.502016744390364,0.150257138098043,-3.34105088613359,0.000834619247141302,0.041619062625075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20093",31.4631012548543,1.2696633048894,0.37979736295912,3.34300189710917,0.000828773332734363,0.041619062625075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36871",56.1041579997015,0.339525701568293,0.101595406990893,3.34193947959409,0.000831951981657054,0.041619062625075,5066,21604,"sp|Q6ZN19|ZN841_HUMAN","Q6ZN19","ZN841",9.07e-29,"Zinc finger protein 841","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872"
"g37753",95.385102535203,1.71719166836647,0.513413185156863,3.34465829474524,0.000823840021657919,0.041619062625075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41788",182.487278034218,0.542857252578535,0.162344426325948,3.34386134999553,0.00082621018148547,0.041619062625075,0,22424,"sp|P06795|MDR1B_MOUSE","P06795","MDR1B",1.53e-19,"ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1B) (Multidrug resistance protein 1B) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)","carboxylic acid transmembrane transport [GO:1905039]; ceramide translocation [GO:0099040]; establishment of endothelial blood-brain barrier [GO:0014045]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to xenobiotic stimulus [GO:0009410]; Sertoli cell barrier remodeling [GO:0061843]; stem cell proliferation [GO:0072089]; transepithelial transport [GO:0070633]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]","GO:0000086; GO:0000139; GO:0005524; GO:0005654; GO:0005739; GO:0005886; GO:0008559; GO:0009410; GO:0009986; GO:0014045; GO:0015562; GO:0016020; GO:0016021; GO:0016324; GO:0031625; GO:0042626; GO:0042910; GO:0045332; GO:0046581; GO:0046943; GO:0047484; GO:0061843; GO:0070633; GO:0072089; GO:0090554; GO:0090555; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1901529; GO:1905039; GO:1990961; GO:1990962; GO:2001225"
"g43630",128.264782531604,0.30713276426121,0.091837431988313,3.34430915163541,0.00082487761600579,0.041619062625075,8966,21370,"sp|O00370|LORF2_HUMAN","O00370","LORF2",9.19e-12,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g44584",599.649818882141,-0.28032293046766,0.0838332482902429,-3.34381568392938,0.000826346186451572,0.041619062625075,0,16131,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.32e-19,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g52112",82.3401307759132,-0.461571162020726,0.138053794424711,-3.34341525304796,0.000827539659620677,0.041619062625075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58981",57.8470370820762,0.368120032768643,0.110166115383563,3.3414996207043,0.000833271303598434,0.041619062625075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73858",1549.78370329891,0.586709613655424,0.175528414605589,3.34253354349354,0.000830173209662062,0.041619062625075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76182",59.2056460157677,0.369179874884868,0.110486962567403,3.34138857930545,0.000833604670166397,0.041619062625075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91175",238.860752445266,-0.333020743269596,0.0996402465107926,-3.34223122614941,0.000831077980085642,0.041619062625075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95880",24.8768854370907,0.651253741868377,0.194906530960181,3.34136438969009,0.000833677308220429,0.041619062625075,625,6974,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.47e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g106475",71.4031008094322,0.850207857175695,0.254464885183578,3.34115984829236,0.000834291752383368,0.041619062625075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129364",18.4488992837089,1.93427237778108,0.578870513481589,3.3414595021389,0.000833391732590539,0.041619062625075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142290",322.73690927581,0.339090177359113,0.101493086631741,3.341017488112,0.000834719651525277,0.041619062625075,0,2480,"sp|P33731|SRP72_CANLF","P33731","SRP72",9.85e-12,"Signal recognition particle subunit SRP72 (SRP72) (Signal recognition particle 72 kDa protein)","SRP-dependent cotranslational protein targeting to membrane [GO:0006614]","GO:0005047; GO:0005783; GO:0005786; GO:0005829; GO:0006614; GO:0008312; GO:0030911; GO:0043022"
"g6353",23.2526072703648,1.2907628307101,0.386397121765746,3.34050839926451,0.000836251511686335,0.0416585097610831,106125,110714,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",9.52e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g5629",648.590485677073,-0.209268648966223,0.0626888211169428,-3.3382131811961,0.000843190311130591,0.0418558777392822,17665,37500,"sp|Q9VMJ7|KDM5_DROME","Q9VMJ7","KDM5",4.39e-17,"Lysine-specific demethylase lid (EC 1.14.11.67) (Histone demethylase lid) (Jumonji/ARID domain-containing protein lid) (Protein little imaginal disks) (Retinoblastoma-binding protein 2 homolog) ([histone H3]-trimethyl-L-lysine(4) demethylase lid)","chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone demethylation [GO:0016577]; histone H3-K4 demethylation [GO:0034720]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; histone H3-K9 acetylation [GO:0043970]; larval somatic muscle development [GO:0007526]; locomotor rhythm [GO:0045475]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of stem cell differentiation [GO:2000737]; oocyte karyosome formation [GO:0030717]; positive regulation of transcription, DNA-templated [GO:0045893]; synaptonemal complex organization [GO:0070193]","GO:0003677; GO:0005634; GO:0006325; GO:0006338; GO:0007526; GO:0016577; GO:0030717; GO:0032452; GO:0032922; GO:0033749; GO:0034647; GO:0034720; GO:0034721; GO:0036098; GO:0043970; GO:0045475; GO:0045893; GO:0046872; GO:0070193; GO:0070822; GO:2000737"
"g18498",521.78274842795,-0.519361651716701,0.155575294179971,-3.33832987078205,0.000842836255928526,0.0418558777392822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31717",74.2097386781683,0.523259691075214,0.156730617319495,3.33859267591954,0.000842039367281282,0.0418558777392822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91720",54.5863399471221,1.48501653218522,0.444781605643398,3.33875437595284,0.00084154940105954,0.0418558777392822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150432",407.135688344893,1.28932758507729,0.386285601757259,3.33775729463379,0.000844574867839464,0.0418876364347682,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26436",159.845320431528,-0.354036639512462,0.106090035241638,-3.33713377232917,0.000846471959493124,0.0419447365161341,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128345",136.045180766051,0.502004754515211,0.150441136773488,3.33688487924054,0.000847230329781652,0.0419453593376582,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15150",764.522510675102,-0.376354976959313,0.112815916291861,-3.33600957497576,0.000849902365112608,0.0420107630675338,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38753",77.5761409107403,0.564853649985436,0.16932252555636,3.33596282083224,0.000850045310814933,0.0420107630675338,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83867",176.127558131855,0.407806915636823,0.122255475121841,3.33569449736626,0.000850866111862446,0.0420144090108584,1796,6184,"sp|P26640|SYVC_HUMAN","P26640","SYVC",2.47e-18,"Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS)","tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]","GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438"
"g91791",266.308823236101,0.643367309705361,0.19289934694854,3.33524877031851,0.000852231215001052,0.042044901749201,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16460",36.4360089857781,-0.678243929180378,0.20347399502092,-3.33331996116086,0.000858161914554457,0.0422197716103278,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64423",199.761609787514,-0.733564021039902,0.220083281605255,-3.33312015201425,0.000858778470221809,0.0422197716103278,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86487",239.49944062431,0.277629693464827,0.0832777121695054,3.3337814672398,0.000856739403325198,0.0422197716103278,458,7124,"sp|Q7QJ33|WDR12_ANOGA","Q7QJ33","WDR12",8.87e-22,"Ribosome biogenesis protein WDR12 homolog","maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]","GO:0000463; GO:0000466; GO:0005654; GO:0030687; GO:0043021; GO:0070545"
"g114648",72.4842826979892,-1.13499171572597,0.340488251659336,-3.33342401740647,0.000857840988384175,0.0422197716103278,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9701",104.992761336438,0.345920396025681,0.103830767899174,3.33157890502739,0.000863548154229006,0.0424171836595177,0,8330,"sp|Q9JMD1|SMBT1_MOUSE","Q9JMD1","SMBT1",9.43e-19,"Scm-like with four MBT domains protein 1","cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]","GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635"
"g26666",29.6503373815054,-0.635966220420469,0.190959560518678,-3.33037119845205,0.000867302786353855,0.0425644356981793,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53850",651.867397386759,0.469571541797438,0.141062527730485,3.32881842791449,0.00087215242845465,0.0427530490920481,8572,13184,"sp|Q5ZJF4|PRDX6_CHICK","Q5ZJF4","PRDX6",5.72e-15,"Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx)","cell redox homeostasis [GO:0045454]; lipid catabolic process [GO:0016042]","GO:0004623; GO:0005615; GO:0005739; GO:0005764; GO:0005829; GO:0008379; GO:0016042; GO:0045454; GO:0047184"
"g71804",75.2251445817673,-0.541738608167376,0.162750033786694,-3.32865435147864,0.000872666341127115,0.0427530490920481,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45499",21.7550529487645,0.884771243445263,0.265878433872159,3.3277285056925,0.000875571498603979,0.0428580437114752,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10686",854.649006931728,-0.772994236789008,0.232333849598691,-3.32708401347542,0.000877599103738485,0.0428826488205559,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21581",360.2934928947,-0.307299812827699,0.0923597920770619,-3.32720338490258,0.000877223227023614,0.0428826488205559,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14627",324.489199625327,-0.390004083310264,0.117247545829823,-3.32633046218579,0.00087997533432905,0.0429125701267032,26373,44984,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.18e-16,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g38786",8637.27896477536,0.417182463546445,0.125438177491762,3.32580137792453,0.0008816472987175,0.0429125701267032,0,3768,"sp|Q5E973|RL18_BOVIN","Q5E973","RL18",4.42e-23,"60S ribosomal protein L18","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0005791; GO:0022625; GO:0042788"
"g85664",33.3912859791396,0.786151270531936,0.236388019556829,3.32568152990909,0.00088202644049765,0.0429125701267032,4913,7964,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",2.61e-42,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g97263",39.7419095131326,0.63964379941753,0.192331973029265,3.32572785139683,0.000881879883555891,0.0429125701267032,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101327",288.885812355281,1.27353136760758,0.382853297313617,3.3264213121413,0.000879688534370667,0.0429125701267032,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66077",236.261101339497,0.370845869086726,0.111522269558054,3.325307766389,0.000883209820410093,0.0429241837726157,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115103",128.663395836707,-0.521733931611208,0.15690659972841,-3.32512419818081,0.000883791558064951,0.0429241837726157,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84416",91.4120146992313,0.342745240691785,0.103085485079036,3.32486421758604,0.000884616058530095,0.0429271582086709,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20022",86.6678398638887,0.345698641680856,0.103984959498596,3.3245061915471,0.000885752666730323,0.0429452598984887,1590,37014,"sp|Q62824|EXOC4_RAT","Q62824","EXOC4",2.14e-15,"Exocyst complex component 4 (Exocyst complex component Sec8) (rSec8)","chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; paraxial mesoderm formation [GO:0048341]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]; vesicle tethering involved in exocytosis [GO:0090522]","GO:0000145; GO:0005902; GO:0006612; GO:0006887; GO:0006893; GO:0006903; GO:0006904; GO:0007268; GO:0008021; GO:0014069; GO:0030010; GO:0030165; GO:0030426; GO:0031252; GO:0031267; GO:0032584; GO:0032991; GO:0035748; GO:0043005; GO:0043025; GO:0043198; GO:0043209; GO:0044091; GO:0044877; GO:0045202; GO:0047485; GO:0048341; GO:0048709; GO:0050850; GO:0051223; GO:0055108; GO:0090522; GO:0090543"
"g50670",168.820484110134,0.294123689137172,0.0884997218880588,3.32344195961657,0.000889139231007681,0.0430723244016658,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87491",57.3081984453115,-0.846146962669368,0.254674238506397,-3.3224678225478,0.000892249615849103,0.0431509406938697,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100342",287.956737659216,0.676396458072885,0.203583445638923,3.32245313930165,0.000892296575992505,0.0431509406938697,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6170",196.225127319679,0.476460433224901,0.143549665765018,3.31913300310178,0.000902974100589431,0.0432184780585687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6771",44.6588569243237,1.00559343018001,0.303064975856423,3.31807866395096,0.000906389540235056,0.0432184780585687,4925,24051,"sp|P21328|RTJK_DROME","P21328","RTJK",6.35e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g14069",1574.73152140484,-0.465023616415747,0.140032373293881,-3.32082935879276,0.000897503929761416,0.0432184780585687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20094",30.8869486638957,1.0795390830913,0.325157445426045,3.32005032724011,0.000900012216822588,0.0432184780585687,18795,22063,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.11e-15,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g22196",167.920699934505,-0.41989897316382,0.126533161837465,-3.31848953322758,0.000905057143815074,0.0432184780585687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28380",2076.47875661528,-0.316904166867422,0.0954547757953049,-3.31994040347439,0.000900366666508078,0.0432184780585687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43009",1917.36674646988,0.302084931654556,0.0909966710591949,3.31973607537846,0.000901025867175504,0.0432184780585687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47028",454.109638894736,-0.599065005599641,0.180521996060653,-3.31851529825963,0.000904973651632079,0.0432184780585687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61871",22.3947796984933,1.59259346479989,0.479749459930054,3.31963576370067,0.000901349655099235,0.0432184780585687,4085,12868,"sp|Q8I7P9|POL5_DROME","Q8I7P9","POL5",4.31e-68,"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]","GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074"
"g69150",23.8346192312024,4.99728400325216,1.50645099085535,3.31725627556907,0.000909061902906845,0.0432184780585687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73253",202.432793327336,0.401620156511979,0.121043424943774,3.31798407636381,0.000906696532974349,0.0432184780585687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77074",88.1863673024935,-0.596226538209414,0.179692554047883,-3.31803697358843,0.000906524838277986,0.0432184780585687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80346",40.9392984100687,-0.438089325186711,0.131928517839203,-3.32065676445075,0.000898059081064814,0.0432184780585687,0,9065,"sp|P21328|RTJK_DROME","P21328","RTJK",2.22e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g82061",192.169795374727,0.866468259987317,0.260985546675939,3.31998561231897,0.000900220874721498,0.0432184780585687,0,8384,"sp|P15144|AMPN_HUMAN","P15144","AMPN",4.12e-11,"Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]","GO:0001525; GO:0001618; GO:0004177; GO:0005615; GO:0005737; GO:0005765; GO:0005793; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008237; GO:0008270; GO:0009897; GO:0016021; GO:0030154; GO:0030667; GO:0038023; GO:0042277; GO:0043171; GO:0070006; GO:0070062"
"g83571",54.1645338790706,-0.498600848485074,0.150303156145428,-3.31730125482292,0.000908915553628501,0.0432184780585687,1681,4154,"sp|P51522|ZNF83_HUMAN","P51522","ZNF83",8.6e-41,"Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g94486",48.0139136435547,-0.457370041992004,0.137843630483076,-3.31803537377202,0.000906530030546939,0.0432184780585687,0,4228,"sp|Q9P255|ZN492_HUMAN","Q9P255","ZN492",9.92e-53,"Zinc finger protein 492 (Zinc finger protein 115)","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g95072",91.4548015891068,0.966456964034455,0.291098710382379,3.32003176092723,0.000900072074904695,0.0432184780585687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102807",118.431992631561,0.345626791104652,0.104116820860927,3.31960569144078,0.00090144674391519,0.0432184780585687,0,6187,"sp|Q4U0S5|PAF1_DANRE","Q4U0S5","PAF1",2.84e-23,"RNA polymerase II-associated factor 1 homolog (PD2-like protein)","heart development [GO:0007507]; histone modification [GO:0016570]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription elongation from RNA polymerase II promoter [GO:0006368]","GO:0000122; GO:0000791; GO:0000993; GO:0003682; GO:0005634; GO:0006368; GO:0007507; GO:0016570; GO:0016593"
"g138677",89.8078007406083,-0.805614489766766,0.242830231539073,-3.3176037623517,0.000907931850102606,0.0432184780585687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158988",25.7843228373187,2.55256575847218,0.769450994888899,3.31738574051846,0.000908640721017498,0.0432184780585687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9747",66.1696503828636,-0.3676809317278,0.110869486436186,-3.31634017209442,0.000912047390526456,0.0432507329999907,80631,83434,"sp|P21328|RTJK_DROME","P21328","RTJK",8.89e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g21076",573.014764549479,-0.348416277293128,0.105051585117747,-3.31662084777309,0.000911131733099101,0.0432507329999907,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112547",248.210458235236,2.4718494692945,0.745347774543183,3.31637063089035,0.000911947982568602,0.0432507329999907,926,4814,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.02e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g4868",36.8639662320338,0.504475167560074,0.152175525882242,3.31508739421378,0.000916144775767351,0.0432626485967316,3845,16340,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.55e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g20936",7390.57990050476,-0.41840560824246,0.126198310586695,-3.31546124743902,0.000914920254373367,0.0432626485967316,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26668",150.575455122594,-0.64494901696436,0.19453245982785,-3.31537995013842,0.000915186406984057,0.0432626485967316,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44366",39.4396967954693,0.700674473442919,0.211348965068277,3.31524913413493,0.000915614825457334,0.0432626485967316,0,20802,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.36e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g46094",82.6756704070323,-0.628599097746711,0.189586415774185,-3.31563363957168,0.000914356111107552,0.0432626485967316,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3891",188.591500812473,-0.400248704775545,0.120768070599715,-3.31419308752696,0.000919080158311304,0.0432640917120747,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12158",71.1012762859964,1.2388180368939,0.373797657817462,3.31414071486467,0.000919252330925808,0.0432640917120747,31558,46724,"sp|Q9GKT2|FXDC2_MACFA","Q9GKT2","FXDC2",5.85e-24,"Fatty acid hydroxylase domain-containing protein 2","lipid biosynthetic process [GO:0008610]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]","GO:0001934; GO:0005506; GO:0005737; GO:0008610; GO:0016021; GO:0016491; GO:0045654"
"g85491",1788.91003961618,0.608916318144094,0.18370569096994,3.31462958457684,0.000917646357123267,0.0432640917120747,6748,8298,"sp|Q08013|SSRG_RAT","Q08013","SSRG",1.02e-18,"Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma)","SRP-dependent cotranslational protein targeting to membrane [GO:0006614]","GO:0005783; GO:0005784; GO:0006614; GO:0016021"
"g129479",50.0593966280844,-0.645727027979207,0.194819182605426,-3.31449408289029,0.000918091229722031,0.0432640917120747,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49949",22.1461051563546,-0.901405489872685,0.272052237003503,-3.31335444913499,0.00092184073681548,0.0433496377257326,0,5623,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.41e-23,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g13240",335.137841640114,-0.321865768818092,0.0972122688932627,-3.31095830271686,0.000929770618932127,0.0436860143274693,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127077",28.0445827758268,1.38969692573509,0.419817446744794,3.31024100239427,0.000932156738522205,0.0437615686877845,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5462",369.38605288445,-0.527333362385421,0.159327525962393,-3.30974424664004,0.000933812534137541,0.0438027394036394,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52879",567.823187539438,0.40260570548235,0.121664212237598,3.30915474713388,0.000935781000390057,0.0438584958532813,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5037",1249.71322219716,-0.263797135640591,0.0797307523563229,-3.30859960359663,0.000937638258749962,0.043908951664126,10335,37240,"sp|Q01484|ANK2_HUMAN","Q01484","ANK2",4e-22,"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259"
"g7789",2236.8153756006,0.529353338776115,0.16003474008582,3.30774017249159,0.0009405202619672,0.044007271691813,82615,86896,"sp|O61661|CHK1_DROME","O61661","CHK1",3.13e-17,"Serine/threonine-protein kinase grp (EC 2.7.11.1) (Chk1 homolog) (Protein grapes)","centrosome separation [GO:0051299]; DNA damage checkpoint signaling [GO:0000077]; intracellular signal transduction [GO:0035556]; mitotic DNA replication checkpoint signaling [GO:0033314]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of syncytial blastoderm mitotic cell cycle [GO:0007348]; spindle assembly [GO:0051225]; wound healing [GO:0042060]","GO:0000077; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0006468; GO:0007348; GO:0033314; GO:0035556; GO:0042060; GO:0051225; GO:0051299; GO:0051726; GO:0106310"
"g6440",28.5699423328595,-0.643183320405387,0.194467498871178,-3.30740778864778,0.000941637071883012,0.0440229029067701,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16826",204.426082630185,-0.420419935486775,0.127145475570943,-3.30660555241066,0.000944337648950401,0.0440758822010527,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113993",4786.22498047714,0.657685710550506,0.198892916053565,3.30673270622359,0.000943909131677808,0.0440758822010527,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30568",197.102646172023,-0.538562865084807,0.162944832562476,-3.30518529870109,0.000949136267156985,0.0441897358948074,0,10013,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.17e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g56280",32.2262018506086,-0.534865425139993,0.161807634224601,-3.30556359533421,0.000947855912365206,0.0441897358948074,0,14683,"sp|P21328|RTJK_DROME","P21328","RTJK",1.82e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g73806",1441.08721665326,0.567568587273906,0.171724409909947,3.30511304462505,0.000949380995097394,0.0441897358948074,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136695",44.5991774492609,-0.49746920358894,0.150522276711026,-3.30495402048685,0.000949919823207251,0.0441897358948074,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12119",306.593669575083,1.90909835666469,0.577855275665543,3.30376555698292,0.000953955721907173,0.0441950266616101,19729,54734,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.13e-17,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g60478",134.460721560076,0.411229072429757,0.124454412776421,3.30425465241252,0.000952292885234025,0.0441950266616101,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79426",86.7649357424864,-0.359542206401336,0.108828068743975,-3.3037635469502,0.000953962561203277,0.0441950266616101,0,9216,"sp|Q9BYN7|ZN341_HUMAN","Q9BYN7","ZN341",7.29e-24,"Zinc finger protein 341","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0046872"
"g81361",70.1914790447444,0.363671764199872,0.110054745048305,3.30446237497757,0.000951587478391362,0.0441950266616101,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131915",32.1816617270367,1.24479872419992,0.376748416870415,3.30405827459143,0.000952960211737708,0.0441950266616101,0,3329,"sp|B2D0J5|EST6_APIME","B2D0J5","EST6",2.71e-18,"Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)",NA,"GO:0005576; GO:0080030"
"g49006",49.3537019724958,-0.599631899520455,0.181534855974357,-3.30312267747168,0.000956145487759987,0.0442338885351184,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87316",40.7212535244361,0.715272033614202,0.21654859322924,3.30305555417305,0.000956374390290245,0.0442338885351184,0,8051,"sp|Q86WI1|PKHL1_HUMAN","Q86WI1","PKHL1",5.34e-12,"Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1)","immune response [GO:0006955]; sensory perception of sound [GO:0007605]","GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016021; GO:0032426; GO:0038023; GO:0120234"
"g3453",150.272614747531,-0.480981915985355,0.145644778970963,-3.30243156935442,0.000958504721211351,0.0442378898619919,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16922",47.1452828278614,0.822086357919629,0.248949522177624,3.30222107168004,0.000959224366895829,0.0442378898619919,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68614",38.1497731779937,0.963983093442381,0.291941264318343,3.30197615500912,0.000960062313482159,0.0442378898619919,2221,11234,"sp|P29291|TNNCB_HOMAM","P29291","TNNCB",1.46e-20,"Troponin C, isoform 2B",NA,"GO:0005509"
"g121439",130.871882622765,1.07055659228997,0.324205000187949,3.30209772110036,0.000959646308166569,0.0442378898619919,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130704",132.241005856692,0.466015227776688,0.141136358708805,3.30187934590391,0.000960393718599839,0.0442378898619919,0,3576,"sp|Q91VD9|NDUS1_MOUSE","Q91VD9","NDUS1",2.25e-53,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0009060; GO:0032981; GO:0042776; GO:0043209; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g61425",21.0274570274796,0.545180963501931,0.165133333865494,3.30145919506473,0.000961833242626712,0.0442679420882255,0,2414,"sp|P21328|RTJK_DROME","P21328","RTJK",1.05e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g138234",249.858536771408,0.393953460076333,0.11934528387935,3.30095540662163,0.000963561961078438,0.0443112443294959,0,2983,"sp|Q00725|SGS4_DROME","Q00725","SGS4",1.61e-11,"Salivary glue protein Sgs-4","puparial adhesion [GO:0007594]","GO:0005576; GO:0007594; GO:0062130"
"g78101",475.466298306159,0.588084876827535,0.17817688297664,3.30056776728233,0.000964894079604677,0.0443362523081097,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82308",280.278126133865,0.513530163866693,0.155628596529878,3.29971596041544,0.000967827299044385,0.0444347289411056,5855,8766,"sp|P80317|TCPZ_MOUSE","P80317","TCPZ",3.39e-15,"T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0001669; GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:0071987; GO:1901998; GO:1904851"
"g102435",35.1206774392237,0.523161377399281,0.15856080960361,3.29943684512678,0.000968790234761714,0.0444426593666137,0,6228,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.5e-13,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g11359",184.78935045274,-0.391677144722212,0.118733662814543,-3.29878768529186,0.000971033240730984,0.0444521903318213,16021,47354,"sp|P21329|RTJK_DROFU","P21329","RTJK",9.02e-23,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g81370",795.698225408433,0.343858168954996,0.104228751094014,3.29907214032371,0.000970049787723647,0.0444521903318213,4394,8904,"sp|P09623|DLDH_PIG","P09623","DLDH",1.98e-45,"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)","cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077]","GO:0001669; GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0031514; GO:0045252; GO:0045454; GO:0050660; GO:0106077"
"g95266",112.064299829568,0.336658866889144,0.102058334054448,3.29869059698287,0.000971369117702222,0.0444521903318213,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49142",22.29390341479,-0.497889302756297,0.150982309510687,-3.29766649066297,0.000974918571932782,0.0445783498558078,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43798",155.644830931837,0.706744584130801,0.214406000953237,3.29629105989877,0.000979704582259278,0.0445797290577883,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48950",38.9961348851004,-0.670043312693808,0.203219859506888,-3.29713500599629,0.000976765377200945,0.0445797290577883,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69303",176.300548061747,-0.346098045566021,0.104973886744141,-3.29699181673233,0.000977263485561497,0.0445797290577883,3805,9110,"sp|P21328|RTJK_DROME","P21328","RTJK",1.94e-20,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g72777",540.345866956314,0.466696809907122,0.141578011794633,3.29639330282511,0.000979348066068469,0.0445797290577883,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87729",354.372223135888,0.416952828803821,0.126472415382874,3.29678869136456,0.000977970495436555,0.0445797290577883,0,7995,"sp|P54385|DHE3_DROME","P54385","DHE3",7.42e-29,"Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3)","glutamate catabolic process [GO:0006538]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]","GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0006538; GO:0042802"
"g99379",27.2974156290909,0.787921742138712,0.239008713978642,3.29662349553131,0.000978545834787685,0.0445797290577883,0,6574,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.24e-20,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g15378",445.152626243327,-0.606345764442837,0.183996758438355,-3.29541547138715,0.000982762642580649,0.0446431493288051,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30260",675.822044508367,-0.4584856141265,0.139126863191783,-3.29544994840062,0.000982642061984159,0.0446431493288051,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98366",64.337791432009,0.427752702216567,0.129819362835475,3.29498383656894,0.000984273410755634,0.0446431493288051,0,5744,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.1e-39,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g130376",304.747239717056,2.11389989973066,0.641534204004608,3.29506967287979,0.000983972803266025,0.0446431493288051,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85298",629.176969062765,0.471074015068887,0.142981250874642,3.29465585303838,0.000985422825830114,0.0446592671799656,115,7219,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.23e-16,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g36469",35.5186585410877,1.16632361825031,0.35403215669427,3.29440022946138,0.000986319517802856,0.0446639149116491,1283,11884,"sp|Q2QEI3|IOD1_XENLA","Q2QEI3","IOD1",1.72e-11,"Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase)","hormone biosynthetic process [GO:0042446]","GO:0004800; GO:0005789; GO:0016021; GO:0042446"
"g51273",276.460839345404,-0.735941518754254,0.223472508881252,-3.29320828963941,0.000990510660185101,0.0447110638337731,5655,16736,"sp|P21328|RTJK_DROME","P21328","RTJK",7.58e-24,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g61723",29.9659290786162,0.681495858687237,0.206995955413653,3.29231485381133,0.000993662997245777,0.0447110638337731,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74524",4846.9830699453,-0.250310066960005,0.0760289692346257,-3.29229857355486,0.000993720525447466,0.0447110638337731,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107663",41.1231719332558,0.484342629475772,0.147092568280243,3.29277430626539,0.00099204073878268,0.0447110638337731,0,5678,"sp|Q9N5X6|ODD2_CAEEL","Q9N5X6","ODD2",5.68e-19,"Protein odd-skipped-related 2","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g125505",28.619477667454,0.625495295531028,0.18997069052246,3.29258841882809,0.000992696784172014,0.0447110638337731,0,3995,"sp|Q80ZD3|S2611_MOUSE","Q80ZD3","S2611",1.66e-15,"Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11)","sulfate transport [GO:0008272]","GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231"
"g125561",50.4993631513842,-0.966872042589794,0.293674023662338,-3.29233083175749,0.000993606540291177,0.0447110638337731,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147477",23.961222137573,1.60832947726439,0.488284273611432,3.29383837281695,0.000988293088676461,0.0447110638337731,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152272",23.6952713503611,1.25275726187407,0.380464755824182,3.29270252420696,0.000992294028853057,0.0447110638337731,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21282",18.4801756259628,1.36525945269974,0.414860766321112,3.2908859153073,0.000998724078165469,0.0448644086295386,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138966",20.15824771276,0.768892367855527,0.233642832368401,3.29088789098036,0.000998717064189308,0.0448644086295386,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45411",378.18891811801,0.538198439826334,0.163575742987201,3.29020935499249,0.00100112866613391,0.0449007005109276,16400,20038,"sp|Q21217|GABT_CAEEL","Q21217","GABT",3.96e-20,"Probable 4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (L-AIBAT)","gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]","GO:0003867; GO:0005739; GO:0005759; GO:0009450; GO:0030170; GO:0034386; GO:0042135; GO:0047298"
"g133752",618.674014892448,0.995267565889145,0.302493509722452,3.29021130668998,0.00100112172183226,0.0449007005109276,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29333",273.440069335428,-0.636660394793563,0.19355376011446,-3.28932072627815,0.00100429511732709,0.0449352155836993,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52339",69.9362805530773,0.831913467715187,0.252905588977443,3.28942302571806,0.00100393012203347,0.0449352155836993,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98162",22.6021783220027,-0.943151363618408,0.286726444109223,-3.28937697584368,0.00100409440868534,0.0449352155836993,1185,6304,"sp|P04323|POL3_DROME","P04323","POL3",6.72e-83,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g31893",261.204382461428,2.59266438473162,0.788444439128111,3.28832858228879,0.00100784137720989,0.0450335275422713,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65225",29.7905188609875,-1.17700526298822,0.357941874415726,-3.28825808634283,0.00100809379424131,0.0450335275422713,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33441",160.62811823163,-0.588837791074364,0.179093865996829,-3.287872467306,0.00100947557352775,0.0450594644494822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1754",11336.9802938549,0.406763817480598,0.123744690517203,3.28712137692928,0.00101217197166127,0.0451439936797567,69535,71911,"sp|Q9V3G1|RL8_DROME","Q9V3G1","RL8",1.4e-42,"60S ribosomal protein L8","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0019843; GO:0022625; GO:0022626"
"g31812",1737.16261772306,-0.488629518164681,0.148672175800582,-3.28662384560841,0.00101396176735946,0.0451879855149213,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139444",210.300771637662,-0.345580717433807,0.10515618443844,-3.28635656836821,0.00101492446702341,0.0451950767017661,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81889",28.8858635410547,-0.468150630839865,0.142472977455043,-3.28589069451847,0.0010166045099828,0.0451983168778284,0,8820,"sp|Q8R180|ERO1A_MOUSE","Q8R180","ERO1A",1.48e-16,"ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.4.-) (Endoplasmic reticulum oxidoreductase alpha) (Endoplasmic reticulum oxidoreductin-1-like protein) (Oxidoreductin-1-L-alpha)","animal organ senescence [GO:0010260]; brown fat cell differentiation [GO:0050873]; cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix organization [GO:0030198]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]","GO:0005783; GO:0005789; GO:0006457; GO:0006979; GO:0010260; GO:0015035; GO:0016491; GO:0016972; GO:0018401; GO:0022417; GO:0030176; GO:0030198; GO:0030425; GO:0030968; GO:0034975; GO:0034976; GO:0045454; GO:0050873; GO:0051085; GO:0051209; GO:0070059; GO:0071456; GO:0071949"
"g123197",30.4040154256279,-0.540264129340568,0.164414471333046,-3.2859889093715,0.00101625011176285,0.0451983168778284,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73724",22.8934511194015,0.489607309924447,0.149018027544674,3.28555757978792,0.00101780737245138,0.0452160523233892,5085,9751,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.75e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g22103",164.588217041299,0.429481044261097,0.130739652792736,3.28500982744663,0.00101978814613165,0.0452325906267637,9477,22094,"sp|B7Z0W9|OTOP_DROME","B7Z0W9","OTOP",1.42e-31,"Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc)","proton transmembrane transport [GO:1902600]","GO:0005886; GO:0015252; GO:0016021; GO:1902600"
"g68271",19.7628505383913,0.928048152144802,0.282497271064819,3.28515793673582,0.0010192522039309,0.0452325906267637,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146500",426.671614185344,0.503783312969328,0.153400747625421,3.28409946344904,0.00102308808483245,0.0453431994224955,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4978",1124.21891764079,-0.69724853348434,0.212369497458449,-3.28318587098771,0.00102640965957935,0.0453817101434487,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16947",148.616837448205,-0.276352347321703,0.0841711755555416,-3.28321834045609,0.00102629143853769,0.0453817101434487,30855,58819,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.85e-32,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g51272",3841.80044768111,-0.456057711559165,0.138920715148204,-3.28286325817307,0.00102758497485563,0.0453817101434487,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55888",33548.8927163336,-1.00580229038427,0.306401516449565,-3.28262830432116,0.00102844172226476,0.0453817101434487,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76791",25.5434734235131,1.41835939999557,0.432093283914015,3.28253053865521,0.00102879841458158,0.0453817101434487,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85549",1102.37416772678,0.48274792350047,0.147052849640953,3.28281923593563,0.00102774544942808,0.0453817101434487,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37447",49.4707151011631,0.7821712914297,0.23831997805091,3.28202149826739,0.001030657469375,0.0454280857308691,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109090",194.829270929224,-0.491895907667742,0.149889529070095,-3.28172295102556,0.00103174923280929,0.0454405954202505,0,5538,"sp|Q8TBB1|LNX1_HUMAN","Q8TBB1","LNX1",1.83e-24,"E3 ubiquitin-protein ligase LNX (EC 2.3.2.27) (Ligand of Numb-protein X 1) (Numb-binding protein 1) (PDZ domain-containing RING finger protein 2) (RING-type E3 ubiquitin transferase LNX)","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005737; GO:0006511; GO:0030165; GO:0042802; GO:0046872"
"g65359",52.5732348883534,0.520298362794545,0.15859528991475,3.28066718169388,0.00103561868743563,0.0455651291673125,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146491",29.2945522282499,1.26116951412916,0.384443163903684,3.28050966317904,0.00103619715168366,0.0455651291673125,378,2299,"sp|P10394|POL4_DROME","P10394","POL4",1.87e-41,"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g83262",225.276025389308,0.610126118553359,0.186001838114592,3.28021553301786,0.00103727810320282,0.0455770274065101,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60598",252.558262067298,0.571928678152203,0.174414377414907,3.2791372284159,0.00104124988898433,0.045715828459217,6565,11007,"sp|Q54TH8|TCPG_DICDI","Q54TH8","TCPG",2.59e-12,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)","protein folding [GO:0006457]","GO:0005524; GO:0005832; GO:0005856; GO:0006457; GO:0016887; GO:0045335; GO:0051082"
"g9290",1148.85085677484,0.299533290112082,0.0913629040279973,3.27850010131347,0.00104360326773609,0.0457721362567199,50798,60474,"sp|Q562A2|ZFR_RAT","Q562A2","ZFR",6.02e-12,"Zinc finger RNA-binding protein",NA,"GO:0003677; GO:0003725; GO:0003727; GO:0005634; GO:0005694; GO:0005737; GO:0008270"
"g64061",92.1062093091438,0.439445812239047,0.134044831148934,3.27834955270143,0.00104416007285252,0.0457721362567199,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33112",86.9219933333673,0.442819286070843,0.135088741346694,3.27798809624249,0.00104549804462993,0.0457903568897913,5666,12764,"sp|Q9HD20|AT131_HUMAN","Q9HD20","AT131",5.39e-38,"Endoplasmic reticulum transmembrane helix translocase (EC 7.4.2.-) (Endoplasmic reticulum P5A-ATPase)","cellular calcium ion homeostasis [GO:0006874]; extraction of mislocalized protein from ER membrane [GO:0140569]; ion transmembrane transport [GO:0034220]; protein transport [GO:0015031]","GO:0005524; GO:0005789; GO:0006874; GO:0015031; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872; GO:0140567; GO:0140569"
"g39188",667.008192723004,0.210583120505594,0.0642453104845296,3.27779753755417,0.00104620405752608,0.0457903568897913,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21235",3299.87389403722,-0.6085717647356,0.1856900483646,-3.27735261041387,0.00104785421394706,0.0457980382717482,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59682",18.6688699228622,0.780200992432716,0.238099866423322,3.27678047095407,0.00104997971804469,0.0457980382717482,0,13531,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.62e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g61544",259.015480289548,0.354778278002084,0.10827457109374,3.27665373705272,0.00105045107518501,0.0457980382717482,0,4895,"sp|Q0V9J0|TMM69_XENTR","Q0V9J0","TMM69",1.72e-28,"Transmembrane protein 69",NA,"GO:0016021"
"g62700",71.3556711697718,-0.634495496715865,0.193638794336451,-3.27669617490707,0.0010502932157005,0.0457980382717482,4685,12625,"sp|A6NJL1|ZSA5B_HUMAN","A6NJL1","ZSA5B",2.66e-24,"Zinc finger and SCAN domain-containing protein 5B","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g157241",41.5744977883813,0.848255669469702,0.258860224407035,3.27688686592457,0.00104958415792234,0.0457980382717482,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9410",240.076708067967,-0.345327162990115,0.105411159110462,-3.276001951826,0.00105287833227029,0.0458184554879632,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63151",94.725286347895,0.330276230382619,0.100807442496427,3.27630800071458,0.00105173795650491,0.0458184554879632,7837,11134,"sp|O17953|DLDH_CAEEL","O17953","DLDH",9.61e-21,"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)","cell redox homeostasis [GO:0045454]; fatty acid biosynthetic process [GO:0006633]","GO:0004148; GO:0005739; GO:0005759; GO:0006633; GO:0045252; GO:0045454; GO:0050660"
"g82359",249.801443437426,0.584106293875435,0.178305598279543,3.27587187116632,0.00105336337516334,0.0458184554879632,0,5534,"sp|P21328|RTJK_DROME","P21328","RTJK",3.06e-12,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g6827",52.334617337827,-0.728776668826099,0.222485049571914,-3.27562085734905,0.00105429993631415,0.0458237534916385,9645,39902,"sp|P21328|RTJK_DROME","P21328","RTJK",1.84e-13,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g86262",23.8079616958024,0.598626194323793,0.182789702297812,3.27494485082357,0.00105682602636913,0.0458980767374923,0,3664,"sp|A7YWE4|AL4A1_BOVIN","A7YWE4","AL4A1",5.9e-17,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)","proline catabolic process to glutamate [GO:0010133]","GO:0003842; GO:0005759; GO:0010133; GO:0016620"
"g6744",260.699672690838,-0.29330729099832,0.0896044727659889,-3.27335546925566,0.00106278727704348,0.0461213595952772,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5727",1089.32527398628,0.203702637476649,0.0622394771482921,3.27288478004573,0.00106455863965336,0.0461626114197259,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9822",129.35069758357,-0.984678048886779,0.301021323632339,-3.27112390911364,0.00107120964151536,0.0461781789488579,0,10062,"sp|P18700|TBB_STRPU","P18700","TBB",3.69e-62,"Tubulin beta chain (Beta-tubulin) (Fragment)","microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]","GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874"
"g13564",86.5018861470826,-0.455732345619666,0.139281160109641,-3.27203151711916,0.00106777672159653,0.0461781789488579,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15700",254.892621322446,-0.479936837515824,0.146707226657491,-3.27139193106215,0.00107019481937991,0.0461781789488579,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17388",2816.00360776043,-0.432943088702513,0.132306156247594,-3.27228226547762,0.00106683009144311,0.0461781789488579,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20119",114.778496339477,0.474330803545381,0.145028562629203,3.27060266575288,0.00107318579539477,0.0461781789488579,22295,46064,"sp|O43102|CBF5_ASPFU","O43102","CBF5",8.59e-29,"H/ACA ribonucleoprotein complex subunit cbf5 (EC 5.4.99.-) (Centromere-binding factor 5) (H/ACA snoRNP protein cbf5) (Small nucleolar RNP protein cbf5)","box H/ACA RNA 3'-end processing [GO:0000495]; mRNA pseudouridine synthesis [GO:1990481]; rRNA pseudouridine synthesis [GO:0031118]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; snRNA pseudouridine synthesis [GO:0031120]","GO:0000454; GO:0000495; GO:0003677; GO:0003723; GO:0005874; GO:0009982; GO:0031118; GO:0031120; GO:0031429; GO:1990481"
"g32218",169.274582438817,-0.648168315130811,0.198174884518758,-3.27068849670231,0.00107286015869964,0.0461781789488579,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34083",620.603676525603,0.56400396962488,0.172437043102271,3.27078195889948,0.00107250567352988,0.0461781789488579,7441,12924,"sp|Q9Z2K9|IDHC_MICME","Q9Z2K9","IDHC",1.25e-17,"Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (IDH1) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDPc) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)","2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004450; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0051287"
"g38164",84.5907421008446,-0.658713732169254,0.201332691322524,-3.27176738085734,0.00106877473436038,0.0461781789488579,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87660",983.597972011845,0.487846524841468,0.149180084171092,3.27018534378868,0.00107477038946081,0.0461781789488579,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87896",89.5772031281578,1.89731114558121,0.580160678076025,3.270320132473,0.00107425835306978,0.0461781789488579,0,7725,"sp|Q64380|SARDH_RAT","Q64380","SARDH",3.59e-20,"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)","choline catabolic process [GO:0042426]; glycine biosynthetic process [GO:0006545]; sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]","GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006545; GO:0008480; GO:0016491; GO:0035999; GO:0042426; GO:0050660; GO:1901053"
"g110507",67.0818906911157,0.909594057131875,0.27804132440017,3.27143477356893,0.00107003268556295,0.0461781789488579,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152027",395.903392798718,0.591327802020672,0.180710980217346,3.27222950874078,0.00106702919520569,0.0461781789488579,0,1655,"sp|A1ZA47|ZASP_DROME","A1ZA47","ZASP",4.7e-17,"PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein)","actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]","GO:0001725; GO:0001952; GO:0003779; GO:0005912; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061"
"g12506",14050.7503355035,1.99921785967957,0.611424941942103,3.26976824551734,0.00107635629641665,0.0462110158954697,58930,68894,"sp|P04069|CBPB_ASTAS","P04069","CBPB",4.45e-24,"Carboxypeptidase B (EC 3.4.17.2)",NA,"GO:0004181; GO:0005576; GO:0008270"
"g37846",374.783108914869,-0.448570997422072,0.137203207091309,-3.26939148822918,0.00107779067775603,0.0462373022870746,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27775",119.157110792269,-0.372155944499826,0.113859805100744,-3.26854542013787,0.00108101825378984,0.0463404181628418,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g882",266.995314244974,0.277778008553527,0.0850250352175185,3.26701433104839,0.00108688178207823,0.0463807579718458,153005,157028,"sp|Q7KRI2|LOLAL_DROME","Q7KRI2","LOLAL",5.23e-24,"Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)","dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; heterochromatin assembly [GO:0031507]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]","GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0031208; GO:0031507; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944"
"g27676",2455.43188355332,-0.371516948760029,0.113695779514006,-3.26764063141202,0.00108447972751096,0.0463807579718458,9505,35294,"sp|C9J069|AJM1_HUMAN","C9J069","AJM1",1.42e-22,"Apical junction component 1 homolog","cell-cell junction organization [GO:0045216]","GO:0005886; GO:0005912; GO:0005929; GO:0016324; GO:0043296; GO:0045216"
"g41532",2542.50657772358,-0.442308332859618,0.135387783729463,-3.26697373038808,0.00108703766781132,0.0463807579718458,6976,22863,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.48e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g52749",52.8406493526121,2.07720541446965,0.635890844658173,3.26660689003356,0.00108844708459224,0.0463807579718458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56697",70.1396683604726,0.440961140813793,0.13498992713628,3.26662255598241,0.00108838686079687,0.0463807579718458,0,14540,"sp|P21328|RTJK_DROME","P21328","RTJK",5.88e-26,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g96771",42.4352840073875,0.635456201651213,0.19451879374993,3.26681134198346,0.00108766136285731,0.0463807579718458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118985",19.6781493488986,1.28248752931876,0.392608831360379,3.26657840292327,0.00108855660401189,0.0463807579718458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123576",868.665323122618,0.560441356064324,0.171552688767948,3.26687596731527,0.00108741311276786,0.0463807579718458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g156269",176.611688740155,0.651684620120949,0.199541616036053,3.26590830056826,0.00109113577101872,0.0464554564978311,0,1307,"sp|P80317|TCPZ_MOUSE","P80317","TCPZ",8.57e-22,"T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0001669; GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:0071987; GO:1901998; GO:1904851"
"g126738",59.2139919945812,-0.571548369020196,0.175022726648232,-3.26556659221129,0.00109245315215187,0.0464763617120464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82899",81.7259164772211,0.331154125813294,0.101434474339847,3.26470983330375,0.00109576266739434,0.0465467401356439,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162064",71.0317761397364,0.919430129648774,0.281624146812997,3.26474182009432,0.00109563894137642,0.0465467401356439,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9872",527.794149285801,-0.365693973454067,0.112049547327556,-3.26368095343597,0.00109974930939462,0.0465753770022383,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55003",469.773198094361,-0.482805689972046,0.14792097167942,-3.26394347258886,0.00109873084333022,0.0465753770022383,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75576",126.776569027075,1.78273998989811,0.546207701971271,3.26384996671444,0.0010990935075145,0.0465753770022383,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115365",615.100192445303,0.442154232630857,0.135462561273599,3.26403272220595,0.00109838479034151,0.0465753770022383,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159612",295.68092620199,0.463763031700798,0.142113526005127,3.26332788114812,0.00110112046099925,0.0465983573871482,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7897",129.243011174611,-0.36698801891376,0.112478916346695,-3.26272719220184,0.00110345686192666,0.0466270629815771,45125,55655,"sp|Q8C863|ITCH_MOUSE","Q8C863","ITCH",2.17e-25,"E3 ubiquitin-protein ligase Itchy (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase Itchy homolog)","apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of alpha-beta T cell proliferation [GO:0046642]; negative regulation of apoptotic process [GO:0043066]; negative regulation of defense response to virus [GO:0050687]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of T cell anergy [GO:0002669]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein deubiquitination [GO:0090085]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0002669; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006511; GO:0006915; GO:0016020; GO:0016567; GO:0016874; GO:0031410; GO:0031901; GO:0032088; GO:0032991; GO:0035519; GO:0043021; GO:0043066; GO:0043161; GO:0043231; GO:0044389; GO:0045087; GO:0045236; GO:0045732; GO:0046329; GO:0046642; GO:0050687; GO:0051607; GO:0051865; GO:0061630; GO:0070534; GO:0070936; GO:0090085; GO:1990763; GO:2000646"
"g46972",264.285177354366,0.27742584462587,0.0850263840744845,3.26282068378728,0.00110309292212222,0.0466270629815771,5585,12597,"sp|Q8CC12|CDAN1_MOUSE","Q8CC12","CDAN1",8.24e-63,"Codanin-1","chromatin assembly [GO:0031497]; chromatin organization [GO:0006325]; negative regulation of DNA replication [GO:0008156]; nuclear envelope organization [GO:0006998]; protein localization [GO:0008104]","GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0006998; GO:0008104; GO:0008156; GO:0012505; GO:0016021; GO:0031497"
"g44890",1545.51834254176,-0.353807278750673,0.108449461513679,-3.26241618734129,0.00110466832673353,0.0466432102343448,5487,20034,"sp|Q9VE46|SC5A7_DROME","Q9VE46","SC5A7",4.48e-27,"High-affinity choline transporter 1","acetylcholine biosynthetic process [GO:0008292]; amino acid transmembrane transport [GO:0003333]; choline transport [GO:0015871]","GO:0003333; GO:0005307; GO:0005886; GO:0008292; GO:0015171; GO:0015220; GO:0015871; GO:0016021"
"g11602",25.1792426797019,-0.538609397134753,0.165108033579217,-3.26216347841327,0.00110565361555642,0.0466497904322014,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18002",27.8992669805309,1.15491725335542,0.35408909015679,3.26165726496691,0.00110762973990131,0.0466981348062442,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67064",72.2817954276066,0.54981289664712,0.168589425243324,3.2612537580787,0.00110920726345227,0.0467296141656049,8809,9664,"sp|Q3TA59|JMJD8_MOUSE","Q3TA59","JMJD8",1.9e-12,"JmjC domain-containing protein 8 (Jumonji domain-containing protein 8)","positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302]","GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006110; GO:0043123; GO:1903302; GO:1903672"
"g25860",81.7820883770834,0.371620988302126,0.113962582839992,3.26090352676454,0.00111057818828759,0.0467523491509512,25555,31132,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.51e-25,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g45814",140.069188536332,0.990583848511196,0.303859122172611,3.26001023575814,0.00111408193131373,0.046864768871314,0,19480,"sp|Q13231|CHIT1_HUMAN","Q13231","CHIT1",1.82e-18,"Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)","chitin catabolic process [GO:0006032]; immune response [GO:0006955]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]","GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0044245; GO:1904724"
"g83201",1105.11141721215,0.214879372696726,0.0659484161837165,3.25829466621493,0.00112083956564346,0.0470434767544174,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95312",69.88056227514,0.458966177565767,0.140859860379385,3.25831770903088,0.00112074854936553,0.0470434767544174,0,5094,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.21e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g144083",187.205860839035,0.59750071164192,0.183376211374104,3.25833273119033,0.00112068921737,0.0470434767544174,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153403",19.016591275609,0.71847720837422,0.220567802528415,3.25739840601468,0.00112438498949331,0.0471570921544243,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146264",54.8962935298638,-0.856394921114641,0.262929071904377,-3.25713286443311,0.00112543740753237,0.0471660586247655,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g228",23.4338128199294,0.611934606867533,0.188054041416534,3.254035926365,0.00113777889791703,0.0472071384817796,156605,169469,"sp|Q8IMX7|MIRO_DROME","Q8IMX7","MIRO",1.6e-21,"Mitochondrial Rho GTPase (Miro) (dMiro) (EC 3.6.5.-)","axonal transport of mitochondrion [GO:0019896]; cellular homeostasis [GO:0019725]; establishment of mitochondrion localization, microtubule-mediated [GO:0034643]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle transport [GO:0048489]","GO:0000226; GO:0000287; GO:0003924; GO:0005509; GO:0005525; GO:0005741; GO:0007005; GO:0007264; GO:0010821; GO:0019725; GO:0019896; GO:0031307; GO:0034643; GO:0047497; GO:0048489; GO:0051646; GO:0097345; GO:1904115"
"g1553",37.1226029383545,-0.434709628797244,0.133613957800943,-3.25347468147654,0.00114002883964204,0.0472071384817796,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6555",124.446830193836,-0.526396863267103,0.161700594123343,-3.25537989591786,0.00113240781019879,0.0472071384817796,0,30018,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.25e-33,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g10432",24.5936753555512,-0.651371086630097,0.200171705321387,-3.25406173457075,0.00113767553569636,0.0472071384817796,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18793",3807.57564443188,0.268589639867018,0.082541764082654,3.25398472945239,0.00113798396795102,0.0472071384817796,0,9879,"sp|Q99PV0|PRP8_MOUSE","Q99PV0","PRP8",0,"Pre-mRNA-processing-splicing factor 8 (Splicing factor Prp8)","cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]","GO:0000244; GO:0000398; GO:0005634; GO:0005682; GO:0016607; GO:0017070; GO:0030532; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070122; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157; GO:0140492"
"g27597",37.7970126122074,0.53457817334722,0.164169175314039,3.25626398697945,0.00112888738854308,0.0472071384817796,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28906",80.9163285771862,0.407915476229086,0.125341329263553,3.25443713279416,0.00113617304167699,0.0472071384817796,18810,23564,"sp|P48506|GSH1_HUMAN","P48506","GSH1",2.15e-25,"Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)","aging [GO:0007568]; blood vessel diameter maintenance [GO:0097746]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]","GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237"
"g32313",21.8679169046186,1.82591423032071,0.56072945305009,3.2563194609961,0.00112866683052641,0.0472071384817796,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32544",6319.99296342794,-0.311821194365874,0.0957679382603495,-3.25600822185577,0.00112990479535215,0.0472071384817796,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33248",899.228568936037,-0.378083934300604,0.116209144065022,-3.25347835011208,0.0011400141193197,0.0472071384817796,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42886",4967.72562039841,-0.26014343558138,0.0799585230182721,-3.25347975126969,0.00114000849725082,0.0472071384817796,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61854",28.3174482020819,-0.762286362233836,0.234312116561084,-3.25329467985541,0.00114075130816788,0.0472071384817796,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87510",154.167108170594,0.369112033961649,0.113464643901412,3.25310177047191,0.00114152605410939,0.0472071384817796,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90102",56.8958823651391,-0.631915267732211,0.194163189088701,-3.25455752296862,0.0011356915805833,0.0472071384817796,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114749",27.5335444930222,-1.12784947359297,0.346509157118231,-3.25489081723788,0.00113435966289954,0.0472071384817796,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124191",218.320099058227,2.45094545292025,0.7529435412705,3.25515170604236,0.00113331810117208,0.0472071384817796,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125509",34.1895509777253,-0.598807951834649,0.183964228601534,-3.25502385103175,0.00113382843373749,0.0472071384817796,0,3995,"sp|Q13905|RPGF1_HUMAN","Q13905","RPGF1",1.67e-45,"Rap guanine nucleotide exchange factor 1 (CRK SH3-binding GNRP) (Guanine nucleotide-releasing factor 2) (Protein C3G)","cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of cell junction assembly [GO:1901888]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0005085; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0007165; GO:0007169; GO:0007265; GO:0007399; GO:0010976; GO:0017124; GO:0032486; GO:0038180; GO:0043231; GO:0043547; GO:0061028; GO:0071320; GO:1901888; GO:1990090"
"g147672",1488.54113290915,0.399757322234745,0.122839097812853,3.25431665774509,0.00113665503107295,0.0472071384817796,264,1750,"sp|O00567|NOP56_HUMAN","O00567","NOP56",7.83e-55,"Nucleolar protein 56 (Nucleolar protein 5A)","rRNA processing [GO:0006364]","GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0045296; GO:0070761; GO:1990226"
"g53864",84.798629914659,0.645801929990734,0.198574034828037,3.252197250008,0.00114516520173278,0.0473228370873294,0,10780,"sp|Q66I12|CCD47_DANRE","Q66I12","CCD47",2.15e-16,"PAT complex subunit CCDC47 (Coiled-coil domain-containing protein 47)","endoplasmic reticulum calcium ion homeostasis [GO:0032469]; protein insertion into ER membrane [GO:0045048]","GO:0005509; GO:0005783; GO:0030176; GO:0030867; GO:0032469; GO:0043022; GO:0044183; GO:0045048"
"g110286",222.575873974655,-0.535240526962104,0.164597538827503,-3.25181367093849,0.00114671168690756,0.0473519520521695,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67827",771.554373369203,0.686414331485702,0.211140926673608,3.25097716629234,0.00115009094071136,0.0474119662498525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94257",102.664121139281,-0.354756138019649,0.109127928493162,-3.2508281144719,0.00115069403525921,0.0474119662498525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154398",135.151985969377,2.14567388689113,0.659963431827095,3.25120117784538,0.00114918509302926,0.0474119662498525,0,1604,"sp|Q3ZCJ8|CATC_BOVIN","Q3ZCJ8","CATC",7.31e-20,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","zymogen activation [GO:0031638]","GO:0005764; GO:0008234; GO:0008239; GO:0031638"
"g7832",63.8552788197759,-1.22111327726351,0.375745618356115,-3.24984036435575,0.00115469806964432,0.0474379319451688,55205,64583,"sp|Q6DE58|ATGA1_XENLA","Q6DE58","ATGA1",3.27e-13,"Autophagy-related protein 101","autophagy [GO:0006914]","GO:0000407; GO:0006914"
"g102736",268.237270157977,0.543040166974003,0.167086753911522,3.25004917661852,0.00115385053728375,0.0474379319451688,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112944",18.8976040010484,0.676102660521398,0.208032262377526,3.24998946218467,0.00115409284898126,0.0474379319451688,1945,3528,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.2e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g117607",29.8109014530454,0.60487262058475,0.186121455561695,3.24988120665244,0.00115453225267389,0.0474379319451688,0,4711,"sp|Q9XYU1|MCM3_DROME","Q9XYU1","MCM3",6.08e-13,"DNA replication licensing factor Mcm3 (EC 3.6.4.12) (Minichromosome maintenance 3 protein) (DmMCM3)","DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0006271; GO:0016887; GO:0030174; GO:0042555; GO:0071162; GO:1902975"
"g9349",961.52020755361,0.382392752942659,0.117716183936441,3.248429741395,0.00116043863009897,0.0474947580853556,0,5032,"sp|Q6PHD9|SBP1_DANRE","Q6PHD9","SBP1",6.05e-14,"Methanethiol oxidase (MTO) (EC 1.8.3.4) (Selenium-binding protein 1)","protein transport [GO:0015031]","GO:0005634; GO:0005829; GO:0008430; GO:0015031; GO:0016020; GO:0018549"
"g10782",30.2196109059409,-0.505368185590475,0.155534172389362,-3.24924213005322,0.00115712938429298,0.0474947580853556,48555,52001,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.38e-19,"PiggyBac transposable element-derived protein 4",NA,NA
"g21412",186.796644072852,-0.459135418587036,0.141357294450034,-3.24804899791943,0.0011619925878427,0.0474947580853556,12873,48184,"sp|Q13136|LIPA1_HUMAN","Q13136","LIPA1",1.72e-81,"Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1)","cell-matrix adhesion [GO:0007160]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165]; synapse organization [GO:0050808]","GO:0005737; GO:0005829; GO:0005925; GO:0007160; GO:0007165; GO:0030424; GO:0030425; GO:0032991; GO:0048786; GO:0050808; GO:0051497; GO:1903077"
"g26057",32.8046578978827,-0.521859076877745,0.160644099317733,-3.24854183312128,0.00115998150755802,0.0474947580853556,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54899",103.807317658859,-0.587786534663903,0.18095758839056,-3.24820053080773,0.00116137389472485,0.0474947580853556,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57213",122.897973334239,-1.25378576759028,0.385915916507045,-3.24885736493688,0.00115869562710219,0.0474947580853556,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82652",902.020018797043,-0.516432276134394,0.158995730333277,-3.24808895843857,0.00116182940360934,0.0474947580853556,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2880",1297.40230585846,0.413780104981784,0.127412766733994,3.24755607768611,0.00116400723776438,0.0475425526988702,2345,14234,"sp|Q15427|SF3B4_HUMAN","Q15427","SF3B4",2.01e-41,"Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (Spliceosome-associated protein 49) (SAP 49)","mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]","GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005689; GO:0006397; GO:0008380; GO:0048026; GO:0071005; GO:1990935"
"g10546",462.032640822536,0.351536871687523,0.1082535972081,3.24734586890216,0.00116486737872027,0.0475431575573189,45194,56624,"sp|P54385|DHE3_DROME","P54385","DHE3",1.44e-33,"Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3)","glutamate catabolic process [GO:0006538]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]","GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0006538; GO:0042802"
"g15455",473.073089560036,-0.576444535626375,0.177561133662349,-3.24645672021077,0.00116851213475538,0.0476521557464093,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15980",8356.26524045816,0.431674333634364,0.132981376834892,3.24612621638236,0.00116986960490739,0.0476521557464093,0,18120,"sp|P56649|G3P_PANVR","P56649","G3P",3.66e-177,"Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12)","glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]","GO:0004365; GO:0005737; GO:0006006; GO:0006096; GO:0050661; GO:0051287"
"g39776",738.717705807259,-0.507809242474918,0.156437922891785,-3.24607507622172,0.00117007978176081,0.0476521557464093,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1505",246.73848296381,-0.430143462136267,0.13255326937936,-3.24506113014247,0.00117425412862355,0.0476768152479036,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33764",127.80719456074,-0.473165691009809,0.145795735498018,-3.24540144739858,0.00117285153386064,0.0476768152479036,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45673",97.9473680700835,0.599394644692294,0.184719058140387,3.24489877074163,0.0011749238279861,0.0476768152479036,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113888",699.770645132918,0.398315517109096,0.122748550046024,3.24497126002506,0.00117462478090061,0.0476768152479036,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122260",45.4981053558306,-0.653958894332632,0.201484663474493,-3.24570060596905,0.00117161985062472,0.0476768152479036,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65153",74.3713652285124,1.01978717725748,0.31433854822876,3.24423200082775,0.00117767782022515,0.0477541138897641,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31813",286.195647664084,-0.574503322773855,0.177138561273597,-3.24324257035437,0.00118177550753978,0.0478857479070983,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4066",32.031151689625,-0.696259532618954,0.214799455739073,-3.24143992927399,0.00118927495751043,0.0479493496560712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21283",28.9793450922373,1.28028246396411,0.394949212219794,3.24163822676931,0.00118844784184276,0.0479493496560712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68629",26.0304887955341,1.33192801595643,0.410777446737375,3.24245653342302,0.00118504023426839,0.0479493496560712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79899",90.2368778243742,1.57078514271717,0.484448779653791,3.24241737968609,0.00118520307312268,0.0479493496560712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108199",26.5157964129476,3.09901155693324,0.956062844165037,3.24143080744835,0.00118931301821093,0.0479493496560712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128880",142.311730380628,-1.18123788868588,0.364383196149207,-3.24174632960349,0.00118799715963132,0.0479493496560712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140037",41.2997641560887,-0.479827948711676,0.148018084406606,-3.2416846268162,0.00118825438005879,0.0479493496560712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8520",29.756268878712,-0.57048483605347,0.176023227371714,-3.2409633920003,0.00119126481013656,0.0479936357103871,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155784",82.9965270595159,-0.460437884547158,0.142080321851605,-3.24068722921433,0.00119241937649555,0.0480057627579547,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65980",1594.21043834568,0.364726001952992,0.112566084260252,3.24010561751219,0.00119485432921091,0.0480693828208009,1999,5244,"sp|Q1HDZ5|EIF3B_BOMMO","Q1HDZ5","EIF3B",7.6e-24,"Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9)","formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]","GO:0001732; GO:0003743; GO:0005852; GO:0006446; GO:0016282; GO:0031369; GO:0033290"
"g8759",156.050311792192,-0.546963870132569,0.168830790033399,-3.23971634572322,0.0011964866044747,0.0481006430370736,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54053",26.5567374272741,0.541985676917798,0.167323337087641,3.2391517307231,0.00119885778137104,0.0481615423856214,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108212",24.7339518368549,0.786933428739858,0.24301845653755,3.23816322410996,0.00120301960453296,0.0482942388280818,0,5625,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",7.02e-68,"PiggyBac transposable element-derived protein 4",NA,NA
"g18840",32.7329475002018,0.804504721827607,0.248498686723592,3.23746065798114,0.00120598566695672,0.0483787773758772,0,42430,"sp|B3EWZ6|MLRP2_ACRMI","B3EWZ6","MLRP2",4.95e-152,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)",NA,"GO:0005576; GO:0016020"
"g60561",44.6176491341401,1.28703892309768,0.397575611952597,3.2372179892441,0.00120701172366224,0.0483854264876776,0,13267,"sp|Q9Y3Q0|NALD2_HUMAN","Q9Y3Q0","NALD2",8.33e-16,"N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)","proteolysis [GO:0006508]","GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016021; GO:0016805; GO:0046872"
"g20773",1074.01921307606,-0.663403839658701,0.204956515816279,-3.23680287507117,0.00120876878732853,0.0484213491003783,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31851",2494.96230190612,-0.269343871788285,0.0832459285363845,-3.23552006114704,0.00121421352781998,0.0485995441175015,0,22596,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.38e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g162699",42.6786023311202,-0.428049621148279,0.132304041700651,-3.23534803356029,0.00121494539719795,0.0485995441175015,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37150",201.257676941545,-0.444112151051958,0.137281285096991,-3.23505240163062,0.00121620407732988,0.0486153160747597,0,12714,"sp|P21328|RTJK_DROME","P21328","RTJK",9.69e-24,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g93930",65.3901644639466,2.22277786664141,0.687287184325389,3.23413256835742,0.00122012806004899,0.048702939924255,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147914",648.261652495176,0.551727901665056,0.170589784221868,3.23423764313742,0.0012196792231496,0.048702939924255,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36186",109.633798369553,-0.558085994332609,0.172604720010949,-3.2333182678736,0.00122361159758702,0.0488073499797795,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43182",163.648672860333,0.337565832559838,0.104430668146548,3.23243965159863,0.00122738057613414,0.0488883416168104,1975,19334,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.24e-22,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g85771",25.887603429506,0.908346600625237,0.281007306708326,3.23246612789348,0.00122726684492119,0.0488883416168104,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10189",669.968398463129,0.486381897788381,0.150568653719196,3.2302998384741,0.00123660457825901,0.0489058823788299,52465,63959,"sp|P91929|NDUAA_DROME","P91929","NDUAA",2.05e-24,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit)","mitochondrial electron transport, NADH to ubiquinone [GO:0006120]","GO:0005737; GO:0005739; GO:0005747; GO:0005759; GO:0006120"
"g21999",64.2582208780945,0.859879764173392,0.266206820322753,3.23011921005953,0.00123738612825068,0.0489058823788299,4205,13200,"sp|P21328|RTJK_DROME","P21328","RTJK",2.32e-12,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g24919",137.028249294672,-0.645588333340225,0.199788048435974,-3.23136613222946,0.00123200017839044,0.0489058823788299,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35122",72.8126965143273,-0.422235930844493,0.130669363584194,-3.23133073631627,0.00123215276829219,0.0489058823788299,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56895",105.497929315399,0.337665720689168,0.104490798060367,3.23153547448351,0.00123127039436904,0.0489058823788299,3935,13169,"sp|Q9VHI4|SF3B5_DROME","Q9VHI4","SF3B5",4.54e-28,"Splicing factor 3B subunit 5 (Pre-mRNA-splicing factor SF3b 10 kDa subunit)","mRNA splicing, via spliceosome [GO:0000398]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","GO:0000124; GO:0000398; GO:0005686; GO:0007283; GO:0010468; GO:0071011"
"g70533",27.5188796300609,0.515038967991021,0.159425136717856,3.23060076092339,0.00123530354768253,0.0489058823788299,3452,10794,"sp|Q07598|SCP2_CHICK","Q07598","SCP2",6.18e-13,"Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X) (SCP-X) (Fragment)","bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; lipid transport [GO:0006869]; positive regulation of intracellular cholesterol transport [GO:0032385]","GO:0003988; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0006635; GO:0006869; GO:0008206; GO:0008289; GO:0032385; GO:0033814; GO:0050632; GO:0050633; GO:0120019; GO:0120020"
"g75053",158.196727911689,0.406008137170732,0.125681601119959,3.23045007027886,0.00123595489676823,0.0489058823788299,0,6647,"sp|B9ENE7|MGN_SALSA","B9ENE7","MGN",2.8e-30,"Protein mago nashi homolog","mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]","GO:0000184; GO:0000381; GO:0003723; GO:0005737; GO:0006397; GO:0006417; GO:0008380; GO:0016607; GO:0035145; GO:0051028"
"g91343",70.0808152498236,0.932703656919729,0.288609716557055,3.23171259805919,0.00123050750376917,0.0489058823788299,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91648",25.9194967241255,-0.509554263582092,0.157710257508363,-3.23095194714949,0.00123378680143713,0.0489058823788299,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99029",449.971683715941,-0.359616594156942,0.111300121366557,-3.23105302798887,0.00123335055994126,0.0489058823788299,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113172",51.4169710615988,-1.1991829737265,0.371249186647133,-3.23012956487984,0.00123734131229237,0.0489058823788299,0,464,"sp|P41383|TBA2_PATVU","P41383","TBA2",4.13e-35,"Tubulin alpha-2/alpha-4 chain","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g27028",23.9759343860805,1.48567355239121,0.460288265563163,3.22770242811532,0.00124788712899491,0.0492516967781975,18585,21884,"sp|P40939|ECHA_HUMAN","P40939","ECHA",3.04e-148,"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]","cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]","GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0009410; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042645; GO:0044877; GO:0070403"
"g138482",110.661530462709,2.08963764050071,0.647396700047043,3.22775454423674,0.00124765981718876,0.0492516967781975,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40517",60.3073177567403,0.444167992404948,0.137621161605926,3.2274687062794,0.00124890701008775,0.0492573829322266,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85062",281.642590385427,-0.36480253804247,0.113042173384558,-3.22713662627,0.00125035741587827,0.0492800292808868,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3092",77.2143028487545,-0.534244355764495,0.165641255910006,-3.22530973838278,0.0012583644557183,0.0493769451541155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7364",402.325176613641,0.582374266078181,0.180543722616916,3.22566887198778,0.00125678668557738,0.0493769451541155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21071",351.750289192369,0.34043344434801,0.105591054362991,3.2240746756605,0.00126380438665177,0.0493769451541155,38938,45824,"sp|P46087|NOP2_HUMAN","P46087","NOP2",2.25e-13,"Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120)","maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]","GO:0000027; GO:0000470; GO:0001510; GO:0003723; GO:0005654; GO:0005730; GO:0008284; GO:0009383; GO:0070475; GO:1901796"
"g22195",299.897878296888,-0.442034283084614,0.137166963416382,-3.22260019522909,0.00127032728196242,0.0493769451541155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26322",941.987057204705,-0.383117231125332,0.118826359365357,-3.22417713688725,0.00126335226356796,0.0493769451541155,13075,37190,"sp|Q0IHQ9|PXYP1_XENTR","Q0IHQ9","PXYP1",2.18e-37,"2-phosphoxylose phosphatase 1 (EC 3.1.3.-) (Acid phosphatase-like protein 2)","chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dephosphorylation [GO:0016311]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]","GO:0000139; GO:0005794; GO:0006024; GO:0010909; GO:0016021; GO:0016311; GO:0016791; GO:0050650"
"g29127",2349.12638064076,0.223590597301032,0.069309229143633,3.22598591938851,0.00125539532961355,0.0493769451541155,0,6403,"sp|P67874|CSK2B_RAT","P67874","CSK2B",1.44e-54,"Casein kinase II subunit beta (CK II beta) (Phosvitin)","adiponectin-activated signaling pathway [GO:0033211]; endothelial tube morphogenesis [GO:0061154]; liver regeneration [GO:0097421]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein phosphorylation [GO:0006468]; regulation of protein serine/threonine phosphatase activity [GO:0080163]; response to testosterone [GO:0033574]; Wnt signaling pathway [GO:0016055]","GO:0000785; GO:0003682; GO:0004674; GO:0005102; GO:0005634; GO:0005737; GO:0005886; GO:0005929; GO:0005956; GO:0006468; GO:0010862; GO:0016055; GO:0016363; GO:0018107; GO:0019887; GO:0019904; GO:0032927; GO:0033211; GO:0033574; GO:0042802; GO:0042995; GO:0043021; GO:0043537; GO:0046872; GO:0061154; GO:0061629; GO:0080163; GO:0097421; GO:0098685; GO:0098794; GO:0098978; GO:0099170"
"g30856",138.803358010999,0.440039126249199,0.136521161402777,3.22323016979732,0.00126753656896887,0.0493769451541155,2461,12754,"sp|P52899|ODPA_CAEEL","P52899","ODPA",5.43e-32,"Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1)","acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]","GO:0004739; GO:0005739; GO:0005759; GO:0006086; GO:0006096"
"g66779",115.146110182334,-0.622170483498725,0.192976779864583,-3.22406915451341,0.00126382875365075,0.0493769451541155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66984",62.2694857982424,2.08734167023369,0.647049342792767,3.22593893879005,0.00125560141320045,0.0493769451541155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70363",41.3117397862205,2.58236752255486,0.80129214873484,3.22275405622301,0.00126964517289689,0.0493769451541155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75500",402.187795011776,0.407616359674787,0.126446378749505,3.22363015616516,0.00126576761539902,0.0493769451541155,205,5304,"sp|Q3TMX7|QSOX2_MOUSE","Q3TMX7","QSOX2",2.18e-47,"Sulfhydryl oxidase 2 (EC 1.8.3.2) (Quiescin Q6-like protein 1)","protein folding [GO:0006457]","GO:0003756; GO:0005615; GO:0005654; GO:0005794; GO:0006457; GO:0016971; GO:0030173"
"g76734",343.113270612689,-0.676594097206315,0.209945876073736,-3.22270725131407,0.00126985263643063,0.0493769451541155,0,6134,"sp|P18258|TBA1_PARLI","P18258","TBA1",7.41e-40,"Tubulin alpha-1 chain","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g79363",2121.09830937753,-0.778404461891367,0.241546273989558,-3.22258939885372,0.00127037515803146,0.0493769451541155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81259",153.045417743461,0.310391438628056,0.0962544625913087,3.22469660389629,0.00126106234675488,0.0493769451541155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93045",124.879236585851,-0.765868004262794,0.237647188648057,-3.22271013858701,0.00126983983763983,0.0493769451541155,3986,7124,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",9.79e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g98066",225.329966982026,-0.676705697484896,0.209953110419092,-3.22312775521214,0.00126798986787921,0.0493769451541155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101642",247.886956070727,3.42375746007744,1.06167991477567,3.22484904576996,0.00126039107945599,0.0493769451541155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146346",21.3658125744942,2.37308215941364,0.735800510098697,3.2251705820309,0.00125897629829577,0.0493769451541155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154269",84.317759876519,0.643368448039855,0.199483490621604,3.22517139656557,0.00125897271615109,0.0493769451541155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g157957",49.2290682516818,1.29455440350829,0.401498230129984,3.22430911610541,0.00126277010868413,0.0493769451541155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133640",118.940085214213,-0.643053134739276,0.199625771598532,-3.22129317066596,0.00127613534777121,0.0495153570463812,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145542",39.9199717345269,0.627910664448073,0.194931035408886,3.22119391163636,0.00127657742820762,0.0495153570463812,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162237",47.455651373679,2.3575518090958,0.731823391757988,3.22147643222019,0.00127531950772786,0.0495153570463812,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1298",1478.49899264542,-0.326534798093362,0.10138447345167,-3.22075744910805,0.00127852302561607,0.0495225151561288,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30813",495.438671434782,-0.317207365088686,0.0984853827546098,-3.22085731117127,0.00127807763410021,0.0495225151561288,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150158",459.222060465684,0.34555539200398,0.107314697518767,3.22001925172972,0.0012818198824352,0.0496160453048317,1060,1971,"sp|Q6P5I8|YIPF5_DANRE","Q6P5I8","YIPF5",2.57e-41,"Protein YIPF5 (YIP1 family member 5)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; vesicle fusion with Golgi apparatus [GO:0048280]","GO:0005789; GO:0005802; GO:0006888; GO:0015031; GO:0016021; GO:0048280; GO:0060628"
"g1696",39.1926981657847,2.3308742299499,0.724482799221571,3.21729409235711,0.00129405876951518,0.0496706092992246,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54728",105.06018188787,0.539948804787949,0.167771747386098,3.21835358575213,0.0012892877496087,0.0496706092992246,11648,15301,"sp|P08548|LIN1_NYCCO","P08548","LIN1",9.01e-13,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g74991",2388.74138277555,0.620598713331305,0.19276789785367,3.21940904186443,0.00128455105803346,0.0496706092992246,0,654,"sp|P52174|NDKA1_BOVIN","P52174","NDKA1",3.6e-15,"Nucleoside diphosphate kinase A 1 (NDK A 1) (NDP kinase A 1) (EC 2.7.4.6) (Nucleoside diphosphate kinase NBR-A) (NDK NBR-A)","cell differentiation [GO:0030154]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; nervous system development [GO:0007399]; UTP biosynthetic process [GO:0006228]","GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006183; GO:0006228; GO:0006241; GO:0006897; GO:0007399; GO:0030154; GO:0046872"
"g84387",21.3555891899562,0.52095723514869,0.161875374988039,3.21826117892968,0.00128970322090847,0.0496706092992246,0,8455,"sp|P21328|RTJK_DROME","P21328","RTJK",2.33e-29,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g91341",62.1541572889063,0.902915699651438,0.280536342145534,3.21853380116803,0.00128847783653509,0.0496706092992246,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94674",121.779738412673,0.937627987921395,0.291440637202711,3.21721773916254,0.00129440322538629,0.0496706092992246,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120176",185.458329895817,0.527886806336432,0.164007253855396,3.21867962499918,0.00128782282777806,0.0496706092992246,0,3381,"sp|Q5ZIA5|COPB_CHICK","Q5ZIA5","COPB",1.18e-21,"Coatomer subunit beta (Beta-coat protein) (Beta-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]","GO:0000139; GO:0005198; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0030126"
"g124341",23.0427375207916,-1.28877706321165,0.40048503796111,-3.21804047854791,0.00129069601433246,0.0496706092992246,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124584",22.7706349136052,1.06158886582682,0.329973135926271,3.21719785717349,0.00129449293385419,0.0496706092992246,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126092",445.519833162385,0.345052400079459,0.107234426823813,3.21773902560586,0.00129205320296611,0.0496706092992246,1012,3014,"sp|Q8MKK4|TRE12_DROME","Q8MKK4","TRE12",2.23e-94,"Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2)",NA,"GO:0005886; GO:0016020; GO:0016021; GO:0051119"
"g129080",699.411332855635,0.438879755742228,0.136366658914655,3.21838020550831,0.00128916808716103,0.0496706092992246,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139361",29.0369942028012,-0.522640845373103,0.162436246579819,-3.2175136792285,0.00129306860808894,0.0496706092992246,0,2650,"sp|Q5RBN1|FND3A_PONAB","Q5RBN1","FND3A",1.28e-13,"Fibronectin type-III domain-containing protein 3A",NA,"GO:0000139; GO:0016021"
"g141887",11934.5911209372,0.451452634912955,0.140326900475196,3.21714962266094,0.0012947105940874,0.0496706092992246,0,2014,"sp|Q56FH2|RS4_LYSTE","Q56FH2","RS4",2.58e-42,"40S ribosomal protein S4","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412; GO:0019843"
"g159355",31.6830498175194,1.31272284149836,0.40814923043886,3.21628155487851,0.00129863356461031,0.0497871499255713,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2789",361.306130369106,0.643453138251402,0.200102143393715,3.21562341781298,0.00130161512515052,0.0498674644882259,41660,51044,"sp|P23438|SSRB_CANLF","P23438","SSRB",2.61e-12,"Translocon-associated protein subunit beta (TRAP-beta) (Glycoprotein 25H) (gp25H) (Signal sequence receptor subunit beta) (SSR-beta)","in utero embryonic development [GO:0001701]","GO:0001701; GO:0005789; GO:0016021"
"g104176",1903.76398665362,-0.273035982381488,0.0849147935219433,-3.21541124999535,0.00130257765553665,0.0498703693006756,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31304",81.4865612297034,2.13476219831536,0.664061393402502,3.21470607917336,0.00130578148821977,0.049959022081943,NA,NA,NA,NA,NA,NA,NA,NA,NA
